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Abstract 
 
 
Nowadays, arterial stiffness assumes special importance as the result of being a marker 
of cardiovascular diseases (CVD), which are the leading cause of disability and worldwide. The 
development of diagnostic tools capable of performing an early and precise quantification of 
pathologic states such as arterial stiffness presents itself as a global strategy to reduce 
cardiovascular (CV) morbidity and mortality. 
 
A non – invasive (PZ) technology for arterial distension waveform (ADW) monitoring 
in the carotid artery has been successfully developed and tested in the past few years. This 
piezoelectric (PZ) device allows the extraction of clinically important information concerning 
arterial stiffness, presenting itself as a practical solution in premature CV risk assessment. 
 
This project consisted not only in the first clinical trials of the previously developed 
device with the performance of repeatability tests, but also in the application of innovative data 
mining tools such as classification and clustering approaches, with the objective of developing 
innovate decision support systems for CV risk estimation. Finally, a case study was also carried 
out in patients that suffered from severe stenosis to prove the usefulness of this technology. 
 
Excellent repeatability results between trials were obtained. Furthermore, the ability to 
detect physiological variations after surgical procedures has demonstrated the clinical feasibility 
of this equipment. Data mining methodologies have also shown their effectiveness in premature 
CV risk determination. 
 
Keywords: Arterial Stiffness, Arterial Distension Waveform, Piezoelectric Sensor, 
Clinical Trials Data Mining. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
v 
 
  
 
Resumo 
 
 
Atualmente, a rigidez arterial assume especial importância pelo facto de ser um 
marcador de doenças cardiovasculares, que são a principal causa de incapacidade e morte no 
mundo. O desenvolvimento de ferramentas de diagnóstico que são capazes de realizar uma 
quantificação exata e prematura de estados patológicos como a rigidez arterial apresenta-se 
como uma estratégia global para reduzir a morbidade e mortalidade cardiovascular. 
 
Com o intuito de monitorizar a onda de distensão arterial na carótida, uma tecnologia 
não – invasiva foi desenvolvida e testada com sucesso durante os últimos anos. Esteve 
dispositivo piezoelétrico permite a extração de informações clinicamente importantes sobre a 
rigidez arterial, apresentando-se como uma solução prática na avaliação do risco cardiovascular 
prematuro. 
 
Este projeto consistiu não só no início dos primeiros testes clínicos do dispositivo 
previamente desenvolvido com a realização de testes de repetibilidade, mas também na 
aplicação de ferramentas inovadoras de mineração de dados através de abordagens 
classificativas e de agrupamento. Por último, um caso de estudo foi realizado em doentes com 
estenose severa de forma a provar a utilidade desta tecnologia. 
 
Foram obtidos excelentes resultados em termos da repetibilidade entre ensaios 
consecutivos. Além disso, a capacidade de detetar variações fisiológicas após procedimentos 
cirúrgicos demonstrou a aplicabilidade clínica deste equipamento. As metodologias de 
mineração de dados também mostraram a sua eficácia na determinação prematura de risco 
cardiovascular. 
 
Palavras – Chave: Rigidez Arterial, Onda de Distensão Arterial, Sensor Piezoelétrico, 
Ensaios Clínicos, Mineração de Dados. 
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Figure 1.1 – Distribution of major causes of death in the world according to a 2008 report from WHO [1]; 
1. Introduction 
 
 
“The best way to predict the future is to invent it” 
- Alan Kay 
 
 
1.1 Motivation 
 
According to World Health Organization (WHO), cardiovascular diseases (CVD) 
represent 31% of all global deaths, making them the leading cause of death and disability 
worldwide (Figure 1.1). In 2008, 17.3 million people died because of CVD. Moreover, it has 
been revealed that CVD mortality had increased at an impressive fast rate in low- and middle- 
income countries during the past twenty years. The global strategies to reduce incidence, 
morbidity and mortality of CVD comprise an efficient identification and reduction of CVD risk 
factors and their determinants and the elaboration of moderate-cost diagnostic tools that can be 
used in early stages of CVD development [1]. 
 
 
Current investigations are focused on non-invasive measures of arterial function, which 
are associated with and are prognostic of CVD in the general adult and elderly population [2-5]. 
The presumption that arterial stiffness is a marker of cardiovascular (CV) events has gained 
support over the last years due to repeated demonstration of its predictive value for myocardial 
infarction, stroke and CV death [6-9]. Therefore, it is believed that early quantification of 
arterial stiffness can ultimately reduce CV morbidity and mortality.  
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Much interest has been paid to the arterial distension waveform (ADW), which contains 
a vast amount of pathophysiological information hidden in its morphology, and since it is 
possible to non – invasively extract ADW parameters that reveal important clinical information 
concerning arterial stiffness, the development of efficient non – invasive ADW acquisition 
modules gained significant relevance. Among diverse non – invasive acquisition techniques, the 
use of piezoelectric (PZ) sensors in ADW measurements has been reported by several authors as 
having a good performance, as result of their high sensitivity and high signal-to-noise ratio 
(SNR) [10-12]. Previous established developments have contributed for a non – invasive 
acquisition device that can be a convenient and suitable solution to assess the hemodynamic 
condition [13, 14]. 
 
The analysis and exploration of large databases is an important issue in the development 
of subsequent algorithms and devices. Therefore, it is critical to expand a database which 
contains subjects not only with cardiac pathologies, but healthy subjects, as well. To 
successfully test and validate this non – invasive acquisition device, clinical validation is of 
crucial importance. Repeatability tests must be performed [15], and so, it is necessary to collect 
a significant number of subjects with and without CVD to determine the precision of a specific 
method. Nowadays, the Bland – Altman method is a respected and efficient “gold – standard” 
for repeatability assessment [16]. 
 
On other hand, with the recent emergence of computer – aided diagnosis technologies, 
new insights for the development of innovative methods for health professional assistance were 
uncovered. By recognizing relationships and patterns in huge amounts of database, data mining 
techniques can be decisive in discovering new biomedical and healthcare knowledge for clinical 
and administrative decision making. In other words, it is expected from data mining techniques 
their becoming as the keystone of future healthcare decision support systems [17-20].  
 
1.2 Previous work 
 
The present work is a continuity project with the ultimate objective of developing a 
highly functional non-invasive device that is capable of efficiently describing and evaluating the 
CV condition. 
The work that fully motivated the use of alternative instrumental methods for non – 
invasive hemodynamic characterization was Pereira’s MsC dissertation, which was based on the 
use of accelerometery concepts for pulse wave velocity (PWV) assessment [21]. Almeida’s and 
Pereira’s MsC dissertations [22, 23] focused in the use and development of PZ sensors for 
ADW acquisition, and also contributed with the development of algorithms capable of rendering 
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information about hemodynamic parameters. Afterwards, important hardware, firmware and 
software advancements were accomplished [13, 14], and more recently, Vieira’s MsC 
dissertation constructed a database and improved ADW signal processing routines even further 
[24, 25]. A preliminary data mining approach was also performed, and proved that data mining 
classification techniques are an interesting tool in the study of arterial stiffness related patterns. 
[26]. 
 
1.3 Objectives 
 
After considering the previous accomplishments, the proposed objectives for this work 
are: 
 Database expansion of the number of subjects in the database. 
 The validation of the previously developed ADW acquisition device using 
repeatability measures. Clinical trials will be performed to assess the 
repeatability of the previously developed non – invasive system between trials, 
between left and right carotid artery and between two successive months. Some 
of the clinical trials will be performed in collaboration with the Centro 
Hospitalar e Universitário de Coimbra. 
 The use of data mining techniques as innovative decision support systems 
regarding CVD, which includes: 
o Classification techniques, for the development of diagnostic procedures to 
determine the CV condition of an undiagnosed subject. Focus will be given 
to artificial neural network (ANN) classifiers, since they were not used in 
previous works, and already revealed themselves as very effective in the 
CVD context. [27-31]. A multiple classifier methodology that is mainly 
based in the method of Gorunescu et al. (2011) [32] will be tested as an 
innovative diagnostic tool. 
o Clustering techniques, to find and distinguish different risk groups in terms 
of future CVD development in a healthy dataset. Shah et al. (2008) [20] 
hypothesized that categorizing a youth based dataset into low- and high – 
risk groups can be a simple and effective tool for evaluating the risk of 
developing CVD in young adults. 
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1.4 Project team composition 
 
This work was developed at Grupo de Electrónica e Instrumentação (GEI), one of the 
research groups of Centro de Instrumentação (CI) of the University of Coimbra (UC). GEI is 
especially dedicated to the study and development of instrumentation and dedicated software for 
biomedical and physics applications, in close partnership with Intelligent Sensing Anywhere 
(ISA). 
Table 1.1 shows an overview of the main contributors of this project and their 
associated staff and students. 
 
 
1.5 Contents by chapter 
 
This dissertation is divided in eight chapters, excluding the references. In the first 
chapter (Introduction), the motivation of this thesis, its main contributions and the project team 
composition are introduced.  Lastly, the chapter-by-chapter structure of the thesis is briefly 
explained. 
In the second chapter (Theoretical Background), the main physiological concepts 
behind this dissertation are presented, with a special focus in defining arterial stiffness and its 
determinant factors in the development of CVD. Distinctive methods for non – invasive arterial 
stiffness assessment are also described, and the angioplasty procedure is detailed as well. 
The third chapter (Clinical Trials – Repeatability) approaches on how to evaluate the 
inherent precision of an equipment using general descriptive statistics, correlation techniques, 
and the Bland – Altman method. Some important studies related with the repeatability of non – 
invasive CV assessment are described in the last sub – chapter. 
The fourth chapter (Data Mining) focuses in introducing data mining and its 
importance in the new century. Data pre – processing, data classification and data clustering 
compose the other sub – chapters, and are rigorously described. 
Team Members Contribution or main area of research 
PhD Professor Carlos M. B. A. Correia 
Scientific and technical advisors 
PhD João Manuel Rendeiro Cardoso 
PhD Student Vânia Maria Gomes de Almeida 
 
Scientific and technical supervisor / Study of 
hemodynamic parameters 
MsC Student João Manuel de Olim Perestrelo 
Borba 
Student responsible for the development of the project 
Table 1.1 – Project team members; 
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Table 1.2 – Gantt diagram of the project tasks; 
In the fifth chapter (Hardware & Software), the state of art of all the hardware and 
software that were previously developed is summarily described. Graphical user interface (GUI) 
improvements are also referred. 
The sixth chapter (Methodology) centers on the work – oriented methodology, in other 
words, all the procedures to obtain results are fully described, including data acquisition and 
data pre – processing setups, feature selection and database characterization. The creation and 
development of a Bland – Altman GUI is another point of interest. Four different datasets, as 
each dataset will be used for a specific study. Dataset I is used for assessing the repeatability of 
the non – invasive system, dataset II is used for a case study with the objective of proving the 
efficiency of the PZ probe in detecting physiological changes between two different conditions. 
Dataset III and dataset IV focuses on data mining methodologies (classification and clustering, 
respectively). 
In the seventh chapter (Results & Discussion), all the obtained results are presented 
and discussed for each of the datasets. In the final sub – section of each dataset, results are 
extensively discussed. 
In the eighth and final chapter (Conclusion & Future Work), conclusions are assessed 
from the developed work, and the main contributions are correlated with the initially proposed 
objectives. Various suggestions and guidelines for a possible future work are presented. 
 
 
 
 
Id Task Name Start Finish
2011
Dez MaiOut JunMarFevSet AgoNov AbrJan Jul
1 16-12-201112-09-2011State of the art review
2 16-12-201126-09-2011Elementary repeatability measurements
5 16-01-201202-01-2012
Writing of paper I – “Validation of a 
waveform delineator for cardiac studies: 
repeatability and data mining analysis”
17 31-08-2012202-07-2012Thesis writing
6
2012
3 02-12-201121-11-2011Dataset II arrangement
4 16-12-201102-12-2011
Data processing and statistical analysis for 
elementary repeatability measurements
17-02-201219-01-2012
Data mining: classification procedures 
(dataset II)
7
8
9
11
12
23-02-201220-02-2012
Poster for 2nd National Meeting of 
Biomedical Engineering
23-03-201227-02-2012Final repeatability measurements (dataset I)
30-03-201216-03-2012First massive data acquisition (dataset III)
10 17-04-201209-04-2012Development of the Bland – Altman GUI
04-05-201218-04-2012
Data processing and statistical analysis for 
final repeatability measurements (dataset I)
13
14
04-05-201230-04-2012Second massive data acquisition (dataset III)
01-06-201214-05-2012
Data mining: clustering procedures (dataset 
III)
06-06-201204-06-2012Preliminary project presentation
15 29-06-201211-06-2012
Writing of paper II – “Indices and 
Repeatability Tests of Cardiovascular 
Function Performed on the Arterial 
Distension Waveform – Case study: 
Angiography Intervention”
16 29-06-201211-06-2012
Writing of paper III – “Data Mining Based 
Methodologies for Cardiac Risk Patterns 
Identification”
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2. Theoretical Background 
 
  
In this chapter, the main physiological concepts of this thesis are discussed. An 
overview of the CV system and the role of arterial stiffness in the development of CVD are 
given, and several methods and indexes for non – invasive assessment of arterial stiffness are 
explained. The angioplasty procedure is also detailed. 
 
  
2.1 Cardiovascular system 
 
The human physiology possesses an effective CV system, which uses blood as a 
working fluid, and consists of the heart, arteries, veins, capillaries and lymphatic vessels. The 
CV system has three important functions [33]: 
 Supply oxygen and nutrients to body tissues 
 Remove carbon dioxide and other wastes from the body 
 Regulate temperature 
 
2.1.1 The heart 
The heart is a vital organ of our physiological system, anatomically located between the 
third and sixth ribs in the central portion of the thoracic cavity. But actually, the heart is 
composed by two detached pumps, separated by a tough muscular wall (interventricular 
septum): a right heart, which pumps blood through the lungs, and a left heart that pumps blood 
through the peripheral organs. Each heart is a pulsatile two – chamber pump, composed of an 
atrium and a ventricle. Each atrium is an essential pump that moves blood into the ventricle. 
The ventricles provide the major source of power that propels the blood through the pulmonary 
circulation (right ventricle) or through the systemic circulation (left ventricle) [34]. Check 
valves between each set of upper and lower chambers ensures that the blood moves in only one 
direction and enables the pressure in the aorta to be much higher than the pressure in the lungs. 
This restricts the blood from flowing backwards [34]. A structure of the heart and the course of 
the blood flow through the heart’s chambers can be found on figure 2.1. 
The pressure values differ between the left pump and the right pump. Because of the 
anatomic proximity of the heart to the lungs, the right side of the heart does not have to work 
very hard to drive blood through the pulmonary circulation, so it functions at a low – pressure 
(< 40 mmHg gauge). In contrast, the left side of the heart does most of its work at a high 
pressure value (up to 140 mHg gauge or more) to drive blood through the whole systemic 
circulation [33, 34]. 
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2.1.2. Common carotid artery 
The left and right common carotid arteries provide the major source of blood to the 
head, neck and brain. Both the right and left common carotid arteries branch into internal and 
external carotid arteries. The internal carotid artery supplies oxygenated blood to the brain and 
eyes, while the external carotid artery provides oxygenated blood to the throat, neck glands, 
face, scalp, mouth and tongue. Both left and right common carotid arteries differ with respect to 
their origins. In the left common carotid, the artery comes directly from the arch of the aorta in 
the superior mediastinum. The right common carotid artery arises from the brachiocephalic 
artery as it passes behind the sternoclavicular joint [34, 35]. 
 
2.2 Arterial stiffness 
 
Arterial stiffness measures the rigidity in the arterial wall or, in other words, the arteries 
capacity of expanding and contracting during the cardiac cycle [4]. Nowadays, there is a 
scientific consensus regarding the importance of arterial stiffness in the development of CVD, 
being the most important parameter of increasing systolic and pulse pressure (PP) [4, 6]. 
 
2.2.1 Arterial structure 
All the arteries are composed of three main layers: intima, media and externa (Figure 
2.2). The intima is the innermost layer, a single layer of endothelial cells and associated 
Figure 2.1 – Structure of the heart and the course of the blood flow. 
From [34]; 
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connective tissue. The middle layer is the media, and is composed of a specific amount of 
elastic and smooth muscle fibers, which varies depending on the size and location of the artery 
in the arterial tree. The outer layer is the externa (or adventitia), which serves as a connective 
tissue is largely composed of collagen fibers [36, 37]. 
 
 
 
 
 
2.2.2 Arterial stiffness mechanisms 
The most accepted model of the arterial tree is the propagative model, which consists of 
a viscoelastic tube whose distributed elastic properties permit generation of a forward pressure 
wave which travels along the tube and whose numerous branch points and high level of 
resistance of tube’s end generate reflected waves [38]. If we would just consider a viscoelastic 
tube without reflection sites, the pressure wave would be progressively attenuated, with an 
exponential decay along the tube. In contrast, a pressure wave that propagates along a 
viscoelastic tube with numerous branches is progressively amplified due to wave reflections, 
from central to distal conduit arteries. Because of this, the amplitude of the pressure wave is 
higher in peripheral arteries than in central arteries. Therefore, it is not accurate to use brachial 
(upper arm artery) PP as a perfect substitute for aortic or carotid PP, especially in younger 
subjects [6]. 
 
2.2.3 Proximal and distal arterial stiffness 
The elastic properties of conduit arteries vary along the arterial tree. Proximal arteries 
are more elastic and, in contrast, distal arteries are stiffer. The elasticity of the proximal large 
arteries is the result of the high elastin to collagen ratio in their walls, which progressively 
declines toward the periphery (Figure 2.3). 
Figure 2.2 – Representation of the arterial structure components: intima, 
media and externa. Adapted from [5]; 
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Table 2.1 – Pathophysiological conditions that affect arterial stiffness. Adapted from [6]; 
µ
µ
 
 
 
 
2.2.4 Associated pathophysiological conditions 
Various reversible and irreversible pathophysiological conditions are associated with an 
increase in arterial stiffness. Those conditions are expressed on Table 2.1. 
 
 
Aging CV risk factors CV diseases 
Other physiological conditions Obesity Coronary heart disease 
Low birth weight Smoking Congestive heart failure 
Menopausal status Hypertension Fatal stroke 
Lack of physical activity Hypercholesterolaemia Primarily non – CV diseases 
Genetic background Impaired glucose tolerance End – stage renal disease 
Parental history of hypertension Metabolic syndrome Moderate chronic kidney disease 
Parental history of diabetes Diabetes type 1 and 2 Rheumatoid arthritis 
Parental history of myocardial infarction Hyperhomocyteinaemia Systemic vasculitis 
Genetic polymorphisms High C – Reactive Protein (CRP) Systemic lupus erythematosus 
Figure 2.3 – Comparison of different arterial vessel types, 
regarding their average lumen diameter, wall thickness, 
and relative tissue makeup. Adapted from [37]; 
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2.2.4.1 Aging 
Age is the most important determinant of arterial stiffness, as stiffening of large arteries 
is a consequence of the normal aging process. The aging process in the arterial tree is not 
homogeneous, as the elastic properties of distal (and more muscular) arteries change little with 
age.  
 
 
 
 
The main structural change with aging is medial degeneration, which leads to 
progressive stiffening of large elastic arteries. Longstanding arterial pulsation in the central 
artery has a direct effect on the structural matrix proteins, collagen and elastin in the arterial 
wall, disrupting muscular attachments and causing elastin filaments to fatigue and fracture. 
Other main causes include changes in the vascular smooth muscle cells also mediate aging – 
associated vascular stiffness, endothelial dysfunction triggered by a decrease in anti - oxidative 
capacity and an increase in oxidative stress, accumulation of advanced glycation endproducts 
(AGE) on the proteins and calcium deposition in the arterial wall. Extrinsic factors that can 
eventually appear with advanced aging may also play a role [5]. 
 
 
 
 
 
 
Figure 2.4 – Causes of arterial aging in a common elastic artery. Adapted from [5]; 
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2.3 Arterial distension waveform 
 
Clinically relevant information can be found in the ADW morphology. Numerous 
methods for ADW acquisition and subsequent analysis are used nowadays, such as invasive 
catheterization and, more recently, non – invasive applanation tonometry.  
The ADW can be acquired at a central or peripheral level. The measurement at 
peripheral zones (such as radial, brachial or femoral artery) uses a transfer function to 
reconstruct aortic waveform which decreases the accuracy of data. In contrast, the measurement 
at the central artery surrogates the true load imposed to the left ventricle and central large artery 
walls. While it requires a higher degree of technical expertise, a transfer function is not 
necessary, thus increasing data precision. The central artery measurement is usually done in the 
carotid arteries, as they are very close to central artery, so their waveforms are equivalent [22]. 
 
2.3.1 ADW morphology 
Considering an acquisition at a central level, the ADW is composed by two main 
components: a forward incident wave, caused by left ventricular contraction and ejection of 
blood into the arterial tree; a backward reflected wave from the periphery that returns to the 
heart due to arterial tree branch points or sites of impedance mismatch [39].  
 
2.3.1.1 Incident wave 
The incident wave occurs due to the capacitive characteristics of the ascending aorta 
segment, after left ventricular blood ejection. Its characteristics depend largely on the left 
ventricular ejection and aorta stiffness [6, 39].  
 Usually, the incident wave has two points of interest that can be observed on the ADW. 
The first point is the systolic peak (SP), and corresponds to the highest pressure value of the 
ADW. The other zone of interest is the incisura (also known as dicrotic wave – DW), which 
corresponds to an increase of the aortic pressure along the ascending aorta after the closure of 
the aortic valve. The incisura phenomenon can be used to obtain systolic duration [40]. 
  
2.3.1.2 Reflected wave 
The characteristics of the backward reflected wave are influenced by reflections 
coefficients values, sites of reflection points and elastic properties of the arterial tree [39]. 
On an ADW, a point of inflection (PI) that directly corresponds to the backward 
reflected wave can usually be observed (except in one case, more on that on the following sub - 
chapter 2.3.2). 
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2.3.2 ADW types 
According to Murgo et al. (1986) [41], four types of ADW can be described (Figure 
2.5), and the determinant criterion for wave classification is the location of the reflected wave.  
 
 
 
 
 
2.4 Non – invasive assessment of arterial stiffness  
 
Several hemodynamic parameters can be used to assess arterial stiffness. All require 
information about simultaneous change in arterial size and arterial pressure in order to quantify 
the change in arterial stiffness. 
 
2.4.1 Pulse pressure (PP) 
PP is the difference between systolic blood pressure (SBP) and diastolic blood pressure 
(DBP). It is considered as a valuable surrogate marker of arterial stiffness as it depends on 
cardiac output, large artery stiffness, and wave reflections [36]. A high PP is often a marker that 
the heart is working harder than the usual to maintain a homeostatic circulation. PP is also 
Figure 2.5 – APW classification according to Murgo et al (1989) [41]. SP represents the systolic peak, PI is the 
point of inflection and DW is the dicrotic wave; 
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known to increase with age [36]. Usually, most PP measures are made from the brachial artery 
using an oscillometric sphygmomanometer.  
PP measurement is very used in clinical setting due to being a very simple and relatively 
efficient technique. However, PP measurements do not consider changes in volume, and 
therefore are not true measures of arterial stiffness. Another problem is the amplification of the 
pressure wave in the periphery [22]. 
 
2.4.2 Arterial compliance and distensibility 
Arterial compliance (C) is defined as the change in volume for a given change in 
pressure and arterial distensibility (D) is the compliance divided by the initial volume: 
   
  
  
     
(2.1) 
 
   
  
    
 
(2.2) 
 
With PP being the pulse pressure and ∆A being the pulse cross – sectional area (∆A = As 
- Ad), with A being the systolic cross-section area and Ad being the diastolic cross-section area.  
Arterial compliance and arterial distensibility can be registered by magnetic resonance 
imaging (MRI), which records the maximum and minimum arterial diameter. The ultrasound 
technique has the advantage of being non-invasive, but the equipment is costly and hard to 
expertise [22]. 
 
2.4.3 Pulse wave velocity (PWV) 
PWV is the speed at which the ADW generated by cardiac contraction travels from the 
aorta through the arterial tree. Studies have showed that PWV is an independent predictor of 
CVD while associated with diverse pathophysiological conditions [42].  
PWV is measured using applanation tonometry such as the Complior (Colson, Paris, 
France) and the SphygmoCor (ArtCor, Sydney, Australia). Even though several different 
measurement sites can be found in the literature, carotid – femoral is the most common pathway 
to evaluate regional arterial stiffness. Carotid – femoral PWV is also considered by many as the 
“gold – standard” non-invasive measurement of arterial stiffness [6, 36]. The transit time is 
measured by two applanation tonometers placed over the peripheral pulse, and the distance 
between them is estimated by direct superficial measurement, as expressed in the following 
equation: 
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 (2.3) 
 
However, PWV estimation can be quite inaccurate unless the artery between the two 
pulses is in a straight line. Also, it can be particularly difficult to assess PWV in obese patients 
[24, 27]. 
According to Moens and Korteweg (1878) [43], the relationship between arterial 
stiffness and PWV can be described by the following equation: 
     √
      
   
 
(2.4) 
 
Where E is the elastic modulus of the vessel wall, h is the wall thickness, r is the vessel 
radius and   is the blood density (approximately 1.05). It is assumed that there is insignificant 
change in vessel area. This equation can be alternatively expressed, according to Bramwell and 
Will (1922) [44] by the following: 
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(2.5) 
 
Where P is the pressure, V is the volume,   is the blood density, D is the volume 
distensibility of the arterial segment and dP . V / dV represents volume elasticity. 
 
2.4.4 Augmentation index (AIx) 
The augmentation index (AIx) measures the strength of the reflected wave relative to 
the total ADW, and is defined as the difference between the second and first peaks 
(augmentation pressure) expressed as a ratio or percentage of the PP (Figure 2.6) [6, 22]. In this 
work, we always considered the AIx expressed as a percentage. AIx has been indicated as a 
surrogate measure of arterial stiffness and, consequently, a marker of CV risk [45]. AIx is also 
known to increase with aging [46, 47]. 
 
The general equation to determine AIx is the following: 
 
     
  
  
  
      
  
 (2.6) 
 
Where AP is the augmentation pressure, PP is the pulse pressure, and P1 is the first 
pressure peak and P2 is the second pressure peak.  
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Table 2.2 – Classification of the different APW according to the inflection point position and AIx calculus. Ps is the 
systolic pressure, Pi is the pressure in the inflection point, and PP is the pulse pressure. Adapted from [27]; 
 
 
 
The key point to determine AIx is to identify the inflection point. Depending on the 
location of the reflected wave in the ADW, the first pressure peak can be a reflection point or a 
systolic point and, consequently, the second pressure peak will be a systolic point or a reflection 
point, respectively. Table 2.2 explains the differences in AIx calculus and what it could indicate 
regarding arterial stiffness. As a note of attention, in the following table, P1 and P2 were 
substituted for Ps (systolic pressure) and Pi (pressure at PI or augmentation pressure). 
 
 
 
 
* As the inflection point cannot be acknowledged, AIx cannot be calculated. 
 
 
ADW Type ADW Properties AIx calculus 
A 
The inflection point occurs before the systolic peak. 
The AIx is positive, and indicates high arterial 
stiffness. 
      
  
      
B 
The inflection point occurs shortly before the systolic 
peak, indicating small arterial stiffness. 
      
  
      
C 
The inflection point occurs after the systolic peak. The 
AIx value is negative, and indicates an elastic and 
healthy artery. 
      
  
      
D 
The inflection point cannot be recognized because the 
reflected wave arrives in early systole and merges with 
the incident wave. 
* 
Figure 2.6 – Augmentation pressure as the difference between the systolic pressure and the 
inflection point pressure. From [6]; 
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Table 2.3 – AIx reference values for the Korean 
population, according to Chung et al. (2010) [47];   
While AIx non – invasive assessment is a very efficient manner of determining local 
arterial stiffness, it has some minor limitations, including erroneous results when the inflection 
point is not well identified and the direct influence of blood pressure and heart rate (HR) in AIx, 
so they must be assessed when measuring AIx [6, 36] 
 
2.4.4.1 Reference values 
Few studies regarding AIx reference values can be found in the literature, due to the 
concept’s recent emergence in the scientific community and the inherent difficulty in acquiring 
a huge sample from the population.  
Janner et. al. (2010) [46] studied 4561 subjects from The Copenhagen City Heart Study, 
and calculated reference values of AIx measured by the SphygmoCor. Internally validated AIx 
reference equations considering age, HR and height were reported for both men and women:  
 
               (   )       (    )       (  )       (      )  (2.7) 
               (   )       (    )       (  )       (      )  (2.8) 
  
Chung et al. (2010) [47] recruited 522 subjects with a mean age of 46.3 years, and 
measured central and peripheral AIx. They divided their sample in four groups according to 
decade of age, and concluded the following mean central AIx values in the Korean population: 
 
 
 
 
 
 
 
 
 
 
 
Both studies also assessed that women present higher Aix values than men [46, 47]. 
 
2.4.4.2 PWV comparison 
Comparisons between AIx and PWV (“gold – standard” method for arterial stiffness 
measurement) have also been reported. Wimmer et al. (2007) [48] reported a medium 
association between ideal PWV and HR – adjusted AIx (r = 0.371) in chronic kidney disease. 
Higher associations in women (r = 0.423) relatively to men (r = 0.361) are also documented. 
Data from a large cohort of healthy individuals in the Anglo – Cardiff Collaborative Trial 
Age range (years) Mean AIx (%) 
≤ 39 23.4 
40 – 49 28.9 
50 - 59 29.7 
≥ 60 34.1 
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(ACCT) showed that central AIx might be a more sensitive marker of arterial aging in young 
and middle – age individuals (< 50 years) and aortic PWV is more sensitive in the older 
population (> 50 years) [49]. 
 
2.5 Angioplasty with stent placement  
 
Both carotid arteries deliver the required blood for the brain. Sometimes, the blood flow 
in a carotid artery can become partly blocked due to an artery narrowing (stenosis), increasing 
the risk of a stroke in short – term. One of the “gold – standard” invasive procedures to treat a 
narrow or blocked carotid artery is the angioplasty with stent placement. 
In this surgical procedure, live angiography is usually the imaging method of choice to 
visualize the blood vessels. After local anesthesia, a surgical cut is executed next to the groin, 
and after a filter device is opened above the lesion, the stent is implanted. The balloon is then 
inflated at the stenosis plaque level, decreasing the stenosis after deflation, and the filter device 
is kept open as prevention for an eventual embolic trapping. With this surgical technique, the 
blood flow was restored to the normal values since the diameter of the vessel enlarged to the 
same imposed by the stent [50].  
This procedure reduces patient discomfort and post - procedure complications, as it has 
the theoretic advantage of decreasing the risk of vessel recoil and recurrent stenosis [50]. 
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3. Clinical Trials - Repeatability 
 
 
It is important to evaluate the inherent precision of an equipment before proceeding 
into an advanced clinical validation. This chapter defines the term repeatability and focus on 
how to assess repeatability with the help of descriptive statistics, correlations techniques and 
the Bland – Altman method. 
 
 
3.1 Repeatability 
 
Repeatability can be understood as the variability of measurements obtained by one 
person while measuring the same item repeatedly. In other words, repeatability is the inherent 
precision of the measurement device [51]. Considering the two probability density functions 
(Figure 3.1), with two different measurements (A and B), the density functions demonstrate that 
measurement B is more repeatable than measurement A. 
 
 
 
 
The best way to examine and assess repeatability is to take repeated measurements on a 
series of subjects. According to the Guidelines for Evaluating and Expressing the Uncertainty of 
National Institute of Standards and Technology (NIST) Measurement Results [52], the 
following conditions need to be fulfilled in the establishment of repeatability: 
 
 
Figure 3.1 – Probability density function between two measurements 
(A and B). Adapted from [50]; 
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 The same measurement procedure; 
 The same observer; 
 The same measuring instrument, used under the same conditions; 
 The same location; 
 Repetition over a short period of time; 
 
3.2 Descriptive statistical analysis 
 
Before assessing the repeatability of a specific equipment, it is important to know how 
is the data. And so, the first step in assessing repeatability is to “know” the data we have at our 
disposal using statistical methods. 
 
3.2.1 Normality assessment 
A normal distribution is used to describe a symmetrical, bell – shaped curve, which has 
the greatest frequency of scores in the middle, while the smaller frequencies lay in the extremes 
(Figure 3.2) [53, 54]. A non – normal distribution is visualized when the normal distribution 
definition isn’t fully respected. Usually, a non – normal distribution can be acknowledged when 
we have a non – symmetrical distribution, with higher extremes frequencies than in the usual 
normal distribution [53, 54]. 
Before any data analysis, it is important to check if the variables in the set of data have a 
normal or non – normal continuous distribution. This normality assessment of the variables in 
our dataset should always be considered, as some tests are risky for non – normal data. The best 
quantitative way to assess normality in continuous data is to apply the Kolmogorov – Smirnov 
(KS) one – sample test, where the maximum difference between the sample cumulative 
distribution and the hypothesized cumulative distribution are compared [55]. 
 
3.2.2 Central tendency measurement 
The most common and effective central tendency numeric measure is the arithmetic 
mean, which is the sum of the values that compose variable divided by the size of the collection. 
However, the mean is not always the best way of measuring the center of the data, due to its 
sensitivity to outlier (e.g. extreme) values. Even a small number of extreme values can corrupt 
the mean. This effect can be counterbalanced by using the trimmed mean, which involves the 
calculation of the mean after chopping off a small percentage of the highest and smallest values. 
However, we should know that trimming too large portions (such as 20 percent) at both ends 
can result in a loss of important information [56]. 
When we are dealing with non – symmetric data, a better measure of the center of data 
is the median. In a dataset of N distinct values, sorted in numeric order, if N is odd, then the 
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median is the middle value of the numeric ordered set. If N is even, the median is the average of 
the middle two values [56]. 
 
3.2.3 Data dispersion measurement 
 The degree to which numeric data tends to spread is the dispersion, or variance of the 
data. Standard deviation (SD) is the most common dispersion measure and shows how much 
variation exists from the average. A low SD indicates that the data points are very close to the 
mean, while high SD values indicates that the data points are spread out over a large range of 
values [56]. 
 The k
th
 percentile of a set of data in numeric order is the value xi having the property 
that k percent of the data entries lies at or below xi. Quartiles are another type of commonly used 
percentiles. The first quartile (Q1) is the 25
th
 percentile; the third quartile (Q3) is the 75
th
 
percentile. One must also perceive that the median of a set of data is equivalent to the 50
th
 
percentile and second quartile (Q2) [56]. The distance between the first and third quartiles is a 
simple measure of spread that gives the range covered by the middle half of the data. This 
distance is the interquartile range (IQR) and is defined as: 
 
           (3.1) 
 
A common rule of thumb for identifying suspected outliers is to single out values falling 
at least 1.5 × IQR below the first quartile or above the third quartile, while extreme values fall at 
least 3 × IQR below the first quartile or above the third quartile.  
The full quantitative summary of the shape of a distribution is often known as the five – 
number summary of a distribution, which consists of the median, Q1, Q3 and the minimum and 
maximum values of the distribution. Those quantitative measure are then, placed in order: 
minimum, Q1, median, Q3, maximum [53, 56]. 
 
3.2.3.1 Boxplot 
The five – number summary can also be expressed graphically by a boxplot (also 
known as box-and-whisker diagram), which is one of the most popular ways of visualizing 
distributions and comparing sets of compatible data (Figure 3.2). The ends of the box are at the 
quartiles, so that the box length is the IQR. The median is marked by a line within the box, and 
the superior and inferior lines are the whiskers. The whiskers are extended to the extreme low 
and high observations only if these values are less than 1.5 × IQR beyond the quartiles. 
Otherwise, the whiskers end at the most extreme observations occurring within 1.5 × IQR of the 
quartiles and every value outside that range is considered as an outlier value and is represented 
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with a dot. Values outside the 3 × IQR are considered as extreme values, and are represented 
with an ‘x’ mark on the boxplot figure [56]. 
 
 
 
 
 
3.3 Statistical tests for group comparison 
 
There is a whole family of statistical techniques that can be used to test for significant 
differences between groups, consequently testing different hypotheses. The most important 
parametric and non – parametric techniques for group comparison will be briefly covered on 
this section, with the main focus on how and when to use each technique. The techniques will 
not be described with further statistical detail, as it is beyond the scope of this dissertation. 
 
3.3.1 Null hypothesis 
The structure of hypothesis testing is formulated with the use of the term null 
hypothesis (H0) referring to any hypothesis that is wished to be tested. Usually, the analyst 
arrives at one of two possible conclusions: accept H0 or reject H0. The rejection of H0 leads to 
the acceptance of an alternative hypothesis (H1) [54].  
H0 is accepted or rejected based on the significance level (α), which is often 0.05, or 
0.01. The null hypothesis H0 is rejected when the p – value (estimated probability of rejecting 
H0 when the hypothesis is true) is lower than α. When the null hypothesis is rejected, the result 
is said to be statistically significant [53, 54]. 
 
 
Figure 3.2 – Representation of four boxplots with different dispersion levels. Outliers can be visualized 
as the dots outside the whiskers; 
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3.3.2 Type I and type II errors  
As the purpose of parametric and non – parametric tests is to test hypothesis, there is 
always the possibility of reaching the wrong conclusion. 
There are two types of errors that one can make. We may reject the null hypothesis 
when it is, in fact, true. In other words, we accept the hypothesis that there is a difference 
between our groups, but there is not. This is the type I error (or false positive (FP)). Although, 
we can also fail to reject the null hypothesis when it is, in fact, false (when the groups do not 
differ, when in fact they do), therefore occurring the type II error (or false negative (FN)). These 
two errors are inversely related. As we try to control for a type I error, we actually increase the 
likelihood of committing a type II error. One should always consider the power of a test and the 
sample size when evaluating the null hypothesis. We can also minimize the possibility of errors 
by choosing an appropriate p – value (usually .05/.01) [53, 55]. Figure 3.3 expresses the four 
possible outcomes of a hypothesis test. 
 
 
 
  
 
 
3.3.3 Parametric tests 
Parametric methods can produce more accurate and precise estimates, having high 
statistical power. However, before applying any parametric tests, one should have to consider 
some general assumptions. 
 
3.3.3.1 General assumptions 
General assumptions apply to all of the parametric techniques and should always be 
checked before applying any parametric test to avoid misleading results. One should know that 
even if the probability of having misleading results with a parametric test is higher with the 
Figure 3.3 – Representation of the possible outcomes that can occur 
while accepting or rejecting H0. Adapted from [54]; 
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violation of one or more of the following rules, it doesn’t exactly mean that the parametric test 
result is misleading [53]:  
 
 Normal distribution – As discussed in 3.2.1, it is important to assess data 
normality as some parametric tests are not usually applicable for non – normal 
data. Fortunately, most of the parametric techniques are reasonably robust, and 
so, with large sample sizes, the violation of this assumption doesn’t cause any 
major problem. 
 Continuous scale – Parametric approaches assume that the dependent variable 
is measured at the interval or ratio level, instead of using discrete categories. 
 Independence of observations – Each observation or measurement must not 
be influenced by any other observation or measurement. A violation of this 
assumption can be very serious, according to Stevens (1996) [57]. 
 Random sampling – The parametric techniques assume that the scores are 
obtained using a random sample from the population. This is often not the case 
in real – life research. 
 Homogeneity of variance – Parametric techniques make the assumption that 
samples are obtained from populations of equal variances. The Levene’s test for 
equality of variances must take a part in t-test and analysis of variance 
(ANOVA) techniques, even though these techniques are robust to violations of 
the homogeneity of variance. 
 
If the researcher is insecure or if one or more general assumptions were violated, the use 
of a non – parametric test must always be considered (more on that on sub – chapter 3.3.4). 
 
3.3.3.2 Independent-samples t-test 
The independent-samples t-test is used when you want to compare the mean scores of a 
continuous variable in two different groups of people or in two different conditions [53]. This 
test will reveal if there is a statistically significant difference in the mean scores for two 
different groups. 
 
3.3.3.3 One – way analysis of variance (ANOVA) 
ANOVA is commonly used when we are interested in comparing the mean scores of 
more than two groups. It compares the variability in scores between two different groups with 
the variability within each of the groups. An F ratio is calculated which represents the variance 
between the groups, divided by the variance within the groups. A large F ratio indicates that 
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Table 3.1 – Comparison between each parametric tests and their respective non – 
parametric alternative. Adapted from [53]; 
there is more variability between the groups (caused by the independent variable) than there is 
within each group (referred to as the error term) [53].  
There are two different types of one – way ANOVA [53]: 
 Between – groups ANOVA – used to compare different subjects or cases in 
each of the groups. 
 Repeated – measures ANOVA – used to compare differences between same 
subjects under different conditions, or measures at different points in time. Data 
needs to be paired for repeated – measures ANOVA to be used. 
 
3.3.4 Non – parametric tests 
As referred in the last sub – chapters, one should always be careful if any general 
assumptions were transgressed. If one or more general assumptions are violated, the parametric 
test results can be misleading, and therefore, a non – parametric approach should be considered. 
[53] Non – parametric tests don’t have such strict requirements, and don’t make assumptions 
about the underlying population distribution. However, they are less robust and sensitive, and 
may therefore fail to detect differences between groups that actually exist (or vice – versa) [58].  
Non – parametric techniques are also useful for data measured on nominal and ordinal 
scales and for very small samples [53]. 
 
3.3.4.1 Non – parametric alternatives to parametric tests 
Each parametric test has its non - parametric alternative, which is usually less robust. As 
described in 3.3.3, if one or more general assumptions are violated, one must consider the use of 
the non – parametric alternative that matches the unusable parametric test. In Table 3.1 you will 
find the parametric tests with the corresponding non – parametric surrogate. 
 
 
 
 
 
 
 
 
 
 
 
3.3.4.2 Mann – Whitney U test 
This technique is the non – parametric equivalent to the independent samples t-test and 
is used to test for differences between two independent groups on a continuous variable. 
However, instead of comparing the means, the Mann – Whitney U test compares the medians. It 
then converts the scores on the continuous variable to ranks across the two groups. It then 
Parametric test Non – parametric alternative 
Independent samples t – test Mann – Whitney U test 
One – way between groups ANOVA Kruskal – Wallis H test 
Clinical Trials - Repeatability 
 
 26  
evaluates whether the ranks for the two groups differ significantly, or not. As the scores are 
converted to ranks, the actual distribution of the scores is irrelevant [53]. 
 
3.3.4.3 Kruskal – Wallis H test 
The Kruskal – Wallis H test is the non – parametric alternative to the one – way 
between groups ANOVA. It is similar to the Mann – Whitney U test (see sub-chapter 3.3.4.2), 
but it allows the user to compare more than just two groups. Just as Mann – Whitney test, 
Kruskal – Wallis H compares the medians, and not the means. Scores are converted to ranks the 
mean rank for each group is compared. As this is a ‘between-groups’ analysis, different people 
must be in each of the different groups [53]. 
 
3.4 Correlation analysis 
 
Correlation analysis is used to describe the strength and direction of the linear 
relationship between two variables [53]. Correlation coefficients provide a numerical summary 
of the direction and the strength of the linear relationship between two variables. The 
relationship between variables can be inspected visually by generating and inspecting a 
scatterplot, which will provide information on both the direction of the relationship (positive or 
negative) and the strength of the association. 
One should know that correlation coefficients indicate linear relationship between 
variables. However, two variables can be related in non – linear fashion (e. g. curvilinear), and 
so, one should always check the scatterplot, especially if low values of r are obtained. Also, 
outliers can have a dramatic effect on the correlation coefficient, especially in small samples. 
One should careful analyze the scatterplot to check for outlier and/or extreme values. 
Two main tests are used to assess correlation: the parametric Pearson product – moment 
correlation (r) and the non – parametric alternative Spearman rank order correlation. 
 
3.4.1 Pearson product – moment correlation 
The Pearson’s correlation test is a parametric test which is designed for detecting linear 
relationships in continuous variables. It can also be used if you have one continuous variable 
and one nominal variable. Pearson correlation coefficients (r) can range from -1 to +1. The sign 
out the front indicates whether there is a positive correlation (as one variable increases, so does 
the other) or a negative correlation (when one variable increases, the other decreases). The size 
of the absolute value (while ignoring the sign) provides an indication of the strength of the 
relationship. A perfect correlation of -1 or -1 indicates that the value of one variable can be 
determined exactly by knowing the value on the other variable. On the other hand, a correlation 
of 0 indicates no relationship between the two studied variables [53].  
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Table 3.2 – Guidelines for correlation level based on the value of the 
correlation coefficient range, according to Cohen et al. (1988) [59]; 
However, the output can range between -1.00 and 1.00, so one should know how to 
interpret these values, and when should we consider small, medium and high relationship 
between two variables. Cohen (1988) [59] has suggested the guidelines presented in Table 3.2. 
 
 
Correlation coefficient range Correlation 
r = 0.10 to 0.29 or r = -0.10 to 0-.29 Small 
r = 0.30 to 0.49 or r = -0.30 to -0.49 Medium 
r = 0.50 to 1.00 or r = -0.50 to -1.00 Large 
 
 
3.4.2 Spearman’s rank order correlation  
 Spearman’s rank order correlation is used to calculate the strength and direction of a 
monotonic association between two variables, without making any assumptions about the 
frequency distribution of the variables. This is the non-parametric alternative to Pearson’s 
product-moment correlation, and should be used instead of Pearson’s product moment 
correlation for highly skewed data or when monotonic relationships are suspected [53, 60]. 
However, some experts believe that Pearson’s and Spearman’s test could be used together, to 
assess by comparison if associations are mostly linear, or monotonic [60]. 
 
3.5 Bland – Altman method 
 
Bland and Altman (1986) [16] have noted that the use of correlation is quite misleading, 
because and high correlation does not necessarily mean that two methods/repeated 
measurements agree. A correlation coefficient only measures the strength of a relation between 
two variables, not the agreement between them. Because of this, data that seems to produce high 
correlations can have poor agreement.  We only have complete agreement between two 
measurements if all the points lie along a line of equality. Also, correlation highly depends on 
the range of the true quantity of the sample and of the group of subjects selected. Bland and 
Altman also concluded that a lack of agreement between different measurements is almost 
inevitable, but what matters is the amount by which the respective different measurements 
disagree [16]. 
Therefore, Bland and Altman have proposed an alternative approach to assess 
agreement in clinical measurement, by plotting the difference between two measurements 
against their mean, allowing the possibility to investigate any possible measurements errors 
and/or lack of agreement. One should also consider the limits of agreement, in which most of 
the differences are expected to lie. To construct a Bland – Altman plot, one should estimate the 
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mean difference (d) and the SD of the differences (s). The limits of agreement must be adjusted 
by subtracting or adding d for each limit of agreement. And so, we would expect most of the 
differences to lie between d – 2s and d + 2s (or d – 1.96s and d + 1.96s, to be more exact). It is 
expected that the differences between both assessments lies within the limits of agreement with 
approximately 95% probability [16]. An example of the Bland – Altman plot is shown on figure 
3.4. 
When using the Bland – Altman plot, both measurements should be paired, and 
independent from one another, to avoid inaccurate results. The mean difference (also known as 
bias) should be zero or as closest to zero as possible. If the bias is significantly different from 
zero, there is worrying discrepancies between methods or measurements, due to problems with 
the process of measurement or if both measurements are not independent from one another [16]. 
It is also important to analyze the variability of the plot and to pay attention for unusual patterns 
in a Bland – Altman plot [16]. 
 
 
 
 
3.6 Related work 
 
Repeatability measurements regarding the usefulness non – invasive techniques for CV 
function assessment is a commonly discussed issue in the scientific community. Among several 
studies, Crilly et al. (2007) [15] studied the repeatability of a radial applanation tonometer for 
pulse wave analysis (PWA). They proved that PWA demonstrates high levels of repeatability 
even when used by relatively inexperienced staff and has the short - term potential to be 
included in clinical practice. Frimodt – Møller et al. (2007) [61] assessed mean day – by – day 
differences in AIx in patients with chronic kidney disease, with AIx = 2.6 ± 11.2. 
Figure 3.4 – Example of a Bland – Altman plot; 
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Results of validations with the purpose of evaluating the repeatability of new devices 
have also been reported. One of these new devices is Arteriograph (TensioMed, Budapest, 
Hungary), an oscillometric method. Horváth et al. (2010) [62] validated Arteriograph by 
comparing aortic AIx, SBP and PWV measurements during cardiac catheterization with the 
values measured by the Arteriograph. This experiment has shown that AIx, SBP and PWV 
oscillometric measures showed strong correlation with the invasively obtained values. 
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4. Data Mining 
 
 
Data mining has attracted a great deal of attention in the information industry and in 
society as a whole in recent years. Firstly, this chapter introduces the concept and describes all 
the data pre – processing routines needed to efficiently execute data mining techniques. Then, 
special focus is given to classification and clustering techniques, which were subsequently used 
to extract new information from a database. 
 
 
4.1 Data mining – Introduction 
 
 Being considered as the most important step in knowledge discovery from data (KDD), 
data mining is usually defined as the automatic or semi – automatic process of discovering 
patterns in data. When data mining techniques are efficiently applied, it can be possible to 
extract implicit, previously unknown and potentially useful information from data [63]. Due to 
this, data mining techniques have attracted a great deal of attention and recognition since the 
start of the new century, due to wide availability of huge amounts of data and the imminent 
need for turning such data into knowledge [64]. 
 Nowadays, in industry, media and in database research communities, and adopting a 
broad view of data mining functionality, data mining is acceptably treated as a synonym for 
KDD [45]. A full view of the data mining process can be observed on figure 4.1. 
 
 
 
Figure 4.1 – Steps of KDD, commonly designated in new century as data mining. Adapted from [64]; 
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4.1.1 Differences between statistics and data mining 
Although they may seem quite similar, statistics and data mining procedures have their 
differences. First, statistics tend to use conservative analysis strategies based on rigorous 
mathematical approaches. Although data mining methods are based on mathematics, many 
techniques adopt a heuristic approach to solve real – world problems. Secondly, while statistical 
analysis is deductive, data mining is inductive [65]. In statistics, a hypothesis is built and then 
data is collected to test the hypothesis, as modern science does. In other words, statistics is a 
process of reasoning from the general to the specific. Data mining can work without a 
hypothesis, as it explores data that have been collected in advance and discovers hidden patterns 
from it. And so, data mining is process of producing general from the specific [66]. 
 
4.2 Data pre – processing 
 
Usually, and before applying any statistical data mining techniques, the data we wish to 
analyze is incomplete, noisy, and inconsistent. As low – quality data will usually lead to low – 
quality mining results, data preprocessing becomes a fundamental step in the data mining 
process. Data pre - processing techniques, when correctly applied, can substantially improve the 
accuracy and efficiency of data mining techniques [64]. 
 
4.2.1 Descriptive statistics analysis 
A preliminary analysis using descriptive data techniques is essential not only to know 
and understand the true properties of the data we wish to mine, but also to identify noise and 
outliers in the dataset. Normality, central tendency and data dispersion measurements are 
generally used to characterize data. These measurements may be expressed analytically or 
graphically. All the descriptive statistical methods were previously described in section 3.2. 
 
4.2.2 Data cleaning 
Data cleaning processes intend to discover and correct discrepancies in the data, which 
may be caused by diverse factors (i.e. human error, errors in instrumentation devices that 
acquire data, erratic code). A preliminary descriptive analysis of the data is essential to discover 
these inconsistencies. Usual data cleaning routines involve missing values removal, noise 
smoothing and outlier identification [64].  
 
4.2.3 Irrelevancy and redundancy analysis 
In a raw database, attributes that are redundant or irrelevant may slowdown and display 
unsatisfactory results. Relevance and redundancy analysis should be performed to detect and 
remove attributes that do not contribute to the data mining tasks.  
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For redundancy analysis, correlation tests can be used to identify whether any two given 
attributes are statistically related. For example, a strong correlation between two specific 
attributes may suggest that one of the two could be removed from further analysis. As for 
irrelevancy, attribute subset selection (or feature subset selection) can be used to identify and 
remove as many irrelevant and redundant features as possible. Irrelevancy and redundancy tests 
help in reducing the dimensionality of the data and will enable data mining techniques to 
operate faster and more effectively [64, 67]. 
 
4.2.4 Data normalization 
Most of the times, data needs to be consolidated into forms appropriate for mining. One 
of the most common transformations is data normalization, which involves scaling all values for 
a given attribute so that they fall within a small specified range, such as -1.0 to 1.0 or 0.0 to 1.0. 
Usually, normalization procedures are necessary when attributes with initially large ranges 
outweigh attributes with smaller ranges (for example, in ANN) [64]. The most common data 
normalization method is min – max normalization. Considering that a value V from an attribute 
A with a minimum and maximum value (minA and maxA, respectively) should fit in the range 
[C, D]. Then the normalized value (V’) can be computed by the following formula: 
 
    
(      )
(         )
(   )    (4.1) 
 
4.2.5 Data discretization 
Data discretization techniques can be used to reduce the number of values for a given 
continuous attribute by dividing the range of the attribute into intervals. Interval labels can then 
be used to replace actual data values. Usually, replacing numerous continuous values by a small 
number of interval labels reduces and simplifies the original data, consequently leading to a 
concise knowledge – level representation of data mining results [64]. On the other hand, many 
techniques don’t deal well with discretized attributes [67]. 
 
4.3 Data classification 
 
Data classification is the process of constructing a model that describes and 
distinguishes data classes or concepts for the purpose of being able to use the classifier to 
predict the class of objects whose class label is unknown (Figure 4.2). Because the class label of 
each training tuple is given, data classification is an example of a supervised learning process 
[63, 66]. 
While Figure 4.2 represents the many steps of data classification, the process can be 
simplified as a two – step process,. The first step is the training step, where a classification 
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model is built by analyzing pre – existent class labeled data. The second step, the testing step, 
examines a classifier for its accuracy using testing data. Subsequently, the model can be used 
for classifying objects with unknown label [66]. Sometimes, another independent set comes to 
surface: the validation set, which is used before the test set to minimize the error.  
 
 
 
 
 
4.3.1 Classification techniques requirements 
Classifiers can be evaluated and compared according to the following criteria [64]: 
 
 Accuracy – The accuracy of a classifier refers to the ability of a given classifier 
to correctly predict the class label of new data. 
 Speed - Speed indirectly refers to the computational costs involved in 
generating (learning speed) and using (classification speed) the classifier. 
 Robustness/Tolerance - The robustness of a classification technique is defined 
by the ability of making correct predictions given incomplete and noisy data. 
Robustness also considers the algorithm dexterity in overcoming irrelevant and 
redundant attributes. 
 Versatility – Versatility refers to the classifier’s ability in dealing with different 
types of attributes (continuous/discrete/binary). 
Figure 4.2 – Diagram representation of the steps of data classification;  
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 Comprehensibility - Comprehensibility refers to the level of understanding and 
insight that is provided by the classifier. Comprehensibility is, however, very 
subjective and difficult to accurately assess.  
 
4.3.1.1 Accuracy evaluation 
 The accuracy of a classifier refers to the ability of a given classifier to correctly predict 
the class label of new or previously unseen data. The accuracy of a classifier on a given test set 
is the percentage of test set tuples that are correctly classified by the classifier. We can also 
speak of the error rate or misclassification rate of the classifier, which is simply 1 – M, where M 
is the accuracy of the respective classifier. Although, we must keep in notice that the error rate 
of the model is optimistic of the true error rate, because the model is not tested on any samples 
that it has not already seen [63, 64]. Also, using training data to derive a classifier and estimate 
the accuracy of the resulting learned model can result in misleading overoptimistic estimates 
due to overspecialization of the learning algorithm to the data. So, accuracy is better measured 
on a class – labeled test set that wasn’t used to train the model. 
As the performance of a classification process is based on the counts of testing objects 
correctly and incorrectly predicted, the confusion matrix (Figure 4.3) is a useful tool in 
analyzing how well your classifier can recognize objects of different classes. Given m classes, a 
confusion matrix is a table of at least size m by m. For a classifier to have good accuracy, ideally 
most of the tuples would be represented along the main diagonal of the confusion matrix, with 
the rest of the entries being close to zero [64]. 
 
 
 
 
 
 
Figure 4.3 – Confusion matrix of observed class versus predicted class; 
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Given two classes, we can talk in terms of positive tuples versus negative tuples. True 
positive (TP) refer to the positive tuples that were correctly labeled by the classifier, while true 
negatives (TN) are the negative tuples that were correctly labeled by the classifier. FPs are the 
negative tuples that were incorrectly labeled as positives. Similarly, FNs are the positive tuples 
that were incorrectly labeled as negatives. And so, we can define accuracy as: 
 
          
(     )
(           )
 (4.2) 
 
However, accuracy measures may not always be enough. In a classifier to classifies 
medical data tuples as either healthy or hypertensive, a hypothetical accuracy rate of 90% may 
make the classifier seem quite accurate. But it could happen that only 3-4% of the tuples are 
actually “hypertensive”, and therefore, an accuracy rate of 90% is not acceptable, because the 
classifier could be correctly labeling only the “healthy” tuples. In this case, sensitivity and 
specificity measures can and should be adopted. Sensitivity is also referred to as the TP positive 
rate, that is, the proportion of positive tuples that are correctly identified, while specificity is the 
TN rate, that is, the proportion of negative tuples that are correctly identified. Also, we may use 
precision to identify the percentage of tuples labeled as “hypertensive” that actually 
“hypertensive” tuples [64]: 
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4.3.2 Definition of training set 
After all the data pre – processing are performed, it is of uttermost importance the 
definition of how the training and testing will proceed, to obtain a reliable estimate of classifier 
accuracy, with methods like holdout, random subsampling and cross – validation among the 
most used. 
 
4.3.2.1 Holdout method 
 In this method, the given data are randomly partitioned into two independent sets: a 
training set and a test set. Typically, approximately two – thirds of the data are allocated to the 
training set, and the remaining one – third is allocated to the test (70 - 30 is another usual ratio 
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for dividing training and testing tuples). The training set is used to derive the model, whose 
accuracy is estimated with the test set. However, this estimate is considered as pessimistic, 
because only a portion of the initial data is used to derive the model [64]. 
Random subsampling is a variation of the holdout method, in which the holdout method 
is repeated k times. The overall accuracy estimate is taken as the average of the accuracies 
obtained [64]. 
 
 
 
 
 
4.3.2.2 Cross - validation 
In k-fold cross – validation (CVN), the initial data are randomly partitioned into k 
mutually exclusive subsets or “folds”, D1, D2, …, Dk, each of approximately equal size. 
Training and testing is performed k times. In iteration I1 partition D1 is used as a test set, and the 
remaining partitions are collectively used to train the model. That is, in the first iteration, 
subsets D2,…,Dk collectively serve as the training set in order to obtain a first model, which is 
tested on D1; the second iteration is trained on subsets D1,D3,…,Dk and tested on D2, and so on. 
Unlike the holdout and random subsampling methods above, here, each sample is used the same 
number of times for training and once for testing. The accuracy estimate is the overall number 
of correct classifications from the k iterations, divided by the total number of tuples in the initial 
data [64].  
A more robust variation is stratified k-fold CVN, where the folds are stratified so that 
the class distribution of the tuples in each fold remains approximately equal to the initial data, 
minimizing the bias and variance in a dataset. Because of that, stratified 10 – fold CVN is 
highly recommended for estimating accuracy and should be used when possible. Otherwise, 10 
– fold CVN is good enough [64].  
Figure 4.4 – The holdout method. Adapted from [64]; 
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4.3.3 Algorithm selection 
After defining how the training and testing will be performed, we should select the 
algorithm that will be evaluated (however, this can be interchangeable in some cases). The 
algorithms that were used in this work will be further described on this sub – section. 
 
4.3.3.1 Artificial neural networks (ANN) 
Inspired by the biological nervous system, ANN are highly sophisticated analytical 
techniques, capable of modeling complex non – linear functions and predicting new 
observations from other observations. They appear as an effective and practical technology, and 
can be implemented by using electronic components or are simulated in specialized software on 
a digital computer [68]. 
Roughly speaking, an ANN is a set of connected input and output units in which each 
connection has a specific weight associated to it. During the learning phase, the network learns 
by adjusting the weights so as to be able to predict the correct class label of the input tuples 
[64]. The network is adjusted by comparing the output and the target, and the weights are 
adjusted until the network output matches the target (Figure 4.5). Usually, many input / target 
pairs are needed to successfully train a network [67]. Also, the network is feed – forward, which 
means that none of the weights cycles back to an input unit or to an output unit of a previous 
layer, making the information move in one direction only. Due to this, it is usual to see ANN 
often called as feed – forward neural networks or feed-forward ANN [64]. 
 
 
 
 
ANN algorithms present important advantages that make their effectiveness undeniable, 
as their outstanding accuracy in general [64, 67] ability to work with continuous attributes and 
above average tolerance to redundant attributes [67]. However, they also have some drawbacks. 
Usually ANN need high computational power, and attributes need to be previously normalized. 
Also, NNs have poor interpretability, because they process information based on the ‘black-
Figure 4.5 – ANN learning process. From [64]; 
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box’ principle and, unlike other ‘transparent’ techniques, such as decision trees, they do not 
directly ‘unveil’ the way they process information [67].  
 
4.3.3.1.1 Linear neural network (LNN) 
Linear neural network (LNN; also known as single – layer perceptron (SLP)) is the 
simplest kind of feed – forward neural network. It is based on the McColluch and Pitts artificial 
neuron [69], which consists of a single input layer with input units and a layer of output nodes. 
The inputs to the network correspond to the attributes measured for each training tuple [64], and 
in this approach, the inputs are fed directly into the outputs. A LNN generic example can be 
found on Figure 4.6. 
 
 
 
 
 
 
If {X1, X2 … Xn} are input features and {w1, w2 … wn} are connection weights 
(typically real numbers in the interval [-1, 1]), then the perceptron computes the sum of 
weighted inputs: 
 
∑    
 
 
(4.6) 
 
The output then goes through an activation function Φ, which is usually a threshold 
function. If the sum is above the desired threshold, output is 1; else, the output is 0. The most 
common method that the LNN algorithm learns from a batch of training instances is to run the 
Figure 4.6 – A LNN generic example, with {X1, X2 … Xn} being input features and {w1, 
w2 … wn} corresponding to connection weights. Adapted from [64]; 
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algorithm repeatedly through the training set until it finds a set of connection weights which is 
correct on all training set instances. Afterwards, the trained model is used for predicting the 
labels on the test set [66]. 
Nowadays, LNN algorithms have been overwhelmed by other more sophisticated ANN. 
Still, they provide themselves as a good alternative and as a benchmark against which to 
compare the performance of more complex ANN [32]. 
 
4.3.3.1.2 Multi - layer perceptron (MLP) 
Multi - layer perceptron (MLP) is the most popular ANN architecture in data 
classification techniques. This may be due to the conclusion that MLP with one or two hidden 
layer are universal approximators in a very precise sense [70, 71]. The MLP consists of a set of 
source units that constitute the input layer, one or more hidden layers of neurons and an output 
layer. From a statistical point of view, they perform nonlinear regression. An example of a 
multilayer feed – forward network is shown on Figure 4.7.  
 
 
 
 
 
 
 
Like the LNN, the inputs to the network correspond to the attributes measured for each 
training tuple, and are fed simultaneously into the input units, making up the input layer. After 
the network inputs pass through the input layer, they are weighted and fed simultaneously to a 
second layer known as the hidden layer, composed of hidden units (sometimes referred to as 
neurodes). The outputs of the hidden layer can be inputs to another hidden layer or inputs to 
Figure 4.7 – A MLP generic example, with {X1, X2 … Xn} being input features and {w1j, 
w2j … wnj} and Wjk corresponding to connection weights between the input layer and the 
next layer. Oj is the output computed by neuron j, and Ok is the output computed by neuron 
k. Adapted from [64]; 
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output units that make up the output layer, which emits the network’s prediction for given tuples 
[64]. An MLP with one input layer, one hidden layer and one output layer is characterized as a 
two – layer MLP. The input layer is not counted as it serves only to pass the input values to the 
next layer. Similarly, an ANN containing two hidden layers in called a three – layer MLP, and 
so on [64]. 
As a learning algorithm, the most well – known and widely used is the backpropagation 
algorithm, which learns by iterative processing of a data set of training tuples, comparing the 
network’s prediction for each tuple with the known target class label. For each training tuple, 
the weights are updated so as to minimize the mean squared error between the network’s 
prediction and the actual target value. These modifications are directed backwards, that is, from 
the output layer through each hidden layer down to the first hidden layer (hence the name 
backpropagation). In general, the weights will eventually converge and the learning process 
stops [64].  
The main problem of the MLP is in defining the most correct topology, or finding the 
topology that gives us the best possible approximation for the problem we wish to model.  
Before training can begin, the user must decide on the network topology by perceiving the 
number of units in each layer. The number of input units and output units is determined by the 
number of initial attributes and known classes, respectively.  Properly determining the optimal 
size of hidden units in the hidden(s) layer(s) is a challenging issue, because an underestimation 
can lead to poor approximation and generalization model capabilities [66], while an 
overestimation results in overfitting [64]. Also, there are no clear rules as a reference number of 
hidden units per hidden layer, and initial weight values also affect the model accuracy. The only 
solution is performance several trial-and-error, repeating the training process with different 
network topologies. Optionally, a different set of initial weights can also help in achieving the 
best possible MLP performance [64]. 
 
4.3.3.1.3 Radial basis function (RBF) 
Radial basis function (RBF) represents an equally appealing and intuitive ANN, 
consisting of a hidden layer of radial units, in which every hidden unit implements a radial 
activation function and each output unit implements a weighted sum of hidden unit outputs. 
RBF training procedures is divided in two stages. In the first stage, the centers and widths of the 
hidden layer are determined by partitioning algorithms. Secondly, the weights connecting the 
hidden layer to the output layer are assessed by singular value decomposition or least mean 
squared algorithms [67]. 
RBF can be trained extremely quickly, much faster than MLP. On the other hand, the 
RBF is more sensitive to the curse of dimensionality [32]. Also, one should know that the 
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danger of overfitting and underfitting is identical to MLP. Selecting the appropriate number of 
basis functions remains a critical issue and should not be ignored [67]. 
 
4.3.3.2 Decision trees induction 
Decision trees induction is the learning of decision trees from class – labeled training 
tuples [64]. A decision tree assumes a flowchart structure, where each internal node (non-leaf 
node) in a decision tree represents a test in an attribute that needs to be classified, and each 
branch represents a possible outcome of the test. Each leaf node represents the outcome of the 
test. The topmost node is the root node, and instances are classified starting at the root node and 
sorted based on their feature values [67]. 
Decision trees induction usually adopts a nonbacktracking approach, and most of the 
decision trees are constructed in a supervised top – down recursive divide-and-conquer manner, 
starting with a training set of tuples and their associated class labels [64]. The training set is 
recursively partitioned into smaller subsets as the tree is being built. Afterwards, the constructed 
decision tree can be used as a classification algorithm, when a tuple with unknown class label is 
tested against the decision tree. A path is traced from the root to a leaf node, which holds the 
classification for the tuple. 
Decision tree classifiers are quite popular, mainly because of their simplicity and 
comprehensibility. People can easily understand why a decision tree classifies and instance as 
belonging to a specific class [67]. Also, decision trees have great capacity of handling high 
dimensional data, and their induction is fast. Their construction does not require any domain 
knowledge or parameter testing and, therefore, is appropriate for exploratory data mining, 
having a good accuracy in overall. Decision trees tend to perform better when dealing with 
discrete/categorical features [67]. 
 
4.3.3.2.1 Random forest 
Proposed by Breiman (2001) [72], random forests are a combination of tree predictors 
such that each tree depends on the values of a random vector sampled independently and with 
the same distribution for all the trees in the forest. The generalization error will eventually 
converge to a limit as the number of trees in the forest enlarges. After a large number of trees is 
generated, they vote for the most popular class [72]. 
 
4.3.3.2.2 C4.5 
C4.5 is a very popular decision tree algorithm. Developed by Quinlan (1984) [73], it 
uses the decision tree induction approach of supervised top – down recursive divide-and-
conquer tree construction. C4.5 is optimized for handling both continuous and discrete attributes 
and pruning the decision trees after their respective creation. 
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4.3.3.3 Bayesian classification 
Bayesian classifiers predict class membership probabilities, such as the probability that 
a given tuple belongs to a particular class [64]. This type of classifiers is based on Bayes’ 
theorem: 
 
 ( | )  
 ( | )  ( )
 ( )
 (4.7) 
 
Where P (C|X) denotes a posterior probability of an event C conditioned by an 
observation X and P (X|C) is the posterior probability of occurring observation X when event C 
is true. P(C) and P(X) are prior beliefs, where P(C) is the probability of the event occurring 
before observing any case X, and P(X) represents the probability of occurring a case X without 
considering any hypothesis C [19, 64]. 
The major advantage of the Bayesian classifiers is their short computational time for 
training. They also present great tolerance to missing values, and are an efficient approach in 
avoiding overfitting of data, because of their simplicity. However, because of this simplicity, 
their accuracy is often lower than other classifiers [66]. 
 
4.3.3.3.1 Naïve Bayesian classification 
Let D be a training set of tuples with associated class labels. Each tuple is represented 
by an n-dimensional attribute vector X = {x1,x2,…xn}, with the attributes represented as 
A1,A2,…An}. Considering a m-dimensional class vector C = {C1,C2,…Cm} and given a tuple, X, 
the classifier will predict that X belongs to the class having the highest posterior probability. 
The classifier predicts that X belongs to class Ci if and only if: 
 
  (  | )    (  | )                  (4.8) 
 
Thus, P(Ci|X) is maximized, and class Ci becomes the maximum posteriori hypothesis. 
By Bayes’ theorem: 
 
 (    )  
 ( |  )  (  )
 ( )
 (4.9) 
 
Only P(X|Ci) needs to be maximized, because P(X) is constant for all classes. If the 
class prior probabilities are unknown, the classes are assumed to be equally likely, therefore, 
P(X|Ci) is maximized [63].  
After that step, an assumption of class conditional independence is performed to reduce 
computation in P(X|Ci). This presumes that the attributes are conditionally independent of one 
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another, given the class label of the tuple X [64]. In order to predict the class label of X, 
P(X|Ci).P(Ci) is evaluated for each class Ci. The classifier will only predict that class label of 
tuple X is the class Ci if and only if: 
 
  ( |  ) (  )    ( |  ) (  )                  (4.10) 
 
In other words, the predicted class label is the class Ci for which P(X|Ci)P(Ci) is the 
maximum [63, 64]. 
4.3.3.3.2 Bayesian Networks 
The Naïve Bayesian classifier makes the assumption of the class conditional 
independence, that is, given the class label of a tuple, the values of the attributes are assumed to 
be conditionally independent of one another. While this simplifies computation, dependencies 
can exist between variables. Bayesian Networks provide a graphical model of causal 
relationships, specify joint conditional probability distributions that allow class conditional 
independencies to be defined between subsets of variables, and can be used for classification 
[64]. 
 
4.3.3.4 Associative classification 
In associative classification, association rules that show strong associations between 
attributes-value pairs that occur frequently in a given dataset are generated. Typically, the 
discovery of association rules is based on frequent itemset mining. Associative classification 
algorithms are regarded as being easy to understand and having very good accuracy. However, 
they are really sensitive to noisy and incomplete datasets [67]. 
 
4.3.3.4.1 RIPPER 
Proposed by Cohen (1995) [74] as an optimized version of the Incremental Reduced 
Error Pruning (IREP) [75], Repeated Incremental Pruning to Produce Error Reduction 
(RIPPER) is based on association rules with reduced error pruning, a very common and 
effective technique of decision tree algorithms.  
In RIPPER, after a training set of data is split into a growing set and a pruning set, a 
single rule set is grown using one subset of the data and subsequently pruned. After the rule set 
has been generated, a simplification phase ensures that the pruning operator that yields the 
greatest reduction of error of the pruning set is chosen. Simplification ends when applying any 
pruning operator increases error of the pruning set [74]. 
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4.3.4 Classification techniques comparison 
As enunciated before, classifiers can be compared according to the criteria defined in in 
4.3.1. Kotsiantis (2007) [67] has performed a review which compares the characteristics of each 
type of classifier, with * representing the worst and **** representing the best. This review was 
adapted to a synthetic table (Table 4.1). Only characteristics that were defined in the criteria 
exposed in 4.3.1 are identified and described in Table 4.1. 
As exposed in Table 4.1, ANN present the highest accuracy of all the analyzed 
techniques and are highly versatile (even though they deal better with continuous attributes). 
However, they are quite sensitive to missing values and irrelevant attributes. Moreover, their 
training speed (with the exception of the RBF) and interpretability are the definitely worst 
among the four techniques. A rigorous pre – processing is absolutely needed when using ANN, 
to fully expose their potential [67].  
As for other techniques, decision trees induction and associative classification also 
present good accuracy, and also excel in terms of versatility and comprehensibility, but decision 
trees are usually the best choice due to their intrinsic high tolerance. Naïve Bayes classification 
has the best training speed, high comprehensibility of the given results and high tolerance to 
missing values. But, on the other hand, it has the lowest accuracy of the comparison [67]. 
 
 
 
Classifier 
Characteristics 
ANN  
Decision 
Trees 
Induction 
Naïve Bayes 
Classification 
Associative 
Classification 
Accuracy **** *** * *** 
Training Speed * *** **** ** 
Tolerance 
Missing 
values 
* *** **** ** 
Irrelevant 
attributes 
* *** ** ** 
Redundant 
attributes 
** ** ** ** 
Versatility ***  **** *** *** 
Comprehensibility * **** **** **** 
 
 
 
Table 4.1 – Comparison between the previously described classification techniques. * represents the worst result and 
**** the best result. Adapted from [67]; 
Data Mining 
 
 46  
4.4 Data clustering 
 
Clustering is the process of grouping a set of objects into a class of similar objects 
(Figure 4.8). A cluster is a collection of data objects that are similar to one another within the 
same cluster, and are dissimilar to other objects contained in other clusters [64].  
The clustering technique can be used in data mining processes, by partitioning the set of 
data into groups based on data similarity and then assigning labels to the number of groups 
created. Unlike classification, clustering is an example of unsupervised learning, which doesn’t 
rely on predefined classes and class-labeled training examples, learning by observation and not 
by examples [64]. Clustering can also be used for outlier detection and as a preprocessing tool 
for other algorithms such as classification or attribute subset selection [63]. 
 
 
 
 
4.4.1 Clustering techniques requirements 
Just like the classification techniques, clustering methods have their own special 
requirements, and can also be evaluated and compared, considering the following criteria [64]: 
 Interpretability – The clustering results must be interpretable, comprehensible, 
and usable. 
 Scalability – Highly scalable clustering algorithms are needed. Many clustering 
algorithms work well on small databases. However, large databases contain 
millions of objects, and clustering on a sample of given large data set may lead 
to biased results.  
 Dimensionality – Clustering methods must be able to deal with high – 
dimension data. While many clustering algorithms are good at handling low – 
Figure 4.8 – The clustering process; 
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dimensional data (few attributes), they give inconsistent results while dealing 
with high – dimensional datasets.  
 Robustness/Tolerance – It is important that clustering methods have high 
noise and missing value tolerance.  
 Ability to deal with different types of attributes – Clustering techniques must 
be able of dealing with different types of data instead of numerical and 
continuous data (binary, categorical, ordinal…). 
 Arbitrary shape detection – It is important to develop algorithms that can 
detect arbitrary shapes. Many clustering algorithms use distance measures to 
determine clusters. Algorithms based on this type of measures tend to find 
spherical clusters with similar size and density, not considering that a cluster 
could be of any shape.  
 
4.4.2 Cluster methods 
Different types of clustering exist on the literature and can be classified into partitional, 
hierarchical, density – based, grid – based and model – based. In this work, mainly due to 
hardware and software limitations, only one partitional clustering approach and one model – 
based algorithm were used. And so, this dissertation will only focus on partitional and model – 
based approaches. 
 
4.4.2.1 Partitional clustering 
 These algorithms decompose a database of n objects into a set of k partitions, where 
each partition represents a cluster and where each object must belong to exactly one group. 
The general criterion of a good partitioning is that objects in the same cluster are related to 
each other, whereas objects of different clusters are very different [76]. A popular approach of 
partitional clustering is the k-means algorithm, where each cluster is represented by the mean 
value of the objects in the cluster [64]. 
 
4.4.2.1.1 K – means algorithm 
The k-means algorithm acknowledges the number of desired clusters input k and 
partitions a set of n objects into k clusters, so that the resulting intra - cluster similarity is high, 
but the inter - cluster similarity is low. Cluster similarity is measured in regard to the mean 
value of the objects contained in a cluster, which can be viewed as the cluster centroid [76]. 
The k-means algorithm starts with a random selection k of the objects, each of which 
initially represents a cluster mean. For each of the remaining objects, an object is assigned to the 
cluster to which it is the most similar, based on the distance between the object and the cluster 
mean. Afterwards, a new mean is computed for each cluster. This process iterates until the 
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criterion function converges [64]. Conventionally, the square – error criterion based on the 
Euclidean distance function is used: 
 
   ∑∑ |     |
 
    
 
   
 
(4.11) 
 
Where E is the sum of the square error for all objects in the data set, p is the point in 
space representing a given object; and mi is the mean of cluster Ci (both p and mi are 
multidimensional). In other words, for each object in each cluster, the distance from the object 
to its cluster is squared, and the distances are summed, resulting in k clusters that are quite 
compact and as separate as possible [64].  
 
 
 
 
 
The k-means clustering method is relatively scalable and efficient in processing large 
datasets. However, it has some major disadvantages, as it is inapplicable to categorical 
attributes, it is unsuitable for discovering clusters with non - convex shapes of very different 
size and is quite sensitive to noise and outliers, because a small number of such data can 
substantially influence the mean value [64, 76].  
 
4.4.2.2 Model - based clustering 
Model – based methods hypothesize a model for each of the clusters and find the best fit 
of the data to the given model. It can also determine the number of clusters based on standard 
statistics, taking noise and outliers into account, yielding robust clustering methods. One well 
known approach is the Expectation – Maximization (EM) algorithm, which performs analysis 
based on statistical modeling [64]. 
 
 
 
 
Figure 4.9 – K-means clustering with Euclidean distance function k = 3. A + represents the mean. of each 
cluster. From [64]; 
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4.4.2.2.1 Expectation – maximization (EM) 
The EM algorithm is a popular clustering algorithm, which is, in fact, a complex 
probabilistic extension of the k-means method. Instead of assigning each object to the cluster 
with which it is most similar, EM assigns each object to a cluster according to a weight 
representing the probability of membership. This means that there are no strict boundaries 
between clusters and new means are computed based on weighted measures [64]. 
EM starts with an initial estimate of the parameters of the ‘parameter vector’, randomly 
selecting k objects to represent the cluster means (as in k-means partitioning). Then, EM 
iteratively refines the parameters (or clusters) based on an expectation step, where for each 
object xi, the probability of cluster membership of each object for each of the k clusters, and on 
an maximization step, where we use the probability estimates from the expectation step to re-
estimate the model parameters. These steps are performed until convergence is achieved [64]. 
The EM algorithm is a simple and easy alternative to the k – means approach, 
presenting good global performance in overall. 
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5. Hardware & Software 
 
 
The developed prototype hardware and software systems are described in this chapter. 
The first sub-section briefly concentrates on the hardware, while the second sub-section focuses 
on the developed and integrated software, including acquisition and processing routines. The 
functionalities of the current MATLAB
® 
software modules for acquisition and processing 
routines are also be presented. 
 
 
5.1 Hardware 
 
Hardware can be generically defined as the mechanical equipment necessary for 
conducting an activity. Hardware is a collective term, as it may include not only the computer, 
but also the cables, connectors, power supply units and other peripheral devices.  
Our prototype hardware module for ADW acquisition consists of a PZ probe and signal 
conditioning circuit.  
 
5.1.1 PZ sensor 
A PZ element is able to convert force or pressure applied to its surface into a 
measurable voltage signal. PZ - based probes have been widely used in ADW measurements 
along the past few years due to their appealing characteristics: high sensitivity, high SNR and 
associated low – cost [13, 14]. The developed PZ probe is presented in Figure 5.1. 
 
 
 
 
The PZ probe consists of one PZ transducer bonded to a plastic block that supports 
bending under normal use. A mushroom polyvinyl chloride (PVC) interface was assembled over 
the PZ element. The pointy interface, which contacts directly with the sensor, exhibits the best 
Figure 5.1 – PZ sensor. (a) outer upper – view, with the easily recognizable mushroom – shaped 
interface (b) probe elements in cut, with (1) mushroom – shaped interface, (2) PZ disc sensor and (3) 
printed circuit board (PCB). From [14]; 
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performance in reproducing waveforms with low root mean square (RMSE) variance and, 
therefore, was the preferred option for ADW measurements [14].  
 
5.1.2 Signal conditioning circuit 
The ADW signal conditioning circuit architecture is shown on Figure 5.2, and consists 
of three main modules: a power supply module, a first amplifying stage and a processing 
module. The power is supplied via an USB cable that’s connected to a personal computer. The 
computer supplies the needed voltage to the other two modules. In the first amplifying stage, the 
raw signal obtained from the PZ probe is amplified with a gain of 1000, using an active 
differentiator mode amplifier, proposed by Almeida et al. (2011) [14]. The signal then proceeds 
to the processing module, where a peak detector coupled with a timer is used to extract the 
reference time signal associated with the signal peak [14]. Since the signal is a time derivative 
of the physiological signal (due to sensor specifications), it is integrated by a Microchip
®
 
(Chandler, Arizona, USA) dsPIC33 microcontroller module. 
 
 
 
 
 
 
5.2 Software 
 
 Software can be defined as the set of programs, procedures and algorithms related with 
the operation of a data processing system. In contrast with hardware, software is not touchable.   
 The algorithms for ADW acquisition and ADW processing modules were previously 
developed and integrated with the MATLAB
®
 language (version 2009a). User – friendly GUIs 
were previously built for each module, resulting in an uncomplicated and user - friendly 
software arrangement. Several improvements were made in both of them during this project, 
Figure 5.2 – Signal conditioning circuit. Adapted from [62]; 
Hardware & Software 
  
 
  53 
which resulted in a clear time - saving optimization while adding some new and necessary 
features. 
 
5.2.1 ADW Acquisition Module 
The ADW Acquisition Module efficiently acquires the pulses from the subject when 
coupled with the previously described hardware. No major modifications were done, except one 
new button, which was added so that the ADW Acquisition Module could perform a direction 
communication with ADW Pulse Analyzer (more on that in sub – chapter 7.1.1). 
 
5.2.2 ADW Pulse Analyzer 
 The acquired raw ADW may contain noise, artifacts and irregular waveforms. Also, 
each acquired pulse isn’t segmented, and so, before applying any operation to retrieve 
information from the ADW, we must prepare the ADW data for feature extraction. The ADW 
Pulse Analyzer was developed to possess all the routines that are necessary to extract, from the 
acquired pulses, the features points that are necessary for a sequential statistical and data mining 
analysis with the help of baseline noise removal and pulse segmentation routines. 
During this work, not only an aesthetic visual optimization was realized, but new 
functionalities were also implemented, including direct connections with the ADW Acquisition 
Module (see sub – chapter 7.1.1) and with an important stand – alone Bland – Altman GUI for 
repeatability assessment (see section 6.4.1.4.1). Other functionalities include processing suites 
for two different types of files: .mat (MATLAB
®
 compatible) and .arff (Weka
®
 compatible – see 
sub-section 6.4.2 and 6.4.3), a tool for automatic file merging and .bmp picture saving. 
Most of the ADW processing routines were already developed and discussed in 
previous works [14, 24]. They will only be briefly presented in the next sub – chapters.  
 
5.2.2.1 ADW onset calculation 
 The used algorithm for ADW onset determination was based on Li et al. (2010) [77]. It 
affirms that the onset of an ADW is related to a zero – crossing point before a maximal 
inflection of its derivative. A third order low pass Bessel filter is applied to the raw signal, 
which a cutoff frequency of 30 Hz to remove noises and artifacts that are common in 
unprocessed signals. Then, differentials are calculated and the local extreme that corresponds to 
the maximal inflection point of each pulse is determined by applying a magnitude threshold. 
Finally, and with the maximal inflections points determined, the first zero crossing before each 
maximum is calculated, matching the onset for each ADW pulse [24]. 
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5.2.2.2 Baseline noise removal  
 The baseline noise can be caused by electrical signal fluctuations, slow motion of the 
neck attached PZ probe, motion artifacts or due to patient breathing. If this noise isn’t properly 
removed, there will be an inaccurate determination of the characteristic points. Also, real time 
visualization results are improved without the baseline noise. 
 The PZ probe has real time baseline elimination based on a reliable baseline restorer 
[14]. Our software also has a baseline fit algorithm for baseline wander removal. This algorithm 
determines the baseline index points, and interpolates the baseline fit from the baseline indexes. 
The signal is corrected by vertical adjustment of each sample between two successive baseline 
indexes and matching the baseline point index to zero amplitude [24]. 
 
5.2.2.3 Morphological analysis 
 During acquisitions, motion artifacts originated from voluntary and involuntary subject 
movement causes volume changes in the ADW, and so, abnormal heartbeats can arise. After 
baseline removal, each ADW beat is analyzed, the mean ADW is calculated, and the RMSE 
between the mean ADW pulse and every individual pulse is calculated, and each pulse is 
computed. The criteria used to remove these pulses consisted in the presence of wide variations 
in amplitude and width pulse [24]. 
 
5.2.2.4 Pulse segmentation and normalization 
After the morphological analysis and abnormal pulse flagging, we should have a clean 
ADW signal. This signal is segmented into individual pulses while the abnormal flagged pulses 
are removed. As the acquired ADW is not calibrated, only morphological characteristics of the 
ADW are analyzed. Normalization procedures are needed to scale heterogeneous beats, so that 
their morphology can be compared efficiently [24]. 
 
5.2.2.5 Spatial feature extraction 
Diverse characteristic points can be extracted from each individual ADW pulse. The 
spatial feature extraction was based in the method proposed by Almeida et al. (2011) [25]. With 
this method, several ADW characteristic points were determined, enabling the possibility to 
classify the ADW type and to establish other parameters to be used in the future.  
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6. Methodology 
 
 
In this chapter, the work oriented procedures for ADW acquisition, ADW processing 
and posterior data pre – processing are described. The collected data was included in a 
database and different datasets were created to ultimately reach different objectives: dataset I 
will be used for repeatability assessment of the non – invasive system, dataset II will focus on a 
case study, and dataset III and IV will be used for classification and clustering methods, 
respectively. Demographic data for all the datasets are presented as well. 
 
 
6.1 ADW acquisition 
 
One hundred and fifty five volunteers (95 female), aged between 18 and 80 years were 
included in this study. Subjects were mainly recruited from advertisements placed in public 
platforms calling for healthy volunteers and from Centro Hospitalar e Universitário de 
Coimbra for unhealthy volunteers. The research was approved by the Committees of the Centro 
Hospitalar e Universitário de Coimbra.  
Before ADW acquisition, all subjects gave informal consent after full explanation of the 
purpose, nature and risk of the used procedures. Subject additional data was registered: age, 
gender, weight, height, smoking habits and diabetes history were collected, and body mass 
index (BMI) was calculated for all subjects. SBP, DBP and HR values were measured with an 
automatic digital oscillometric sphygmomanometer (Omron M6 Confort, Kyoto, Japan).  
In a few cases (especially in unhealthy subjects), obtaining SBP, DBP and HR could not 
be possible. And so, the guidelines in Table 6.1 were used to correct missing data. The age and 
the subject’s healthy or unhealthy status were considered in completing SBP, DBP and HR 
missing data. Age was divided in two groups for healthy subjects, < 40 and > 40, as SBP 
usually increases with aging in healthy subjects. For unhealthy subjects, it was acknowledged if 
they were in critical condition, or not. HR correction was always considered to 75 beats per 
minute (BPM), as it is the value for which AIx is usually corrected when assessing AIx @ 75 
BPM (although AIx was not corrected in this work). References values for SBP and DBP were 
taken from [78]. 
The patient measurement protocol was mainly based on the subject condition 
standardization of Van Bortel et al. (2002) [79]. Subjects remained quiet and seated on a 
comfortable chair. Acquisitions were made at a similar time of the day, and in the same 
temperature controlled room (22 – 23ºC), to minimize the climatic variation. The non – invasive 
PZ sensor is placed over the carotid artery during data acquisition and held by a collar to clench 
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the sensor in the patient’s neck, and to rule out the influence of the operator, because interaction 
of the sensor with the operator’s hand could increment additional noise. At least 3 acquisitions 
of roughly 30 – 40 seconds were made per subject.  
If differences between left and right carotid in a subject was studied, 3 acquisitions of at 
least 30 seconds were performed for each carotid. If repeatability assessment between months is 
performed, the subject would return roughly 1 month later to perform the acquisition once 
again, undergoing the same procedures and conditions as in the first monthly acquisition. 
 
 
 
 
6.1.1 ADW signal reproducibility 
After ADW acquisitions, ADW processing routines were performed for each 
measurement. ADW signal reproducibility was assessed after pulse segmentation methods to 
illustrate the low variability of this non – invasive method. 4 subjects with different ADW type 
predominance were chosen. For each ADW type, two consecutive waveform and five 
consecutive waveforms were extracted, and the average waveform was plotted as tested for 
correlation. 
 
6.2 Data pre - processing 
 
Before we analyze the data, it must be rigorously pre – processed to avoid low – quality 
results. Usual data cleaning routines (missing value removal and outlier identification) were 
executed to discover and correct discrepancies in data. The gain ratio attribute evaluator 
technique for irrelevancy and redundancy analysis was performed before data mining 
procedures. Data normalization to transform the attributes into a 0 to 1 range were applied to the 
data in neural network classification tasks, due to their need of standardized inputs to perform 
efficiently. 
In missing value removal routines, all type D ADWs (see section 2.3.2) were removed 
from the database. This was due a technical issue of the spatial feature extraction algorithm, 
which is not able to detect a reflection point (which is actually an intrinsic characteristic of the 
Missing Variable 
Healthy  
(< 40 years) 
Healthy  
(> 40 years) 
Unhealthy 
Unhealthy  
(critical condition) 
SBP (mmHg) 110 120 140 160 
DBP (mmHg) 75 80 90 100 
HR (bpm)                                                      75 
Table 6.1 – Guidelines for SBP, DBP and HR missing data, considering healthy and unhealthy subjects; 
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type D waveform) and, therefore, AIx can’t be calculated. As the reflection point and AIx 
values of the type D ADWs are equal to zero, the non – removal of these waveforms would 
eventually present inaccurate results of the subsequent descriptive statistics and data mining 
routines. And so, only ADWs from type A, B and C were stored in the database. 
 
6.3 Database 
 
After all data pre – processing routines were performed, the final result is a group of 
pulse tuples with a maximum of 29 features for each subject in both .mat and .arff format, and 
all the processed data are stored in a dedicated database. From all the subjects, roughly 80% are 
healthy subjects between 18-30 years old, 5% are healthy subjects between 30 – 70 years old 
and 15% are unhealthy subjects. 8% of the volunteers have data in for left/right and two 
successive months, for repeatability assessment reasons. 
We considered healthy volunteers as subjects with no documented history of CV 
disorders. Unhealthy subjects were classified according to their hypertensive status and CV 
disorder history. Age was not a discriminant factor in this manual classification. 
 
6.3.1 Feature characterization 
Each tuple is in fact, a previously parameterized pulse, and has a maximum of 29 
attributes (plus 1 attribute in the .arff file, which represents the desired class). Prominent points 
extracted from the ADW were selected: systolic point time (SPT), reflection point time (RPT), 
dicrotic wave time (DWT), systolic point amplitude (SPA), reflection point amplitude (RPA) and 
dicrotic wave amplitude (DWA). AIx was calculated according to the guidelines in Table 3. 
Other ratios of interest (R1 – R4) were calculated using the feature points extracted values. Some 
statistical measurements were performed to assess the variance associated to pulse morphology. 
For time and amplitude positions, the root mean square of successive differences (RMSSD) for 
each of prominent points. The full width at half maximum (FWHM) was also calculated for all 
pulses.  
Demographic data that was acquired after informal consent (age, gender, smoker, 
diabetes, height, weight, BMI, SBP, DBP, and HR) complete the feature composition. When 
applicable, the dataset class is classified as: 1 = healthy subjects, 2 = unhealthy subjects. Each 
attribute is further described and detailed in Table 6.2.  
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The work – oriented methodology from section 6.1 to 6.3 is expressed on Figure 6.1 in a 
concise graphical manner. 
Attribute Description Equation Unit 
SPT Time at systolic time / upstroke time 
-- 
[ms] RPT Time at  reflection point 
DWT Time at dicrotic wave 
SPA Systolic amplitude 
[a.u] RPA Reflected wave amplitude 
DWA Dicrotic wave amplitude 
AIx Augmentation Index See chapter 2.4.3 (Table 2.2) [%] 
R1 
Downstroke time between systolic 
and dicrotic wave 
|        | [ms] 
R2 
Quotient between dicrotic wave 
amplitude and systolic amplitude 
      ⁄  [a.u] 
R3 
Difference between systolic 
amplitude and reflected wave 
amplitude 
|        | [a.u] 
R4 
Quotient between systolic amplitude 
and reflected wave amplitude 
{
      ⁄             
            ⁄          
 [a.u] 
FWHM Full width at half maximum 
 
[ms] 
RMSE 
Root mean square error between each 
pulse and the average pulse (pulse 
morphology variability) 
√
∑ (          ) 
   
   
 
 [%] 
RMSSD_SPT 
Root mean square of successive 
differences of attribute X (RMSSDX), 
with X = SPT ˅ RPT ˅ DWT ˅ SPA ˅ 
RPA ˅ DWA 
√
∑ (        ) 
   
   
   
 
[ms] RMSSD_RPT 
RMSSD_DWT 
RMSSD_SPA 
[a.u] RMSSD_RPA 
RMSSD_DWA 
Age 
 
-- [years] 
Gender 1 = Male 2 = Female -- [male/female] 
Smoker 1 = Smoker 2 = Non - Smoker -- [yes/no] 
Diabetes 1 = No 2 = Yes -- [yes/no] 
Body height 
 
-- [m] 
Body weight 
 
-- [kg] 
BMI Body mass index 
          
(           ) 
 [kg/m2] 
SBP Systolic blood pressure -- [mmHg] 
DBP Diastolic blood pressure -- [mmHg] 
HR Heart rate -- [beats per minute] 
Table 6.2 – Description of all the attributes included in the database. Attributes with white background were used for 
dataset I and II. Attributes with white and brown background were used for dataset III. All the attributes on the table 
were used in dataset IV; 
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Table 6.3 – Demographic data comparison for each of the created datasets. Data are expressed as mean ± SD; 
 
 
6.4 Experimental datasets 
 
 In the database, each subject tuples can be posteriorly merged with other subject’s 
tuples automatically with the help of a tool, and without overlapping. This is crucial in creating 
different datasets without a time – consuming manual merging and for studying different 
aspects of scientific interest. Therefore, four different experimental datasets were created: 
dataset I was created for repeatability assessment and dataset II focused on a case study of a 
group of subjects which were monitored under carotid intervention. Dataset III and IV were 
created for data classification and data clustering procedures, respectively. Demographic data 
comparison is expressed in Table 6.3.  
 
 
 
* M.D – missing data 
 
Variable 
Dataset I Dataset II Dataset III Dataset IV 
  Sub – group I Sub – group II Diagnostic  
Age (years) 23.50 ± 2,43 72.5 ± 5.44 24.16 ± 3.86 58.16 ± 1..77 35,16 ± 11,77 21.19 ± 2,28 
Gender (M/F) 4/8 4/2 13/12 12/13 4/6 31/62 
Smoker (yes/no) 0/13 M.D* 3/22 4/21 1/9 7/86 
Diabetes (yes/no) 0/13 M.D* 0/25 2/23 M.D* 0/93 
Weight (kg) 59.66 ± 10.96 M.D* 65,28 ± 10,42 72.66 ± 14.13 M.D* 61.53 ± 10.25 
Height (m) 1.66 ± 0.06 M.D* 1,70 ± 0,06 1.64 ± 0.09 M.D* 1.68 ± 0.09 
BMI (kg/m
2
) 21.45 ± 2.71 M.D* 21,76 ± 4,89 29.08 ± 8.64 M.D* 21.62 ± 2.63 
SBP (mmHg) 105.25 ± 5.86 144.33 ± 40.08 110,20 ± 11,94 150.84 ± 26.29 M.D* 108.26 ± 11.88 
DBP (mmHg) 65.66 ± 6.71 81 ± 18.34 69,80 ± 10,17 88.92 ± 16.45 M.D* 69.54 ± 7.64 
HR (beats/min) 71.16 ± 10.64 72.5 ± 3.53 68,44 ± 10,72 63.04 ± 7.71 M.D* 70.84 ± 10.87 
Figure 6.1 – Work – oriented methodology; 
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6.4.1 Dataset I – Repeatability Assessment 
Dataset I is composed of 12 healthy subjects (8 female), aged < 30 years and with no 
documented history of CV disorders. Two successive monthly sessions containing both left and 
right carotid data were monitored. As referred in 6.1, at least 3 acquisitions of roughly 30 – 40 
were made per carotid on each subject, for a total of 3 trials per carotid site, per month.  In this 
group, only 7 attributes were used: SPT, RPT, DWT, SPA, RPA, DWA and AIx. This dataset has a 
total of 2983 pulses, with ≈ 200 – 250 pulses for each subject. 
In this dataset, the differences between trials (intra – subject variability), left and right 
carotid and between successive months for each subject were studied using statistical 
approaches, with the objective of assessing the repeatability of the developed non – invasive 
system in acquiring data.  
All data were analyzed with Predictive Analytics Software Statistics 18.0 (SPSS, Inc, 
Chicago, IL). The level of statistical significance was set at p < .05 for all analyses. A Bland - 
Altman GUI was developed to create, visualize and save Bland – Altman plots.  
 
6.4.1.1 Normality assessment 
The first step when dealing with new data is the normality analysis, to verify if there is 
any violation of the statistical techniques assumptions, which will ultimately decide in using a 
parametric or non – parametric test in advanced statistical analysis. All attributes were tested for 
normality using the KS, and divided by month, trial, carotid site and subject. If the significance 
result of the KS test is < .05, the null hypothesis is rejected, and the variable has a non – normal 
distribution. Else, the variable is normal. 
 
6.4.1.2 Correlation analysis 
Correlation analysis was performed to assess if linear relationships do exist among the 
seven variables. Scatterplots were constructed to primarily visualize possible relationships and 
to identify the existence of sub – groups in the dataset. With respect of the given result of our 
distributions (6.4.1.1), parametric and/or non – parametric correlation tests will be used to 
assess the strength and direction of possible correlation.   
 
6.4.1.3 General statistical analysis 
After the normality tests, and with the assistance of quantitative measures and boxplot 
graphics, a global view from our data divided by month and carotid site is checked. A 
categorization of the data by subject is also important, as pulse variability may be different from 
subject to subject. Sub – categorization by month, carotid site and trial are done for each 
subject. The objective of this general statistical analysis is to assess differences between groups. 
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Statistical tests were used to assess significant differences in AIx, for each subject, 
according to different sub – categorizations: between months, between left and right carotid and 
between trials. A low rate of significant differences between groups can be a landmark in 
validating the repeatability of the non – invasive system. With respect of the given result of the 
normality assessment, parametric and/or non – parametric approaches were used to assess the 
differences between groups. 
 
6.4.1.4 Agreement - Bland – Altman plots 
Bland – Altman plots were constructed only for the AIx attribute, as it is the 
hemodynamic index of interest. The objective is to assess the agreement between two 
measurements with the non – invasive system, which will ultimately show the repeatability of 
the AIx measured by the PZ probe. Each Bland – Altman plot will have 12 points, as each point 
represents a subject. The following agreements tests were conducted: 
 
 Test A - Month 1 & month 2 
 Test B - Month 1 right carotid & month 1 left carotid 
 Test C - Month 2 right carotid & month 2 left carotid 
 
6.4.1.4.1 Bland – Altman developed GUI 
A Bland – Altman GUI was developed in MATLAB during the course of this work due 
to difficulties in finding an efficient compatible Bland – Altman software. The software can 
measure the agreement between two variables with the same number of lines and one single 
column. The program only supports .mat – type files. If more than one column exists on the 
variable, the program considers the first column. If both samples have a different number of 
lines, the program stops. 
Figure 6.2 shows the software with the Bland – Altman graphic displayed at the center 
and with more information displayed in the left and right part of the GUI. The left part (Sample 
1 and Sample 2) displays each value of each variable, for direct quantitative comparison. The 
right part (Statistics) gives important quantitative information about the plotted Bland – Altman 
graphic, including the mean of differences, the SD, the coefficient of repeatability (CR, which is 
the same as 2*SD, the 2*SD + Mean and Mean – 2*SD limits and finally, the agreement, which 
is expressed as ratio, between 0 and 1. We expect 95% to be inside the limits, and so, an 
agreement value higher or equal to 0.95 will reveal good agreement. If somehow, any point is 
outside the limits (very common), the agreement will lower progressively. 
 The software also supports saving to .bmp image, or to .fig (MATLAB® Figure) and 
statistic values are saved in a .xls file (Microsoft Excel
®
 compatible). 
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6.4.2 Dataset II – Case Study: Angioplasty 
In this group, the same attributes as dataset I were used: SPT, RPT, DWT, SPA, RPA, 
DWA and AIx. Smoker, diabetes, weight, height and BMI information was not collected, as it 
was not necessary for the objective of this dataset. 
Subjects from dataset II suffered from stenosis and were monitored under angioplasty 
carotid intervention, in collaboration with Centro Hospitalar e Universitário de Coimbra. An 
angiography was carried out to visualize the blood circulation. The ADW was simultaneously 
collected with the developed PZ probe and the cardiac catheterization monitor Axiom Sensis 
(Siemens, Munich, Germany) invasive equipment. A small segment of 3 – 4 seconds was 
chosen from each method before and after carotid intervention. A direct comparison was 
performed, although it was only possible through visual inspection, due to limitations in the raw 
data availability that was obtained from the invasive device. 
 
6.4.3 Dataset III – Data Mining: Classification 
 Dataset III has three sub – groups included. The first sub – group is composed of 25 
healthy subjects, while the second sub – group is composed of 25 unhealthy subjects. Both of 
these sub – groups were used for classifier construction.  
 All attributes were used, except demographic data, for a total of 19 attributes (which 
class label totalizing 20). Categorical class values were determined for each sub – group, with 
the first sub – group having class = 1 (healthy) and the second sub – group having class = 2 
(unhealthy). Considering only the first and second sub – group, dataset III contains a total of 
Figure 6.2 – Bland – Altman for Repeatability Measurements software, with the Bland – Altman plot in the display; 
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2947 pulses. Attributes were normalized previously to any classification procedure, to speed up 
the learning phase and rule out weight problems (which are common in ANN). 
The third and last sub – group consists of undiagnosed subjects, in other words, subjects 
that weren’t used for classifier construction and have unknown class. 10 subjects that weren’t 
included in classifier construction compose this diagnostic sub – group and this multiple 
classification methodology will be tested against this undiagnosed sub – group to predict their 
CV condition. 
 As we have pre – determined classes in dataset III, it is an ideal dataset for classification 
procedures, in other words, constructing models that describe and distinguish between healthy 
and unhealthy subjects, for the purpose of being able to use the classifier to predict the class of 
subjects whose class label is unknown. For these classification procedures, Weka 3.6.4 
(Waikato Environment for Knowledge Analysis), which is a free machine learning software 
based in Java
TM
 language, was the preferred option, due to its affordability, versatility and 
efficiency. Weka supports .arff files (attribute - relation file format), which is one of the output 
files of the ADW Pulse Analzyer after ADW processing. 
 
6.4.3.1 Classifier selection 
 Eight classifiers, from four different types of classification methods, are selected to be 
constructed. Classifiers are evaluated according to their accuracy, sensitivity, specificity, 
precision and training speed. RMSE is also calculated for each classifier. The classifiers are: 
 
 Decision tree induction - C4.5 (which is named J48 in Weka) and random forest;  
 Associative classification - RIPPER (named JRip in Weka); 
 Bayesian classification - Naïve – Bayes and Bayesian network;  
 Neural networks – 1 – hidden layer MLP, 2 – hidden layers MLP and RBF;  
 
The three classifiers with best combined result of accuracy, specificity and sensitivity 
are chosen for the following multiple diagnostic procedure. 
 
6.4.3.1.1 ANN performance study 
Special focus was given to neural network methods, as they were never tested before 
among the previously performed classification procedures with the developed non – invasive 
system. Also, neural networks are quite sensitive to slight parameter changes, and so, a specific 
parameter tuning was performed for each neural network – based classifier, ensuring a 
maximization of the classifier’s accuracy in differentiating healthy from unhealthy subjects. 
Different parameter configurations were tested for each neural network, while manipulating one 
of the parameters and comparing the accuracy, sensitivity, specificity and precision measures 
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for each configuration. The best configurations are chosen for classifier comparison with 
decision tree induction, Bayesian and associative classification methods. 
During this neural network parameter tuning, all nominal attributes were removed, as 
neural networks cannot handle nominal values as inputs, but only as targets. In neural networks, 
the dataset was also normalized between 0 and 1. 
  
6.4.3.2 Diagnostic with multiple classifier methodology 
A multiple classifier methodology is used due to its potentialities in producing more 
reliable results in comparison with single classifier analysis. These ensemble methodologies 
consist on the assumption that the classification should not be based on the result of one, and 
only one classifier. This class prediction should be done by a combination of more than one 
classifier, minimizing the possibility of occurring FPs and FNs.  
A weight voting classification is adopted, and the 3 - best classifiers are assembled to 
predict the class of subjects. Considering that the voting system is equal – weighted for the three 
classifiers, if at least two classifiers consider the subject as healthy, the predicted class is 
healthy. Else, high CV risk factor/unhealthy is the given classification. 
 
6.4.4 Dataset IV – Data Mining: Clustering 
This dataset consists of 93 healthy and young subjects between 18 – 30 years, with no 
documented history of CV disorders with unknown class label. A total of 4471 pulses compose 
this dataset. All of these subjects’ data were obtained at two different moments: in March, while 
collaborating with SCDSOS (Sudden Cardiac Death Screening of Risk Factors) and in May, 
during a mobilized screening in the Department of Physics of the University of Coimbra in 
collaboration with MsC student Inês Santos. This dataset is destined for clustering methods, 
which will attempt to categorize the objects of the dataset into two and three different clusters, 
where each cluster will represent different risk groups based on arterial patterns. The full list of 
29 parameters was initially used for clustering procedures (with the unknown class attribute 
totalizing 30).  
The objective of the clustering method in the context of this dissertation is to find and 
distinguish different risk groups in terms of future CVD development in a healthy dataset. 
Just like in classification routines, Weka was the preferred software for clustering. Only 
two clustering methods were used: k – means algorithm and EM, due to Weka’s software 
limitations. 
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6.4.4.1 Two and three risk groups clustering 
EM and k – means clustering were used for partitioning the dataset in two distinct risk 
groups. Results were compared for each clustering method. For three risk groups partitioning, 
only the algorithm with more satisfying results was used.  
When k – means clustering is performed, the categorical attributes (gender, smoker, 
diabetes) were removed, due to k – means incompatibility with these features. So, for EM, 29 
attributes were used, and 26 attributes were used in k – means clustering. 
 
6.4.4.1.1 Attribute subset selection 
After the group clustering, attribute subset selection with the two partitioned class was 
performed to find the most important attributes in class determination for two and three risk 
groups. The gain ratio attribute evaluator with 10 – fold CVN attribute selection mode is the 
preferred attribute subset selection method.  
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7. Results & Discussion 
 
 
All the results for each dataset are presented this chapter. This section also presents 
inter – communication improvements between ADW acquisition and ADW processing GUIs and 
ADW signal reproducibility during acquisition.  
An extensive discussion is presented in the last sub – section of each dataset section. 
 
 
7.1 ADW acquisition 
 
ADW acquisition procedures went underway according to the guidelines presented in 
6.1. A minor but important modification is now presented, due to its importance in ADW 
acquisition routines. Signal reproducibility during acquisition is also assessed. 
 
7.1.1 Inter – communication between GUIs 
Even though the previously developed GUIs for ADW acquisition and ADW processing 
are fully functional, there was no direct communication between them. This evoked a big 
problem: the impossibility to confirm in the moment if the acquired signal was good for 
subsequent processing and feature points extraction, as sometimes, due to intrinsic or external 
factors, it was difficult to assess if a collected signal was well acquired by the platform, or not. 
This problem was solved by adding and programming a button that is able to transfer all the raw 
information from one GUI to another. 
In the Figure 7.1, it is possible to visualize the ADW Acquisition Module and the ADW 
Pulse Analyzer Module. There’s a highlight in the “Save&Transfer” button of the ADW 
Acquisition Module, which is responsible for transferring all the current acquired data to the 
ADW Pulse Analyzer Module. In the ADW Pulse Analyzer Module, the “Transfer from RS232” 
button is highlighted, and will successfully transfer the recently acquired raw signal for ADW 
analysis. 
With this minor adjustment, performing quality control procedures right after the 
ADW acquisition is directly feasible and, therefore, there is an improvement in the quality 
of parameter data stored in the database. 
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7.1.2 ADW signal reproducibility 
The next image shows two consecutive normalized ADWs from the same type, and 
from the same subject (Figure 7.2). Correlation results are also expressed in the figure. The 
subject selection in the database was random for each ADW type.  
 
 
Figure 7.2 – Signal reproducibility for each ADW type; 
Figure 7.1 – Communication between the APW Acquisition and APW Pulse Analyzer modules; 
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Table 7.1 – Correlation coefficient (r) results for 10 sets of two 
consecutive normalized pulses for each ADW type; 
Each ADW type has shown excellent reproducibility, with good correlation (r > 0.99) 
for all ADW types. Coefficient of determination (r
2
) values for each case are > 0.985 (lowest r
2
 
corresponds to ADW Type D = 0.9876).  
For each of the ADW types, 10 sets of two consecutive normalized pulses were 
randomly extracted for different subjects, and correlation coefficients were computed. Results 
are expressed in Table 7.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Globally, ADW type D has the lowest correlation coefficients, even though they are 
very satisfying. The lowest r
2
 in the table is Run 2 of ADW type D (r = 0.9834), with r
2
 = 
0.9670.  
Therefore, it is safe to say that spatial feature information that is extracted from the 
ADWs will present low variability between pulses, for the same subject. 
 
 
 
  
Set of 2 
consecutive 
pulses 
ADW Type 
A B C D 
1 0.9932 0.9940 0.9945 0.9934 
2 0.9935 0.9932 0.9923 0.9834 
3 0.9942 0.9954 0.9965 0.9912 
4 0.9897 0.9965 0.9956 0.9899 
5 0.9940 0.9954 0.9923 0.9876 
6 0.9953 0.9959 0.9920 0.9945 
7 0.9912 0.9972 0.9935 0.9865 
8 0.9916 0.9934 0.9956 0.9923 
9 0.9935 0.9979 0.9941 0.9912 
10 0.9932 0.9929 0.9922 0.9945 
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Table 7.2 – KS test significance values for each of the variables, categorized by month, carotid site and trial. 
Values in bold correspond to normal distributions. A P – value of < .05 was considered as significant; 
7.2 Dataset I – Repeatability Assessment 
  
 To successfully validate the repeatability of our sensor, its variability needs to be 
evaluated according to each of the groups included in the study: month, carotid site and subject.  
 
7.2.1 Normality assessment 
The results of the KS test for assessing the normality of our data in terms of month, 
carotid site and trial are expressed in Table 7.2.  Normality was also assessed for each subject, 
and results are represented in Table 7.3. 
 
 
 
 
The KS test for each of the categories (month, carotid site and trial) revealed that the 
dataset is non - normal in its majority. A normal distribution was presented in two occasional 
situations (and are represented in bold, on each table). When the KS test was performed with 
subject as a category (Table 7.3), results still indicate a non – normal distribution for every 
attribute, in overall. However, DWA and RPT evidenced normal distribution in some subjects. 
Concluding the normality assessment of dataset I, the data presented here is almost 
100% non – normal. This result was expected, as our dataset I is relatively large, and non – 
normal distributions are quite common in large datasets. These results might suggest that a latter 
non – parametric approach when using statistical tests to assess differences between groups 
might be a wiser choice, because in non – parametric tests, the values are converted to ranks, so 
the actual distribution of the values in a variable does not matter. 
 
 
Variable Total Month 1 Month 2 Left Right 
Trial 
1 
Trial 
2 
Trial 
3 
SPT (ms) < .05 < .05 < .05 < .05 < .05 < .05 < .05 < .05 
RPT (ms) < .05 < .05 < .05 < .05 < .05 < .05 0.10 < .05 
DWT (ms) < .05 < .05 < .05 < .05 < .05 < .05 < .05 < .05 
SPA (a.u) < .05 < .05 < .05 < .05 < .05 < .05 < .05 < .05 
RPA (a.u) < .05 < .05 < .05 < .05 < .05 < .05 < .05 < .05 
DWA (a.u) < .05 < .05 < .05 < .05 < .05 < .05 0.07 < .05 
AIx (%) < .05 < .05 < .05 < .05 < .05 < .05 < .05 < .05 
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Table 7.3 – KS test significance values for each of the variables, categorized by subject. Values in bold correspond to 
normal distributions. A P – value of < .05 was considered as significant; 
 
 
 
 
7.2.2 Correlation analysis 
Initially, and before performing any correlation tests, two scatter plots between some of 
the variables included in dataset I were constructed, for a primary correlation analysis. The 
scatterplots of RPT as a function of SPT and RPT as a function of AIx are presented in Figure 
7.3. 
 
 
 
 
In both scatter plots, it is possible to visualize the existence of two completely distinct 
groups. One of the groups represents pulses with negative AIx, which is related with late 
reflection wave arrival, and the other group represents pulses with positive AIx, directly related 
Variable 
Subject 
1 2 3 4 5 6 7 8 9 10 11 12 
SPT (ms) < .05 < .05 0.17 < .05 < .05 < .05 < .05 < .05 < .05 < .05 < .05 < .05 
RPT (ms) < .05 < .05 < .05 < .05 < .05 < .05 < .05 < .05 0.12 0.21 0.47 < .05 
DWT (ms) < .05 < .05 < .05 < .05 < .05 < .05 < .05 < .05 < .05 < .05 < .05 0.06 
SPA (a.u) < .05 < .05 < .05 < .05 < .05 < .05 < .05 < .05 < .05 < .05 < .05 < .05 
RPA (a.u) < .05 < .05 < .05 < .05 0.10 < .05 < .05 < .05 0.26 < .05 < .05 < .05 
DWA (a.u) < .05 < .05 < .05 0.13 0.19 0.21 < .05 0.10 < .05 0.45 0.25 0.14 
AIx (%) < .05 < .05 < .05 < .05 0.28 < .05 < .05 0.54 < .05 < .05 < .05 < .05 
Figure 7.3 – Scatter plot of (a) RPT as a function of SPT; and (b) RPT as a function of AIx; 
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Table 7.4 – Analysis with the Pearson’s product – moment correlation test for Group A and Group B. r values are 
expressed in each cell. Numbers on bold indicate strong correlation; 
with early reflection wave arrival (and consequently, late systolic time point). For that reason, 
the correlation analysis will be performed for two separate groups. In group A, all pulses 
will have negative AIx (which means that RPT > SPT). Group B will have the remaining 
pulses, which have positive AIx (where RPT < SPT).  
Correlation analysis with the Pearson’s test was performed for both groups individually, 
to assess the strength and direction of possible linear associations between variables. Although 
the data is non – normal, dataset I is large enough to use a parametric alternative. Results of the 
correlation analysis with the Pearson’s test for both groups are presented in Table 7.4. 
Guidelines by Cohen (1988) [59] will be used to determine if the correlations reveal strong, 
medium or low associative significance (see Table 3.2). 
 
 
 
 
 
 
Group A 
Pearson’s 
SPT (ms) RPT (ms) DWT (ms) SPA (a.u) RPA (a.u) DWA (a.u) AIx (%) 
SPT (ms)  0.618 0.351 0.557 0.292 0.351 0.292 
RPT (ms) 0.618  0.405 0.370 -0.361 -0.131 0.361 
DWT (ms) 0.309 0.405  0.284 -0.027 -0.343 -0.027 
SPA (a.u) 0.557 0.370 0.284  0.412 0.336 0.412 
RPA (a.u) 0.292 -0.361 -0.027 0.412  0.657 1.000 
DWA (a.u) 0.351 -0.131 -0.343 0.336 0.657  0.657 
AIx (%) 0.292 0.361 -0.027 0.412 1.000 0.657  
Group B 
Pearson’s 
SPT (ms) RPT (ms) DWT (ms) SPA (a.u) RPA (a.u) DWA (a.u) AIx (%) 
SPT (ms)  0.775 0.927 -0.005 0.091 -0.230 -0.091 
RPT (ms) 0.775  0.750 -0.131 0.487 -0.246 0.487 
DWT (ms) 0.927 0.750  -0.078 0.133 -0.326 0.133 
SPA (a.u) -0.005 -0.131 -0.078  0.017 0.037 0.017 
RPA (a.u) 0.091 0.487 0.133 0.017  0.189 -1.000 
DWA (a.u) -0.230 -0.246 -0.326 0.037 -0.189  0.189 
AIx (%) -0.091 0-287 -0.133 -0.017 -1.000 0.189  
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Analysis will be given for each group in separate: 
 
 Group A – This group represents all pulses with negative AIx. A strong linear 
correlation between SPT and RPT was determined. Other strong associations are 
found between RPA and DWA, and SPT and SPA. However, one of the 
associations revealed perfect positive association: RPA and AIx. As RPA values 
get smaller, AIx values will also be negatively smaller, even if it usually 
represents a good result in terms of arterial stiffness. 
 Group B – This group represents all pulses with positive AIx. As in group A, a 
strong linear association between SPT and RPT was determined. A strong linear 
association between DWT and RPA can also be visualized. In group B, instead 
of a perfect positive correlation between RPA and AIx, the result is a perfect 
negative correlation. In other words, when RPA is lower, AIx is subsequently 
higher (which indicates high arterial stiffness). 
 
This perfect association between RPA and AIx in both groups separately is not visible 
when both groups are coupled. This is logical, as RPA only indicates the strength of the AIx. 
The direction is determined by the comparison between SPT and RPT, with a negative AIx 
occurring when RPT > SPT and a positive AIx arising when SPT > RPT. If one would try to 
assess the correlation between RPA and AIx with groups coupled, a very low association would 
be presented, as the direction of the RPA values was not preserved when AIx values rose.  
 
7.2.3 General statistical analysis 
A comprehensive quantitative and visual statistical analysis follows, complemented 
with the use of statistical tests, if needed to confirm a hypothesis.  
 
7.2.3.1 Categorization by month 
While giving a quick overview of dataset I, Table 7.5 also compares dataset’s I 
descriptive data categorized by month. A Mann – Whitney U non – parametric test was 
conducted to compare each of the continuous variables between months. Also, and as we are 
dealing with non – normal data, an AIx boxplot was constructed to visualize the median and the 
range in a simple and visual manner (Figure 7.4). 
At a first look, it is possible to verify the existence of big differences between SPT 
between month 1 and month 2, with month 1 having lower SPT. RPT only changed slightly, and 
so we will have a lower AIx value in month 1 than in month 2. As for SPA, RPA and DWA, they 
seem to reveal very low variability, mainly because they are normalized attributes. However, 
Results & Discussion 
 
 74  
Table 7.5 – Descriptive data categorized by month. All data is expressed as mean ± 
SD. P indicates the Mann – Whitney test significance value. A P – value of < .05 was 
considered as significant; 
the Mann – Whitney test revealed that there are significant differences between months, in 
all seven variables. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The boxplot of Figure 7.4 also displays a lower AIx for the first month. The median AIx 
for the first and second month is -6.66% and 3.89%, respectively, which represents a huge 
difference, in overall. 
 
 
 
  
 
Variable Total Month 1 Month 2 P 
SPT (ms) 166.27 ± 62.44 155.63 ± 58.76 177.74 ± 64.26 < .05 
RPT (ms) 167.70 ± 37.36 168.90 ± 40.12 166.41 ± 34.09 < .05 
DWT (ms) 289.47 ± 52.27 285.98 ± 61.72 293.23 ± 39.31 < .05 
SPA (a.u) 0.996 ± 0.008 0.996 ± 0.008 0.996 ± 0.009 < .05 
RPA (a.u) 0.87 ± 0.08 0.86 ± 0.085 0.88 ± 0.066 < .05 
DWA (a.u) 0.71 ± 0.14 0.70 ± 0.15 0.72 ± 0.13 < .05 
AIx (%) -1.16 ± 15.05 -2.67 ± 15.94 0.48 ± 13.84 < .05 
Figure 7.4 – Boxplot of the AIx categorized by month. The median for the first measurement is -6.66% and 3.89 
for the second measurement; 
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Table 7.6 – Descriptive data categorized by month and sub – categorized by carotid site, to assess differences between 
left and right carotid in each month. All data is expressed as mean ± SD. P columns indicate the Mann – Whitney test 
significance value. A P – value of < .05 was considered as significant; 
Outliers can be having a huge impact in these dissimilarities between months, but as 
was referred before, in the methodology, no outlier elimination was executed, as it was 
hypothesized that they could have special meaning. It should be also reminded that this table 
only gives a global overview of the variability of our data between months, and subjects need to 
be analyzed individually. Even if the dataset’s difference between months is significant, that 
does not mean that each subject has significant differences between months. A categorization by 
subject, sub – categorized by month will be later performed.  
 
SPA was removed from subsequent statistical analysis, as it was previously normalized 
to values ≈ 1, during pre – processing. Hence, its relevance in the analysis is negligible. 
 
7.2.3.2 Categorization by carotid site and month 
Table 7.6 and Figure 7.5 AIx boxplot display the differences between left and right 
carotid in each month. A Mann – Whitney non – parametric test was performed to compare each 
of the variables carotid site differences in each month. 
  
 
 
   
A primary analysis, complemented with the Mann – Whitney statistical test reveals 
that there are no significant differences between left and right carotid in each month and, 
therefore, measuring on the left or right carotid may be irrelevant considering our dataset I 
population (< 30 years).  
Variable Total 
Month 1 
 
Month 2  
Left Right P Left Right P 
SPT (ms) 166.27 ± 62.44 159.02 ± 63.44 153.14 ± 55.15 0.85 178.52 ± 64.28 176.94 ± 64.27 0.49 
RPT (ms) 167.70 ± 37.36 165.97 ± 36.867 171.04 ± 42.24 0.11 165.98 ± 32.56 166.84 ± 35.61 0.16 
DWT (ms) 289.47 ± 52.27 290.03 ± 65.34 283.01 ± 58.80 < .05 294.53 ± 35.78 291.91 ± 42.60 0.15 
RPA (a.u) 0.87 ± 0.08 0.85 ± 0.09 0.87 ± 0.08 < .05 0.88 ± 0.06 0.88 ± 0,07 0.33 
DWA (a.u) 0.71 ± 0.14 0.71 ± 0.15 0.70 ± 0.15 0.10 0.73 ± 0.12 0.73 ± 0,13 0.81 
AIx (%) -1.16 ± 15.05 -2.12 ± 17.44 -3.07 ± 14.75 0.31 0.58 ± 14.28 0.36 ± 13,38 0.64 
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Figure 7.5 – Boxplot of the AIx categorized by carotid site and by month. For the first month, the AIx right and 
left carotid median is -7.31% and -5.73%, respectively. For the second month, the AIx right and left carotid median 
values are 3.58% and 4.96%, respectively; 
Figure 7.5 reveals almost identical median for each of the carotid site while sub – 
categorized in each month. 
 
 
 
 
  
When considering the first month, the AIx right and left carotid median is -7.31% 
and -5.73%, respectively. As for the second month, the AIx right and left carotid median 
values are 3.58% and 4.96%, respectively.  
 Finally, a Mann - Whitney U test was performed to find out if there are AIx 
differences between left and right carotid site, without month categorization. A P – value < 
.05 was considered as significant. Results demonstrated that there were no significant 
differences between left and right carotid site (U = - 1, 89, P = 0.06). Accordingly, the null 
hypothesis is not rejected. Although, this significance value is quite small and there is a 
higher risk of erroneously accepting the null hypothesis. The small significance value can be 
explained by the fact that both months were considered, and as assessed in sub – chapter 
7.2.2.1, there are significant differences between months. An individual approach must be 
performed to assess this. 
 Concluding, no dissimilarities are found not only between measurements in 
right and left carotid in each month, but also between left and right carotid without 
month categorization. 
 
7.2.3.3 Categorization by subject 
An analysis of our data while categorized by subject seems like the most efficient way 
of describing the information at our disposal, as pulse variability may differ from subject to 
subject regarding each of the seven attributes and a particular analysis must be executed.  
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Figure 7.6 – Boxplot of the AIx categorized by subject; 
Table 7.7 – Table of each subject AIx IQR; 
As AIx is the hemodynamic parameter of interest, it will be the only studied parameter 
in this section. Figure 7.6 displays an AIx boxplot, categorized by each of the twelve subjects 
that compose this dataset, and complemented with the IQR of the AIx of each subject (Table 
7.7). 
 
 
 
 
Figure 7.6 is very useful for visualizing the variability on each subject. Seven subjects 
(1, 2, 5, 6, 8, 11 and 12) present a negative AIx as a median value, and the other five volunteers 
(3, 4, 7, 9 and 10) present positive AIx. As hypothesized, relevant differences exist between 
subjects and a particular analysis is the most correct approach.  
 
 
Without any sub – categorization, it can be assessed that in there are subjects with low 
to medium-high variability. Subjects with medium high – variability contain a larger IQR and 
more extended ± 1.5 × IQR limits.  
The lowest variability is found on subject 3, which also has the highest AIx of all the 
subjects. This can be explained by the fact that the subject is a woman and is the eldest of the 
sample (29 years). Women tend to have higher AIx values than men, and with aging, AIx also 
increases. Subject 6 and 9 also have low variability (but the latter presents excessive outliers). 
AIx (%) 
Subject 
1 2 3 4 5 6 7 8 9 10 11 12 
IQR 17.25 16.57 3.78 13.25 10.67 9.24 17.89 14.55 4.75 15.99 16.95 16.96 
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Table 7.8 – Table of each subject AIx divided by month. AIx median values are indicated. Mean rank, U and P 
represent the conclusions given by the Mann Whitney test. A P – value of < .05 was considered as significant; 
Medium variability is found on subject 2, 5 and 10. A latter sub – categorization of each subject 
by month, carotid site and trial can be crucial in finding out where the variability truly lies. 
Significant differences exist between subjects and, therefore, different ADW profiles 
can be found on this dataset. 
 
7.2.3.3.1 Sub – categorization by month 
A statistical analysis of each subject sub – categorized by each month can be helpful in 
assessing the differences between months on each subject. A Mann – Whitney U test was 
conducted to assess if these AIx dissimilarities do exist between months, in each subject. 
Results are expressed in Table 7.8. 
 
 
 
Table 7.8 indicates that only subject 1 and 4 did not present significant differences 
between months. Even subjects with few differences in the median (subjects 2, 3 and 5) 
revealed high dissimilarities between each month. This could be due to differences in the 
variability of each month measurement, which is directly influencing the ranks.  
Subject Month Median AIx (%) Mean rank U P 
1 
Month 1 -6.06 98.98 
-0.323 0.75 
Month 2 4.48 101.65 
2 
Month 1 -9.14 120.29 
-2.345 < .05 
Month 2 -8.35 142.22 
3 
Month 1 19.85 141.42 
-3.116 < .05 
Month 2 18.54 112.67 
4 
Month 1 6.13 75.87 
-1.076 0.28 
Month 2 3.97 83.73 
5 
Month 1 -19.68 183.45 
-4.460 < .05 
Month 2 -15.76 236.21 
6 
Month 1 -8.91 150.75 
-7.637 < .05 
Month 2 -16.07 82.07 
7 
Month 1 9.47 155.06 
-3.548 < .05 
Month 2 11.08 193.66 
8 
Month 1 -12.10 124.86 
-5.577 < .05 
Month 2 -4.06 181.27 
9 
Month 1 6.34 59.12 
-3.420 < .05 
Month 2 9.26 83.70 
10 
Month 1 -2.39 105.88 
-4.812 < .05 
Month 2 11.55 150.42 
11 
Month 1 -9.02 92.00 
-6.218 < .05 
Month 2 4.62 148.38 
12 
Month 1 13.11 117.39 
-5.406 < .05 
Month 2 -3.41 74.00 
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Figure 7.8 – Boxplot of the AIx categorized by subject and sub – categorized by carotid site; 
Figure 7.7 – Boxplot of the AIx categorized by subject and sub – categorized by month; 
Figure 7.7 display AIx boxplots for each subject, divided by month. Most of the 
subjects present unexpected variabilities in the quartiles, between months. The given result 
directly agrees with the conclusion drawn from sub – section 7.2.3.1: there are significant 
differences in AIx between months, as only 2 of 12 subjects presented no AIx 
dissimilarities in each month.  
 
 
 
 
7.2.3.3.2 Sub – categorization by carotid site 
A statistical analysis of each subject sub – categorized by each month can be helpful in 
assessing the differences between months on each subject. Figure 7.8 displays AIx boxplots for 
each subject, divided by carotid site. 
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Table 7.9 – Table of each subject AIx divided by carotid site. AIx median values are indicated. Mean rank, U and 
P columns represent the conclusions given by the Mann Whitney test. A P – value of < .05 was considered as 
significant; 
While performing a visual investigation, and in most of the subjects, few differences 
can be spotted between the median AIx in the carotid site. Discarding the variability of left and 
right measurements, few or no dissimilarities between each median are found in subjects 1, 3, 5, 
6, 7, 10 and 11. Subjects 4, 9 and 12 present medium median variations, while subjects 2 and 8 
are highly influenced by the carotid site. However, it is important to confirm if few differences 
do exist with a statistical test, in this case, and once again, the best option in the Mann – 
Whitney test.  
Table 7.9 displays the medians sub – categorized by carotid site, for each subject. A 
Mann – Whitney U test was performed to assess the existence of AIx dissimilarities between 
left and right carotid, on each subject. 
 
 
 
 
 
Mann – Whitney U test revealed no significant differences between left and right 
carotid site in subjects 1, 3, 6, and 11. Unexpectedly, significant differences were found 
between left and right in subject 5, 7, and 10. Subject 5 revealed significant differences at P = 
Subject Carotid site AIx median (%) Mean rank U P 
1 
Right -5.18 98.68 
-0,502 0.62 
Left -4.46 102.82 
2 
Right -13.75 82.00 
-11,955 < .05 
Left 2.86 194.59 
3 
Right 19.73 139.99 
-1,822 0.07 
Left 18.18 129.48 
4 
Right 2.97 60.53 
-4,769 < .05 
Left 9.42 95.38 
5 
Right -16.93 220.09 
-2,604 < .05 
Left -18.63 189.33 
6 
Right -11.28 116.63 
-0,764 0.45 
Left -9.49 123.46 
7 
Right 9.48 157.42 
-2,777 < .05 
Left 10.96 187.26 
8 
Right -3.62 194.37 
-8,474 < .05 
Left -14.92 109.83 
9 
Right 7.65 60.47 
-3,383 < .05 
Left 9.64 84.43 
10 
Right 9.02 107.89 
-4,216 < .05 
Left 12.04 146.97 
11 
Right -5.74 120.74 
-0,580 0.56 
Left -3.52 126.39 
12 
Right 3.95 112.46 
-6,308 < .05 
Left -4.86 63.43 
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.05, but does not reveal significant differences at a P = .01 level (U = – 2.777, P = 0.01), which 
can be a clear indication that the difference is not so significant at all. 
 
7.2.3.3.3 Sub – categorization by month and carotid site 
A Mann – Whitney test is conducted to assess differences between left and right 
carotid in each subject, while considering each month separately. Results are quite interesting 
(as they are extensive, they are presented in Appendix A). For subjects 1, 3, 5, 7, 9, 11 and 12, 
at least one month revealed no differences in the AIx values between left and right carotid. 
However, subject 6 revealed significant differences in each month, which clearly contradicts the 
result expressed on table 7.8. This means that differences do exist in subject 6 as well. 
These results and the result expressed in 7.2.3.3.2 do not contradict the 
conclusions that were reached in 7.2.3.2, because in most of the subjects, at least one 
measurement revealed that there are no significant differences between left and right 
carotid. However, it is enough to distrust them.  
 
7.2.3.3.4 Sub – categorization by month, carotid site and trial 
 It is important to evaluate the intra – subject AIx variability. A low variability between 
different trials is expected, considering that the subject and the room remain in the same 
conditions (section 6.1) between each trial.  
 In each subject, trials were further sub – categorized by month and carotid site. This was 
done because results prior to this study revealed that there were significant differences between 
months, and that similarities between left and right carotid site do seem to exist, but cannot be 
totally trusted. Due to its power to assess if dissimilarities exist between three or more groups, 
the Kruskal – Wallis H test was performed between the three trials, divided by left and right 
carotid site, on each month. A P – value < .05 was considered as statistically significant. The 
table results are very extensive, and so, they are presented in Appendix B. The conclusions 
obtained regarding intra – subject variability follows:  
 
 Subject 1 – In month 1, the three trials of each carotid site did not present 
significant dissimilarities [Right: X
2
 = 0.491, P = 0.78, Left: X
2
 = 0.539, P = 
0.76]. In month 2, trials did not present significant differences only in right 
carotid site [X
2
 = 4.798, P = 0.09]. 
 Subject 2 – In month 1, no significant discrepancies between trials was 
obtained only in left carotid [X
2
 = 4.798, P = 0.09]. In month 2, both carotid 
sites revealed no significant differences between trials. [Right: X
2
 = 2.606, P = 
0.27, Left: X
2
 = 3.915, P = 0.14].  
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 Subject 3 – In month 1, both carotid sites revealed significant differences 
between trials. In month 2, only right carotid site did not present dissimilarities 
[X
2
 = 2.815, P = 0.24]. 
 Subject 4 – In month 1, only the left carotid site did not reveal significant 
differences in AIx between trials [X
2
 = 5.664, P = 0.06]. In month 2, both 
carotid sites did not present significant discrepancies between trials [Right: X
2
 = 
0.201, P = 0.90, Left: X
2
 = 1.370, P = 0.50]. 
 Subject 5 – The only non – significant result is in month 1, in the right carotid 
site. [X
2
 = 4.426, P = 0.10]. 
 Subject 6 – In month 1, both carotid sites did not present significant differences 
[Right: X
2
 = 3.322, P = 0.19, Left: X
2
 = 0.079, P = 0.96]. In month 2, right 
carotid site did not present significant differences at P = .05 [X
2
 = 4.503, P = 
0.10]. Left carotid site presented significant differences at P = .05, but is 
considered as a not significant result at P = .01 [X
2
 = 6.981, P = 0.03]. 
 Subject 7 – In month 1, dissimilar results between trials were obtained in both 
carotid sites. On the other hand, month 2 left and right carotid site trials 
presented results with no dissimilarities between trials. [Right: X
2
 = 4.243, P = 
0.12, Left: X
2
 = 2.894, P = 0.24]. 
 Subject 8 – In month 1, both right and left carotid site did not have significant 
discrepancies between trials [Right: X
2
 = 3.134, P = 0.21, Left: X
2
 = 1.087, P = 
0.58]. In month 2, left carotid did not present significant dissimilarities [X
2
 = 
1.175, P = 0.56]. Right carotid site presented significant differences between 
trials at P = .05, but is considered as a not significant result at P = .01 [X
2
 = 
6.138, P = 0.046]. 
 Subject 9 – In both months, left carotid site did not reveal significant 
differences in AIx between trials [Month 1: X
2
 = 0.542, P = 0.76, Month 2: X
2
 = 
0.542, P = 0.76]. 
 Subject 10 – In month 1, left and right carotid site revealed significant 
differences between trials. In month 2, both carotid sites revealed no 
dissimilarities between trials [Right: X
2
 = 0.875, P = 0.64, Left: X
2
 = 5.900, P = 
0.052]. 
 Subject 11 – In month 1, only the left carotid site presented no significant 
differences in AIx between trials [X
2
 = 0.626, P = 0.73]. In month 2, the left 
carotid site did present no significant differences between trials, as well [X
2
 = 
1.264, P = 0.53]. 
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Figure 7.9 – Bland – Altman AIx plot between month 1 and month 2. The bias is -1.5%, and the upper 
and lower limits are 11.43% and -14.43%, respectively; 
 Subject 12 – In month 1, both carotid sites revealed no significant 
discrepancies between trials [Right: X
2
 = 5.638, P = 0.06, Left: X
2
 = 0.356, P = 
0.84]. In month 2, the result was equally satisfactory, with both carotid sites 
revealing no significant differences in AIx between trials [Right: X
2
 = 2.023, P 
= 0.36, Left: X
2
 = 5.172, P = 0.08]. 
 
All subjects revealed at least one comparison between three trials that did not present 
significant differences. No dissimilarities between trials in both right and left carotid site in a 
single month can be noticed in most of the subjects (subjects 1, 2, 4, 6, 7, 8, 10, 12). In four 
possible not – significant outcomes for each subject, six subjects presented three not – 
significant results. One subject revealed four not – significant outcomes. In conclusion, the AIx 
variability between trials has shown excellent results. 
 
7.2.4 Agreement assessment 
This sub - section will reveal the results of the Bland – Altman plots. Further sub – 
sections are made for each of agreements of interest (see section 6.4.1.4): 
 
7.2.4.1 Test A - Month 1 & month 2 
Figure 7.9 displays a Bland – Altman AIx plot of two measurements: month 1 and 
month 2. The bias is -1.5%, and the upper and lower limits are approximately 11.43% and -
14.43%, respectively. 
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Figure 7.10 – Bland – Altman AIx plot between month 1 left carotid and month 1 right carotid. The bias 
is 3.44%, and the upper and lower limits are 21.32% and -14.44%, respectively; 
The AIx bias between month 1 and month 2 differs a bit from zero. However, it is a 
small difference (1.5%), and considering that we are measuring AIx and a variation of 1.5% can 
be considered as irrelevant, it is not clinically significant. No trends can be visualized, and the 
variability looks quite consistent along the graphic. Not all of differences between 
measurements between month 1 and month 2 lie within the limits of agreement, as 91.7% of the 
differences are inside the limits. This value is quite high, nonetheless, which can be a clear 
indication that there is a relative agreement in AIx between months. 
 
7.2.4.2 Test B - Month 1 right carotid & month 1 left carotid 
The following figure displays a Bland – Altman AIx plot of two measurements: month 
1 right carotid and month 1 left carotid. The bias is 3.44%, and the upper and lower limits are 
21.32% and -14.44%, respectively. 
The AIx bias between month 1 and month 2 differs from zero by 3.44%. No trends can 
be visualized, but the variability increases in the extremes. All of differences between 
measurements between month 1 and month 2 lie within the limits of agreement. 
 
 
 
 
7.2.4.3 Test C - Month 2 right carotid & month 2 left carotid 
Figure 7.11 displays a Bland – Altman AIx plot of two measurements: month 2 right 
carotid and month 2 left carotid. The bias is -0.70%, and the upper and lower limits are 16.03% 
and -17.44%, respectively. 
The bias is relatively low (0.70%), which means that there is low discrepancy between 
left and right measurements in month 2. Variability is consistent, and no patterns can be 
visualized. Only one of the differences between measurements does not lie within the limits of 
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Figure 7.11 – Bland – Altman AIx plot between month 2 left carotid and month 2 right carotid. The bias 
is -0.70%, and the upper and lower limits are 16.03% and -17.44%, respectively; 
agreement, which represents relatively good agreement. A comparison between test B bias with 
the given bias for test C reveals that month 1 measurement was of lower quality while compared 
with month 2. However, there is enough agreement between AIx values in left and right 
carotid site on each month. 
 
 
 
 
7.2.5 Dataset I – Discussion 
There are significant differences in AIx between months, as only 2 of 12 subjects 
presented no AIx dissimilarities in each month (sections 7.2.3.1 and 7.2.3.3.1).  
A Bland – Altman AIx plot revealed low bias and relative agreement between 
months (sections 7.2.4.1, 7.2.4.2 and 7.2.4.3). 
The fact that there are significant differences in AIx between months does not 
necessarily mean there is lack of agreement between months. A low bias revealed that both 
measurements revealed very similar results on average. There is relative agreement, as 91.7% of 
the differences between months are inside the limits of agreement. But, in spite of that, the 
Bland – Altman method assumes that 95% of measurements must be inside both limits of 
agreement, so there is not a total agreement. 
Some problems must have interfered with the measurements while assessing month – to 
– month repeatability. As revealed in 7.2.4.2 and 7.2.4.3, month 1 revealed a bias that was 
higher than unexpected, which could mean that the quality of the measurement was not as good 
as in the second month. Also, misplacement of the sensor at the carotid or differences in the 
subject/room that passed unnoticed to the operator while doing the second measurement can be 
some of the possible explanations. More studies need to be performed between sessions and/or 
months.  
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No AIx dissimilarities are found not only between measurements in right and left 
carotid in each month, but also between left and right carotid without month 
categorization (section 7.2.3.2). Bland – Altman plots have also revealed that there is 
enough agreement between AIx values in left and right carotid site on each month 
(sections 7.2.4.2 and 7.2.4.3). 
A further statistical analysis categorized by subject revealed that those 
dissimilarities were not so significant at all, as for most of the subjects, at least one 
measurement revealed that there are significant differences between left and right carotid.  
Results were not totally contradicted, and the assumption that there are no differences 
between left and right is maintained. However, these results could be mistrusted (section 
7.2.3.3.2 and 7.2.3.3.3). 
The subject by subject analysis revealed that more studies are needed to ultimately 
confirm that there are no differences between left and right carotid in a young dataset. Still, 
there is enough evidence to assume that few differences seem to exist between left and right 
carotid site AIx in dataset I, which is composed of young subjects (18 – 30 years). Still, one 
should always consider the possibility (even if improbable) that a cardiovascular disorder in one 
of the carotid arteries of a subject may be interfering with given results. Also, for some subjects, 
one of the carotid sites was harder to capture efficiently, which could definitely influence the 
acquired ADW and consequently, the extracted parameter values. 
The fact that few differences exist between left and right coincides with a recent study 
from Luo et al. (2011) [80]. This study concluded that dissimilarities in left and right carotid 
only start to exist from 35 years onwards, with the left carotid becoming thicker than right 
carotid due to hemodynamic and biochemical different effects on the carotid intima – media 
thickness of each carotid site. Increased AIx is associated with increased intima – media 
thickness, as both are associated with CV risk. As the dataset I age range is between 18 – 30 
years, no differences between left and right carotid site should be observed. And results from 
dataset I indicate that in both months, the left carotid seems to be slightly thicker (due to higher 
AIx), but not enough to be considered as a statistically significant result.  
A more rigid approach in ‘catching’ the carotid to acquire the ADW of each subject 
and wider time measurements (≈ 60 – 80 seconds) are important guidelines for improvements in 
future carotid site measurements. A ‘live’ ADW quality control procedure right after the 
acquisition method could be very useful, so that each of the signals that are stored in the 
database have assured top – quality. 
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The AIx variability between trials has proved excellent results, with good AIx 
repeatability between trials (section 7.2.3.3.4). 
The fact that a good AIx repeatability between trials was ascertained is extremely 
important, as it strengthens the possibility that differences between months and left and right 
carotid site could be due to sensor displacement. During each of the three trials, sensor is not 
displaced, and remains fixed in the same position, and considering that the seated subjects 
remains seated, comfortable and in the same temperature controlled room, it is expected that the 
results should correspond to good repeatability. 
While practicing scientific investigation, the quality of the research is directly related 
with the quality of the used instruments. Therefore, this result also assures that the uncertainties 
regarding repeatability between months and between left and right carotid are not due to 
hardware, firmware underperformance, software imperfections, but mainly due to overlooked 
guidelines in the acquisition process between months. More rigid and demanding patient 
measurement protocols could and should be implemented, to minimize even further any 
possible external influences. 
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7.3 Dataset II – Angioplasty: Case Study 
 
Figure 7.12 shows a set of three – four pulses detected invasively and non – invasively, 
before and after carotid intervention. 
 
 
 
 
 
 
ADW physiological differences can be denoted before and after angioplasty, revealing 
that anomalous reflection waveform disappeared with the carotid intervention. This 
phenomenon is detected not only by the reference method, but also by the developed non – 
invasive system.   
The SPT, RPT and DNT attributes were measured for the non – invasive method before 
and after the angioplasty procedure (Figure 7.13). As expected, DNT associated time did not 
change, due to the inexistence of known cardiac valves complications. However, visible 
changes occurred in the SPT and RPT analysis. Before the surgical procedure, RPT occurs earlier 
than SPT, but after the intervention, this tendency is inverted, with SPT occurring first than RPT. 
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Figure 7.12 – Set of three – four pulses that were detected invasively and non – invasively, before and after 
carotid intervention, for the same subject. RPT for a specific pulse is represented by red and blue circles, 
corresponding to APW collected before and after carotid intervention, respectively; 
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7.3.1 Dataset II – Discussion 
In general, non – invasive measurements are less accurate when compared with invasive 
trials, mainly due to the dependency of conditions of measurement and operator. However, the 
non – invasive PZ probe is just as capable of effectively detecting physiological modifications 
before and after angioplasty procedures. This proves the usefulness of this technology, and can 
facilitate early identification of cardiac problems through screening trials. 
 
 
 
 
 
 
Figure 7.13 – SPT, RPT and DNT time parameterization comparison 
before and after carotid intervention; 
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7.4 Dataset III – Classification 
 
Neural network classification methods were the first to be constructed, as a performance 
study for MLP (both with 1 and 2 hidden layers) and RBF involving a meticulous parameter 
tuning was arranged. Usually, the neural network with higher accuracy was chosen, but 
sensitivity, specificity and precision measures also play an important role, and were not 
neglected. 
 
7.4.1 Dataset III characterization 
 Dataset III histogram characterization for each attribute follows in Figure 7.14. Blue 
histograms are associated with sub – group I (healthy subjects), while red histograms are 
associated with sub – group II (unhealthy subjects). These histograms display the class 
distribution in each attribute in a small matrix, as the full descriptive analysis is extensive. A 
full overview of the data is presented in Appendix C. 
 
 
 
 
 
 
 
Figure 7.14 – Dataset III characterization. Blue histogram represents sub – group I (healthy) and red histogram is 
associated to sub – group II (unhealthy); 
Results & Discussion 
  
 
  91 
Analyzing the prominent points that were extracted from the ADW, it can be assessed 
that RPT occurs earlier than SPT for sub – group II, while sub – group displays the opposite, as 
expected. The RPT histogram displays sub – group II predominance in lower values, and the SPT 
histogram shows sub – group I prevalence in lower SPT values. The AIx histograms display a 
predominance of the healthy sub - group in the left part of the total histogram, as expected. SPA 
and RPA do not seem do hide any potentially useful information regarding dissimilarities in 
arterial stiffness function. DNT and DNA do not seem to reveal any important particularity, as 
well. However, red histograms have a slight prevalence in higher DNT and DNA values. 
Ratios R1 – R4 present important visual information, as there is a clear formation of 2 
sub – groups in each ratio histogram, and can be important attributes in procedures that involve 
group formation from raw data (clustering, for example). As for other attributes, RMSSD 
attributes do not have any visual dissimilarity. RMSE does not seem to be a significant attribute 
for discerning between the two sub – groups, as well. 
 
7.4.2 ANN performance study 
Different parameter configurations were tested for each neural network, while 
manipulating one of the parameters and comparing the accuracy, sensitivity, specificity and 
precision values.  
 
7.4.2.1 MLP (1 – hidden layer) 
Different runs were performed while manipulating one single parameter. Training 
method, hidden neurons, training time (in epochs), learning rate (%) were adjusted and 
prematurely, only accuracy was measured. The default run (which is, in fact, the default Weka 
configuration for the MLP) is indicated in Table 7.10 as the grey row, and may be used as a 
‘baseline’ model for direct performance comparison between configurations.  
Some interesting facts can be observed in Table 7.10. Changing the k value in k – fold 
CVN doesn’t seem to maximize accuracy when compared to the default configuration (run 2 - 
4). A changing to a higher training time is useless (run 10) and modifying the learning rate 
doesn’t seem the change accuracy as well (run 11 – 14). However, the manipulation of the 
number of hidden neurons is an important issue. When more hidden neurons are added, the 
accuracy seems to increase (Run 6 and 7). 
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Table 7.10 – 1 – hidden layer MLP performance study, while manipulating diverse MLP characteristic parameters. The 
grey row indicates the default Weka configuration for 1 – hidden layer MLP; 
 
 
 
 
As the ‘hidden neurons’ parameter seems to have capital importance, it was 
manipulated a little bit further. Comparing run 6 and run 7, the first presents itself as having 
higher accuracy, which suggests that the optimal number of hidden neurons may be 
approximately 20. While maintaining the default configuration for the other parameters, the 
‘hidden neurons’ parameter was continuously changed for values between 15 and 25. Table 7.11 
expresses these results, while adding sensitivity, specificity and precision measures to assess 
which configuration is the best. 
Table 7.11 shows that the optimal value might be between 19 and 20 neurons, for run 5 
and 6, respectively. Each run has the same accuracy, with run 5 having higher sensitivity and 
precision. On the other hand, run 6 has higher specificity. Each of the runs can be used as a 
model for future classifier comparison. Run 6 is chosen because of its higher specificity, which 
is quite important considering that healthy and unhealthy subjects are being studied. One should 
consider models with higher specificity, because it is preferable having a classifier with few FPs 
as possible, to avoid misdiagnosing unhealthy patients as healthy. However, methods with high 
Run 
Training 
method 
Hidden  
neurons 
Training time 
(epochs) 
Learning rate 
 (a. u.) 
Accuracy 
 (%) 
1 10 – fold CVN 10 500 0,3 96.64 
2 5 – fold CVN 10 500 0,3 96.06 
3 20 – fold CVN 10 500 0,3 96.30 
4 40 – fold CVN 10 500 0,3 96.51 
5 10 – fold CVN 0 500 0,3 94.03 
6 10 – fold CVN 20 500 0,3 96.98 
7 10 – fold CVN 40 500 0,3 96.70 
8 10 – fold CVN 10 1 0,3 87.78 
9 10 – fold CVN 10 100 0,3 94.64 
10 10 – fold CVN 10 1000 0,3 96.53 
11 10 – fold CVN 10 500 0,1 96.53 
12 10 – fold CVN 10 500 0,01 93.52 
13 10 – fold CVN 10 500 0,2 96.33 
14 10 – fold CVN 10 500 0,5 96.33 
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Table 7.11 – 1 – hidden layer MLP performance study, while manipulating the ‘hidden neurons’ parameter. The 
grey row indicates the default Weka configuration for 1 – hidden layer MLP; 
sensitivity shouldn’t be discarded, as high FNs rates can also lead to other problems regarding 
patient physical and psychological discomfort. 
 
 
 
 
 
Therefore, the preferred configuration for the 1 – hidden layer MLP is the default 
configuration with the ‘hidden neurons’ parameter equal to 20.  
 
7.4.2.2 2 – hidden layers MLP 
Similarly to 7.4.2.1, different runs were performed while manipulating one single 
parameter. Training method, hidden neurons, training time and learning rate were the 
parameters of choice. Accuracy, sensitivity, specificity and precision measures helped in finding 
the best model, in overall. The default run is indicated in Table 7.12 as the grey row. 
Learning rate changes did not impress once again in 2 – hidden layers MLP. 
However, this time, changes in the training method revealed some interesting results. Run 
3 gives the best values of specificity and precision from all runs overall. However, the 
sensitivity value is quite lower than one should expect. On the other hand, run 9 revealed 
the best value of sensitivity, but neglects specificity. Run 11 presents itself as a more 
balanced run, with higher accuracy as well. And so, run 11 is the chosen run for future 
classifier comparison. 
Run 
Hidden  
neurons 
Accuracy 
(%) 
Sensitivity  
(%) 
Specificity  
(%) 
Precision  
(%) 
1 15 96.06 95.43 96.64 96.38 
2 16 96.57 96.56 96.58 96.35 
3 17 96.67 96.56 96.78 96.56 
4 18 96.84 96.63 97.04 96.85 
5 19 96.98 96.84 97.10 96.91 
6 20 96.98 9677 97.17 96.83 
7 21 96.70 96.07 97.10 96.40 
8 22 96.77 96.98 96.58 96.37 
9 23 96.34 95.93 96.71 96.47 
10 24 96.60 96.35 96.85 96.62 
11 25 96.34 96.35 96.32 96.08 
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Table 7.12 – 2 – hidden layers MLP performance study, while manipulating diverse MLP characteristic parameters. The 
grey row indicates the default Weka configuration for 2 – hidden layers MLP; 
 
 
 
 
7.4.2.3 RBF 
Two parameters were varied in the RBF performance study: clustering seed (a random 
estimate of the initial weight) and number of clusters (which is, in fact, the number of RBF). 
Results are expressed in Table 7.13. 
It is possible to note that the accuracy, sensitivity, specificity and precision of the 
default configuration, when compared with the MLP, is much lower. However, by manipulating 
the parameters, it was possible to obtain similar MLP accuracies. Clustering seed is not a 
definitive factor in raising accuracy, but run 3 was the best while modifying the clustering seed 
value. The number of clusters was of crucial importance, with run 9 presenting the best results. 
Therefore, in runs 11 – 13, we used the same number of clusters as run 9 (100) and manipulated 
the clustering seed for 3 values: 1, 5, and 10. 
 
 
 
 
 
Run 
Training 
Method 
Hidden 
Neurons 
Learning 
Rate 
Accuracy 
(%) 
Sensitivity 
(%) 
Specificity 
(%) 
Precision 
(%) 
1 10 – fold CVN 10, 10 0.3 96.44 96.49 96.33 96.15 
2 5 – fold CVN 10, 10 0.3 95.89 95.23 96.52 96.24 
3 20 – fold CVN 10, 10 0.3 96.64 95.79 97.44 97.22 
4 40 – fold CVN 10, 10 0,.3 96.61 96.21 96.98 96.75 
5 10 – fold CVN 10, 10 0.01 93.96 94.25 93.69 93.33 
6 10 – fold CVN 10, 10 0.1 95.79 96.77 94.88 94.65 
7 10 – fold CVN 20, 20 0.3 96.51 96.56 96.45 96.22 
8 10 – fold CVN 5, 20 0.3 96.30 95.93 96.65 96.40 
9 10 – fold CVN 20,5 0.3 96,.13 97.12 95.20 94.99 
10 10 – fold CVN 21,21 0.3 96.44 96.42 96.45 96.22 
11 10 – fold CVN 22,22 0.3 96.74 96.52 96.91 96.70 
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Table 7.13 – RBF performance study, while manipulating diverse MLP characteristic parameters. The first row 
indicates the default Weka configuration for 2 – hidden layers MLP; 
 
 
 
 
Run 11 and run 12 present the best results, with the same accuracy (96,23%), the same 
precision (96,23%), but different values of sensitivity and specificity, with run 11 being more 
sensitive and run 12 being more specific. Before, in 7.4.2.1 and 7.4.2.2, runs with higher 
accuracy and specificity were preferred. This time, run 11 was the opted run, as RBF has as it 
is the most sensitive RBF model. 
 
7.4.3 Classifier selection 
After the neural network performance study, the other classifiers were constructed using 
10 – fold CVN. Accuracy, sensitivity, specificity and precision were measured, and RMSE 
values were computed. Training speed was also measured, and training speed ranges were 
discretized into 5 groups, even though it was not a factor in choosing the three best classifiers. 
Training speed guidelines are shown in Table 7.14.  
 
 
 
Run 
Clustering 
seed 
Number of 
clusters 
Accuracy 
(%) 
Sensitivity 
(%) 
Specificity 
(%) 
Precision 
(%) 
1 1 2 91.92 92.56 91.33 91.92 
2 5 2 92.74 94.32 91.26 92.74 
3 10 2 92.81 94.11 91.59 92.81 
4 20 2 92.74 93.61 91.92 92.74 
5 1 5 92.26 90.46 93.96 92.26 
6 1 10 94.49 94.25 94.71 94.49 
7 1 20 95.32 95.02 95.60 95.32 
8 1 50 95.79 94.46 97.04 95.79 
9 1 100 96.03 94.74 97.24 96.03 
10 1 250 95.32 94.53 96.06 95.32 
11 5 100 96.23 96.23 95.79 96.65 
12 1 100 96.23 95.23 97.17 96.23 
13 10 100 95.76 95.12 96.36 96.13 
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Table 7.14 – Discretized guidelines for 
different training speed ranges; 
Table 7.15 – Classifier selection results, with rankings assessed by descendent accuracy; 
 
 
 
 
 
 
 
 
 
 
 
 
Classifier selection results follow up in Table 7.15, with the column with ranking by 
descendent accuracy included. 
 
 
 
 
All classification methods except Bayesian based - classification exhibited accuracy 
values > 95%. Random forest was the best classifier, in overall, by having the highest accuracy 
and sensitivity. Comparing with the other classifiers, MLP ANN methods require high 
computational resources, as they can take between 30 seconds and several minutes to be trained. 
ANN have shown excelling results in the specificity department, which means that the FP error 
rate is inferior, in other words, misdiagnosing unhealthy patients as healthy is less likely to 
happen when using MLP classifiers.  
Range (s) Discretized value 
0 – 2 ***** 
2 – 10 **** 
10 – 20 *** 
20 – 60 ** 
> 60 * 
Classifier 
Training 
speed (s) 
RMSE 
(%) 
Accuracy 
(%) 
Sensitivity 
(%) 
Specificity 
(%) 
Precision 
(%) 
Ranking 
MLP (1 HL) ** 16.09 96.98 96.77 97.17 96.83 2 
MLP (2 HL) * 17.46 96.74 96.56 96.91 96.70 3 
RBF *** 18.58 96.23 96.23 95.79 96.65 4 
C4.5 **** 20.10 95.72 95.58 95.86 95.58 5 
Random 
forest 
**** 14.60 97.15 97.47 96.85 96.66 1 
RIPPER *** 19.89 95.72 96.14 95.34 95.07 6 
Naïve Bayes ***** 34.00 88.05 86.60 89.42 88.46 8 
Bayesian 
network 
***** 32.16 89.01 84.84 92.90 88.46 7 
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Table 7.16 – Diagnostic with a 3 – best multiple classifier methodology; 
In the global classifier performance study above, the three best classifiers with 
highest accuracy were selected: random forest, 1 – hidden layer MLP and 2 - hidden 
layers MLP. 
 
7.4.4 Diagnostic with 3 – best multiple classifier methodology 
The three best classifiers were combined and applied to sub – group III, which is a 
group of 10 undiagnosed subjects to predict their CV condition. The predicted class depends on 
the percentage of positive and negative pulses (1 = healthy and 2 = high CV risk factor, 
respectively) for each classifier. An output diagnosis is then obtained combining the three 
classifier results, based on an equal – weighted voting system. Results are shown in Table 7.16. 
 
 
 
 
The assumption that the classification of an undiagnosed subject should not be based on 
the result of one, and only one classifier is supported by the given results, as the global final 
result was never the same final result for each classifier: 
 In subject 2, for example, the random forest model defines the subject as having 
high CVD risk. However, both MLP output is contradictory, and due to that, the 
final decision is that the subject is healthy.  
Subject 
Random 
forest 
MLP 
(1 – HL) 
MLP 
(2 – HL) Final Result 
% Pulses 
1 2 Result 1 2 Result 1 2 Result Ratio Decision 
1 64 36 1 85 15 1 92 8 1 3/3 1 
2 12 88 2 72 28 1 72 28 1 2/3 1 
3 2 98 2 93 7 1 33 67 2 1/3 2 
4 0 100 2 77 23 1 12 88 2 1/3 2 
5 70 30 1 98 2 1 87 13 1 3/3 1 
6 89 11 1 99 1 1 99 1 1 3/3 1 
7 0 100 2 33 67 2 20 80 2 0/3 2 
8 53 47 1 91 9 1 36 64 2 2/3 1 
9 12 88 2 76 24 1 62 38 1 2/3 1 
10 0 100 2 77 23 1 13 87 2 1/3 2 
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 Other examples are subject 3, 4 and 10, where random forest and 2 – hidden 
layers MLP agreed that the subject could have a high CVD risk, while 1 – 
hidden layer MLP assessed these subjects as healthy.  
 Subject 8 is an example where 2 – hidden layers MLP defined the subject as 
having high CVD risk. Although, the final result is that the subject is healthy, as 
random forest and 1 – hidden layer MLP defined him as a healthy patient. 
There are also subjects with explicit full agreement between the three classifiers 
(subjects 1, 5, 6 and 7). Even though we obtained high accuracy values for each of the used 
classifier models, at least once there was a contradiction between a single model and the other 
two models.  
The results of this multiple classifier diagnostic procedure clearly show the 
versatility and usefulness of this method. By using an ensemble model like the proposed, 
the error rate is minimized and accurate diagnostics are more probable and feasible. 
 
7.4.5 Dataset III - Discussion 
In the global classifier performance study, the three best classifiers that were 
selected for the subsequent diagnostic methodology were: random forest, 1 – hidden layer 
MLP and 2 - hidden layers MLP (section 7.4.3). 
The fact that random forest was the best classifier in terms of accuracy confirms the 
effectiveness and superior performance of the classifier, which was already suggested in a 
previous study with a similar dataset by Almeida et al. (2011) [26]. 
3 ANN trained classifiers were ranked in the top 4 out of 8 possible classifiers. This 
demonstrates that when ANN problems regarding low tolerance to noise and bad 
comprehensibility are attenuated and/or bypassed, coupled with studies to maximize the 
accuracy of the model, ANN have superior classification performance, as hypothesized by 
Kotsiantis (2007) [67]. MLP – based ANN have also shown excelling results in the specificity 
department, which means that the FP error rate is low, in other words, misdiagnosing unhealthy 
patients as healthy is less likely to happen when using MLP classifiers.  
 
The results of this multiple classifier diagnostic procedure clearly show the 
versatility and usefulness of the method. By using an ensemble model like the proposed, 
the error rate is minimized and accurate diagnostics are more probable and feasible 
(section 7.4.4). 
The implementation of a model that is based on the guidelines of the work by 
Gorunescu et al. (2011) [32] successfully demonstrated that the assumption that the 
classification of an undiagnosed subject should not be based on the result of one and only one 
classifier. 
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Figure 7.15 – Dataset IV histogram characterization; 
7.5 Dataset IV – Clustering 
 
Clustering methods are very useful when little or no information is known from a 
dataset. Consequently, risk group assessment in a healthy population became a definite 
opportunity with this dataset.  
 
7.5.1 Dataset IV characterization 
Dataset IV characterization follows in Figure 7.15. More detailed figures (with mean ± 
SD included) are annexed in Appendix D. 
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Figure 7.16 – Plots of RPT as a function of SPT after clustering in (a) EM and (b) k-means clustering for two risk 
group assessment. Blue = class 1 and red = class 2; 
A primary visual histogram analysis to attributes AIx, SPT, R1, R3 and R4 suggests the 
existence of two or more possible sub – groups.  
 
7.5.2 Two risk group clustering 
Figure 7.16 displays both plots of the RPT as a function of SPT after 2 - class EM (a) and 
k – means clustering (b). Different colored points represent different pulse labels (blue = class 1; 
red = class 2). Categorical features were eliminated in the k – means clustering method, as this 
technique has some serious versatility problems with categorical attributes. 
 
 
 
  
 
 
The EM plot presents visually average results, as some pulses of class 1 look 
completely mislabeled. Visually, the results of k – means clustering are more desirable and 
satisfying, as it partitioned the dataset in two perfectly homogeneous risk groups are possible 
with this dataset. For both EM and k – means, the blue group (class 1) presents itself as a more 
healthier partition than the red group (class 2), as it represents the points where the reflection 
wave arrived after the systolic point, and so, it can be assumed that class 1 represent a group 
with a lower risk of developing CVD and class 2 represents a group with higher CVD risk. 
However, the fact that the reflection point is after the systolic point does safely means that the 
subject is healthy, as some other attributes may influence the pulse class determination.  
When analyzing for differences in the cluster centroids, between clustering methods 
(Table 7.16), some small dissimilarities can be found. The biggest differences are found in SPT, 
AIx and R4. It is possible that the k – means algorithm considers these three attributes with 
higher average merit than the EM algorithm. An attribute subset selection for both algorithms 
can be performed to erase these doubts (see section 7.4.1.1). 
Another visual interpretation of Table 7.17 is needed to find out where are the biggest 
differences between the class labels 1 and 2. At first glance, the biggest differences lay in AIx, 
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Table 7.17 – Results for both clustering methods in two risk group assessment. Class 1 and 
class 2 represent the blue and red clusters of figure 7.15, respectively. Each scalar attribute 
in each cluster is the cluster centroid (mean value for each cluster); 
SPT, RPT, R3 and R4. RMSSD_SPT and RMSSD_RPT results are also quite dissimilar. Another 
important conclusion is that the group with higher risk (EM - cluster 2) has approximately 85% 
of pulses from women gender. This might suggest that in the dataset IV age range, women 
have higher AIx than men. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Attribute Full Data 
Clustering Method 
K - means EM 
1 2 1 2 
Cluster pulses 4471 2463 2008 2315 2156 
Gender 
M 1327 
-- -- 
993 334 
F 3144 1322 1822 
Smoker 
Yes 231 
-- -- 
108 123 
No 4240 2207 2033 
Diabetes 
Yes 0 
-- -- -- -- 
No 4471 
Age 21.41 21.66 21.11 21.71 21.11 
Weight 60.46 63.21 57.09 63.17 57.55 
Height 1.67 1.70 1.65 1.70 1.65 
BMI 21.36 21.75 20.88 21.73 20.96 
SBP 107.89 108.62 106.99 108.67 107.05 
DBP 69.48 68.90 70.17 68.85 70.15 
HR 71.01 72.88 68.71 73.05 68.81 
SPT 163.45 117.06 220.34 116.64 213.67 
RPT 159.29 179.87 134.04 179.96 137.10 
DWT 281.99 274.36 291.34 273.72 290.86 
SPA 0.996 0.9965 0.9954 0.9966 0.9954 
RPA 0.87 0.89 0.85 0.89 0.86 
DWA 0.74 0.70 0.80 0.69 0.80 
R1 118.54 157.29 71.00 157.07 77.19 
R2 0.75 0.70 0.81 0.70 0.80 
R3 0.0033 -0.11 0.14 -0.11 0.12 
R4 -0.11 -0.89 0.86 -0.89 0.74 
AIx 0.35 -11.23 14.55 -11.38 12.93 
RMSSD_SPT 24.35 21.68 27.62 18.43 30.69 
RMSSD_SPA 0.0036 0.0029 0.0044 0.0011 0.0063 
RMSSD_RPT 41.60 49.27 32.19 49.30 33.33 
RMSSD_RPA 0.16 0.18 0.14 0.17 0.15 
RMSSD_DWT 35.51 42.77 26.61 43.53 26.91 
RMSSD_DWA 0.09 0.11 0.06 0.11 43.52 
FWHM 448.21 433.43 466.34 431.39 466.26 
RMSE 0.0529 0.0540 0.0515 0.0536 0.0521 
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7.5.2.1  Attribute subset selection 
The gain ratio attribute evaluator results for both clustering methods are expressed in 
the graphic of Figure 7.17, which shows the average merit of each attribute in determining each 
pulse class label.  
 
 
 
As expected, AIx is the most important attribute in defining class labels. All ratios 
(except R2) and wave reflections (SPT and RPT) are also important in distinct group definition. 
As for demographic attributes, BMI and gender have the highest average merit values, although 
they don’t look significantly important. As suggested before, by visual plot analysis, age does 
not seem to be an important factor. Other attributes like smoker, RMSE and diabetes seems to 
be irrelevant. 
The successful clustering in two risk groups suggests that AIx and wave reflections 
phenomenon have a crucial importance in CV risk assessment in young subjects. 
Surprisingly, age does not seem to be an important factor in determining risk groups for 
subjects between 18 and 30 years.  
 
7.5.3 Three risk group clustering 
The k – means clustering was the chosen algorithm for three risk group clustering, as 
the observed results for k – means were visually better than EM. Just like in two risk group 
clustering, categorical features were eliminated, as k – means has some serious incompatibilities 
with categorical attributes. The clustering for three risk group assessment is presented in Figure 
7.18. 
 
 
Figure 7.17 – Attribute subset selection for each clustering method in two risk group assessment; 
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Figure 7.18 – Plot of RPT as a function of SPT after k-means clustering for three risk group determination. 
Green = class 1, blue = class 2 and red = class 3; 
 
  
 
 
 
As observed in Figure 7.18, a complete visual distinction between three risk groups 
could not be materialized. This could be due to irrelevant features taking part in the clustering 
process, and/or due to low robustness of the algorithm. A progressive attribute removal could be 
performed to attempt a visual correction. However, Table 7.17 does reveal a whole different 
perspective. 
Analyzing Table 7.18 and correlating with Figure 7.18, it can be acknowledged that 
cluster 1 (green homogeneous zone in figure 7.17) is mostly represented by ADW type C 
pulses, where RPT > SPT. Adding to that, the mean AIx is negative (-11.49), which represents 
cluster 1 as a low CVD risk group. Cluster 3 (red points in Figure 7.18) pulses are mostly type 
A and type B pulses, where SPT > RPT. Cluster 3 could represent a group with higher CV risk. 
Cluster 2 pulses (blue points in Figure 7.18) represent the less homogeneous group, as they are 
scattered in the whole plot. They are a combination of type B and type C pulses, with the similar 
mean AIx of the full data. They can represent an intermediate group in terms of CV risk. 
With three risk group clustering, it was possible to assess groups which represent 
different combinations of ADW types, which could be helpful in assessing CV risk 
development. 
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Table 7.18 – Results for both clustering methods in two risk group assessment. Cluster 1, cluster 
2 and cluster 3 represent the green, blue and red clusters of figure 7.17, respectively. Each scalar 
attribute in each cluster is represented as mean; 
 
 
 
 
7.5.3.1  
7.5.3.2  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.5.3.1 Attribute subset selection 
Results of the gain ratio attribute evaluator with 10 – fold CVN mode for the three 
clusters follow on Figure 7.19.  
The outcome is identical to two risk group differentiation results. R3, R4, AIx and wave 
reflections attributes are among the highest rated attributes, strengthening the hypothesis that 
AIx and wave reflections phenomenon have a capital importance in CV risk assessment in 
younger subjects. For three risk group assessment, RMSSD_RPT and RMSSD_RPA also 
Attribute Full Data Cluster 1 Cluster 2 Cluster 3 
Number of 
Pulses 
4471 2126 540 1805 
Age 21.41 21.73 21.14 21.13 
Weight 60.46 23.21 61.82 56.81 
Height 1.67 1.70 1.69 1.65 
BMI 21.36 21.70 21.61 20.88 
SBP 107.89 108.67 108.53 106.77 
DBP 69.48 69.07 68.37 70.29 
HR 71.01 72.94 71.82 68.49 
SPT 163.45 116.58 154.30 221.39 
RPT 159.29 180.22 162.41 133.70 
DWT 281.99 274.41 276.39 292.59 
SPA 0.996 0.9965 0.9955 0.9957 
RPA 0.87 0.89 0.90 0.85 
DWA 0.74 0.69 0.74 0.80 
R1 118.54 157.83 122.09 71.20 
R2 0.75 0.70 0.75 0.81 
R3 0.0033 -0.11 -0.02 0.14 
R4 -0.11 -0.89 0.23 0.85 
AIx 0.35 -11.49 -1.66 14.90 
RMSSD_SPT 24.35 19.92 42.14 24.23 
RMSSD_SPA 0.0036 0.0026 0.0053 0.0042 
RMSSD_RPT 41.60 29.89 163.60 18.88 
RMSSD_RPA 0.16 0.063 0.90 0.055 
RMSSD_DWT 35.51 39.97 62.35 22.23 
RMSSD_DWA 0.09 0.11 0.12 0.05 
FWHM 448.21 432.25 450.56 466.31 
RMSE 0.0529 0.0538 0.0577 0.0504 
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assume relative importance. Demographic data continues to be quite irrelevant, with BMI being 
the highest rated demographic attribute. Age is once again lowly rated. 
 
 
 
 
7.5.4 Dataset IV - Discussion 
Two risk groups clustering results suggest that in the same age range, women have 
higher AIx than men (section 7.5.2). 
This result confirms the conclusions reached by Janner et al. (2010) [46] and Chung et 
al. (2010) [47], which determined that, in the same age range, women have higher AIx than 
men. 
 
Age does not seem to be an important factor in determining risk groups for 
subjects between 18 and 30 years (section 7.5.2).  
Aging is the most important determinant in arterial stiffness assessment. With aging, 
arterial stiffness increases, and the risk of CVD is higher as well. The fact that age was not an 
important factor in determining different risk group is possibly due to the short age range of 
dataset IV. Still, it can also be an indication that an increase in the arterial stiffness due to the 
aging process is not so predominant until 30 years old. More studies need to be performed on 
this area.  
 
 
 
Figure 7.19 – Attribute subset selection for k – means clustering in three risk group assessment; 
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The successful clustering in two risk groups suggests that the wave reflections 
phenomenon and carotid AIx have a crucial importance in CV risk assessment in young 
subjects (section 7.5.2).  
Data from McEniery et al. (2005) [49] revealed that central AIx might be a more 
sensitive marker of arterial aging in young and middle – age individuals (< 50 years) and aortic 
PWV is more sensitive in the older population (> 50 years), in healthy individuals. Although 
aortic PWV could not be measured in this dataset, carotid AIx (which is a direct surrogate of 
central AIx and wave reflections) has shown a crucial importance in determining arterial aging, 
and consequently, CV risk, as it was the most important attribute in terms of average merit in 
the partitioning process. 
The success of two risk group clustering also demonstrates the efficiency of the PZ 
sensor in acquiring distinct and accurate CV information in a healthy population. 
 
With three risk group clustering, it was possible to assess groups which represent 
different combinations of ADW types, which could be helpful in assessing CV risk 
development. The hypothesis that AIx and wave reflections phenomenon have a capital 
importance in CV risk assessment in younger subjects was also strengthened. (section 
7.5.3). 
Excluding type D ADW, other ADW types are a clear indication of the CV condition of 
a subject. With the three risk group clustering, it was possible to determine three different risk 
groups that could be directly correlated with type A, type B and type C predominance. 
Identically to two risk group assessment, CV three risk group determination demonstrated that 
AIx and wave reflections phenomenon were the most important attributes in determining 
different clusters. 
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8. Conclusion & Future Work 
 
 
 After the academic project is concluded, it is necessary to evaluate and provide the 
main contributions that this work has given to the scientific community. Future work guidelines 
are also provided. 
 
 
8.1 Main contributions 
 
This work has given the following main contributions to the academic community: 
 
1. A significant increase in the subjects included in the database, which will 
undoubtedly be useful in future work. 
 
2. The repeatability of the previously developed ADW acquisition system was 
successfully validated: 
o The non – invasive system repeatability between months and between 
left/right carotid did not present the best results. There are some indications 
of no differences between left and right carotid for the 18-30 age range. 
However, the excellent repeatability results between trials, for each subject, 
have shown that dissimilarities are not due to hardware, firmware or 
software imperfections. 
o Bland – Altman plots have shown sufficient agreement between months and 
between left and right carotid. 
o A performed case study in subjects with stenosis also accomplished in 
proving that the developed PZ probe is able to detect physiological 
alterations after surgical procedures with good accuracy. 
 
3. The successful use of data mining techniques for the development of 
innovative decision support systems: 
o Classification techniques have shown their usefulness in assessing CVD risk, 
especially ANN classifiers, which were never approach in the context of this 
work, and displayed superior results in comparison with other classifiers, 
especially in the specificity department. Also, it was demonstrated the full 
potential of multiple classifier methodologies in producing more trustworthy 
diagnostic outputs in comparison with single classifier analysis. 
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o Clustering procedures can be important in the premature determination of 
different CVD risk groups, as it was possible to assess completely distinct 
risk groups in a young dataset. AIx and wave reflections have proven their 
important in the partitioning of distinct clusters, where each cluster indicates 
different CV risk groups. It was also proven that age is not an important 
factor is risk group determination in the 18 – 30 age range, and the fact that 
women have higher AIx than men, in the same age range was also 
confirmed. 
o Finally, the success of the data mining techniques is also correlated with the 
efficiency of the PZ sensor in acquiring accurate CV information from 
healthy and unhealthy subjects. 
 
4. A creation and development of a tool for repeatability agreement tests using 
the Bland Altman method, which is now open – source for future 
improvements. Other several optimization improvements in previously 
developed GUIs were also made. 
 
It is safe to say the main objectives proposed at the start of this work were fully 
accomplished. 
 
8.2 Future work 
 
The final section of this work sets new, ambitious objectives, which will surely help in 
defining future work methodologies. Future investigation guidelines are presented, by topics: 
 
1. Conclusive assessment of the non – invasive system repeatability between 
months and between left/right carotid. 
Results for the repeatability between months and between left/right carotid were very 
promising, but still inconclusive.  
 Some minor changes in the ADW acquisition protocol can be important in assuring few 
differences in measurements between months, as for example, the measured subject should 
refrain from tobacco and/or coffee consumption 3 hours before the measurement. As for 
left/right repeatability, a more rigid approach in the operator ‘catching’ the carotid and wider 
time measurements (≈ 60 – 80 seconds) could be important in improving data quality. However, 
for wider time measurements, high computational resources are needed. 
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2. Reproducibility assessment of the non – invasive system. 
Reproducibility is the variability of the measurement system caused by differences in 
operator behavior [51]. It is important to assess it, to demonstrate if the PZ sensor is sensitive to 
differences in operator or not, by having two or more operators performing clinical trials, and 
assessing agreement between operators on each subject. At the moment, reproducibility studies 
are already undergoing in GEI. 
 
3. Repeatability and reproducibility assessment with “gold – standard" devices 
comparison. 
To further validate the developed non – invasive system, a comparison with results from 
“gold – standard” devices (SphygmoCor®, for example) is absolutely needed to evaluate and 
demonstrate the accuracy of the PZ sensor in providing CV information that agrees with the 
golden standard instrument. 
 
4. Database improvements for future establishment of AIx reference values for 
the Portuguese population. 
The database already has 155 subjects, and was significantly increased in past year, 
especially in the 18 – 30 age range. However, there is still a lack of data from unhealthy 
subjects. There are few data from healthy subjects in the 30 – 50 age range as well. The 
acquisition of data from the referred groups can be important in having a database with 
sufficient subjects to perform an establishment of AIx reference values for the Portuguese 
population. 
 
5. Implementation of biochemical attributes in future trials. 
 Recent studies have determined that CVD progression is marked by the inflammatory 
indicator CRP and that early indicators of heart attack are the inflammatory marker CD40 and 
the cardiac myofilament protein troponin [81, 82]. There is a clear indication that biochemical 
parameters can be interesting attributes to be included in future trials, so that it is possible to 
assess their impact in CV risk assessment with data mining procedures. However, there is a 
clear difficulty in obtaining the expression of these markers. 
 
6. Implementation of new classification algorithms. 
 After proving the usefulness of ANN in the context, other classification methods should 
be tested to assess their efficiency in the CVD prediction field. Support vector machines 
(SVMs) can be of particular interest, as they are referred in the literature as the classification 
technique with higher accuracy in overall, despite their problems regarding the transparency of 
the results and low tolerance to noise and missing values [67].  
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7. Clustering techniques in unhealthy patients. 
 Instead of performing clustering techniques in a healthy sample for the determination of 
different CV risk groups, there is interest in applying clustering techniques in a sample that is 
composed of patients with different CVD, with the objective of assessing the power of the 
clustering methodologies in partitioning the data into groups that represent different CV 
pathologies. 
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Table A.1 – AIx table of subjects 1-10 divided by month and carotid site. Mean rank, U and P represent the 
conclusions given by the Mann Whitney test. A P – value of < .05 was considered as significant; 
Appendix A – Dataset I (1) 
 
AIx table and boxplot of each subject, categorized by carotid site and 
month  
 
Subject Month Carotid site AIx median (%) Mean rank U P 
1 
Month 1 
Right -7.77 40.45 
-1.896 0.06 
Left -2.60 54.16 
Month 2 
Right 5.78 64.13 
2.372 < .05 
Left -7.91 49.16 
2 
Month 1 
Right -12.10 49.33 
-7.369 < .05 
Left -5.62 100.64 
Month 2 
Right -15,57 35.02 
-8.780 < .05 
Left 6.83 91.16 
3 
Month 1 
Right 19.99 67.14 
-0.482 0.63 
Left 19.47 63.75 
Month 2 
Right 19.32 77.32 
-4.883 < .05 
Left 17.64 45.92 
4 
Month 1 
Right -5.94 32.55 
-2.809 < .05 
Left 8.56 48.41 
Month 2 
Right 3.19 28.19 
-4.249 < .05 
Left 17.28 49.63 
5 
Month 1 
Right -18,32 129.35 
-3.597 < .05 
Left -21,89 96.95 
Month 2 
Right -15.08 93.68 
-0.818 0.41 
Left -16.22 87.32 
6 
Month 1 
Right -11.16 44.80 
-5.383 < .05 
Left -6.24 87.55 
Month 2 
Right -11.74 69.41 
-2.756 < .05 
Left -19.87 37.08 
7 
Month 1 
Right 8.32 92.38 
-2.756 < .05 
Left 10.83 115.32 
Month 2 
Right 10.79 65.75 
-0.929 0.35 
Left 11.21 72.08 
8 
Month 1 
Right -4.79 127.59 
-9.291 < .05 
Left -17.98 55.93 
Month 2 
Right -2.75 68.69 
-2.545 < .05 
Left -8.03 52.51 
9 
Month 1 
Right 7.02 29.08 
-0.262 0.79 
Left 6.14 30.30 
Month 2 
Right 7.75 27.88 
-4.015 < .05 
Left 9.79 52.06 
10 
Month 1 
Right -5.12 42.48 
-5.779 < .05 
Left 12.79 80.31 
Month 2 
Right 12.05 73.46 
-2.410 < .05 
Left 11.19 57.54 
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Table A.2 – AIx table of subjects 11 and 12 divided by month and carotid site. Mean rank, U and P represent 
the conclusions given by the Mann Whitney test. A P – value of < .05 was considered as significant; 
Figure A.1 – AIx boxplots of subjects 1-4 divided by month and carotid site;  
 
 
 
 
 
 
 
Subject Month Carotid site AIx median (%) Mean rank U P 
11 
Month 1 
Right -9.02 56.56 
-0.045 0.96 
Left -11.99 56.18 
Month 2 
Right 6.21 75.48 
-3.000 < .05 
Left -2.89 55.39 
12 
Month 1 
Right 15.42 35.07 
-1.672 0.09 
Left 2.40 23.56 
Month 2 
Right -1.23 75.45 
-4.431 < .05 
Left -4.89 46.89 
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Figure A.2 – AIx boxplots of subjects 5-10 divided by month and carotid site;  
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Figure A.3 – AIx boxplots of subjects 11 and 12 divided by month and carotid site;  
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Table B.1 – AIx table of subjects 1-3 divided by month, carotid site and trial. Mean rank, Chi - square and P 
represent the conclusions given by the Kruskal Wallis test. A P – value of < .05 was considered as significant; 
Appendix B – Dataset I (2) 
 
AIx table of each subject categorized by month, carotid site and trial  
 
 
 
Subject Month Carotid Trial Mean rank Chi - square P 
 
 
 
1 
 
 
1 
Right 
Trial 1 23.00 
0.491 0.78 Trial 2 25.53 
Trial 3 26.33 
Left 
Trial 1 17.23 
0.539 0.76 Trial 2 20.08 
Trial 3 19.82 
2 
Right 
Trial 1 39.10 
4.798 0.09 Trial 2 29.41 
Trial 3 27.80 
Left 
Trial 1 19.00 
7.323 < .05 Trial 2 23.10 
 Trial 3 32.75 
 
 
 
2 
 
 
1 
Right 
Trial 1 55.12 
15.969 < .05 Trial 2 42.86 
Trial 3 28.93 
Left 
Trial 1 26.79 
0.952 0.62 Trial 2 32.07 
Trial 3 28.00 
2 
Right 
Trial 1 35.92 
2.606 0.27 Trial 2 27.35 
Trial 3 35.00 
Left 
Trial 1 26.36 
3.915 0.14 Trial 2 24.87 
 Trial 3 35.25 
 
 
 
3 
 
 
1 
Right 
Trial 1 71.97 
56.407 < .05 Trial 2 22.29 
Trial 3 34.41 
Left 
Trial 1 14.25 
10.106 < .05 Trial 2 28.17 
Trial 3 19.00 
2 
Right 
Trial 1 36.23 
2.815 0.24 Trial 2 27.15 
Trial 3 31.24 
Left 
Trial 1 24.90 
7.886 < .05 Trial 2 27.06 
 Trial 3 39.05 
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Table B.2 – AIx table of subjects 4-6 divided by month, carotid site and trial. Mean rank, Chi - square and P 
represent the conclusions given by the Kruskal Wallis test. A P – value of < .05 was considered as significant; 
 
 
 
 
 
 
 
Subject Month Carotid Trial Mean rank Chi - square P 
 
 
 
4 
 
 
1 
Right 
Trial 1 9.91 
13.223 < .05 Trial 2 13.40 
Trial 3 24.00 
Left 
Trial 1 30.00 
5.664 0.06 Trial 2 17.50 
Trial 3 31.71 
2 
Right 
Trial 1 22.50 
0.201 0.90 Trial 2 22.87 
Trial 3 21.00 
Left 
Trial 1 17.62 
1.370 0.50 Trial 2 13.50 
 Trial 3 14.43 
 
 
 
5 
 
 
1 
Right 
Trial 1 76.27 
4.426 0.10 Trial 2 74.55 
Trial 3 59.72 
Left 
Trial 1 32.34 
18.710 < .05 Trial 2 61.21 
Trial 3 53.39 
2 
Right 
Trial 1 52.86 
7.272 < .05 Trial 2 36.31 
Trial 3 49.78 
Left 
Trial 1 26.97 
24.987 < .05 Trial 2 55.58 
 Trial 3 55.89 
 
 
 
6 
 
 
1 
Right 
Trial 1 37.59 
3.322 0.19 Trial 2 27.84 
Trial 3 30.94 
Left 
Trial 1 34.44 
0.079 0.96 Trial 2 34.48 
Trial 3 33.05 
2 
Right 
Trial 1 34.10 
4.503 0.10 Trial 2 23.52 
Trial 3 28.69 
Left 
Trial 1 18.67 
6.981 < .05 Trial 2 26.24 
 Trial 3 33.00 
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Table B.3 – AIx table of subjects 7-9 divided by month, carotid site and trial. Mean rank, Chi - square and P 
represent the conclusions given by the Kruskal Wallis test. A P – value of < .05 was considered as significant; 
 
 
 
 
 
 
 
Subject Month Carotid Trial Mean rank Chi - square P 
 
 
 
7 
 
 
1 
Right 
Trial 1 75.73 
18.806 < .05 Trial 2 62.94 
Trial 3 40.40 
Left 
Trial 1 56.46 
6.661 < .05 Trial 2 42.17 
Trial 3 38.91 
2 
Right 
Trial 1 36.23 
4.243 0.12 Trial 2 46.07 
Trial 3 34.36 
Left 
Trial 1 28.00 
2.894 0.24 Trial 2 26.58 
 Trial 3 35.25 
 
 
 
8 
 
 
1 
Right 
Trial 1 41.11 
3.134 0.21 Trial 2 46.83 
Trial 3 36.08 
Left 
Trial 1 44.26 
1.087 0.58 Trial 2 50.00 
Trial 3 51.10 
2 
Right 
Trial 1 28.79 
6.138 0.046 Trial 2 30.33 
Trial 3 18.07 
Left 
Trial 1 33.08 
1.175 0.56 Trial 2 37.55 
 Trial 3 31.33 
 
 
 
9 
 
 
1 
Right 
Trial 1 23.73 
10.339 < .05 Trial 2 23.64 
Trial 3 11.46 
Left 
Trial 1 10.63 
0.542 0.76 Trial 2 9.17 
Trial 3 11.67 
2 
Right 
Trial 1 11.33 
8.045 < .05 Trial 2 9.00 
Trial 3 18.36 
Left 
Trial 1 25.25 
4.687 0.10 Trial 2 38.06 
 Trial 3 33.23 
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Table B.4 – AIx table of subjects 10-12 divided by month, carotid site and trial. Mean rank, Chi - square and P 
represent the conclusions given by the Kruskal Wallis test. A P – value of < .05 was considered as significant; 
 
 
 
 
 
Subject Month Carotid Trial Mean rank Chi - square P 
 
 
 
10 
 
 
1 
Right 
Trial 1 18.47 
7.754 < .05 Trial 2 32.18 
Trial 3 32.15 
Left 
Trial 1 25.96 
12.369 < .05 Trial 2 33.35 
Trial 3 45.96 
2 
Right 
Trial 1 35.92 
0.875 0.64 Trial 2 30.42 
Trial 3 34.19 
Left 
Trial 1 28.81 
5.900 0.052 Trial 2 27.83 
 Trial 3 39.96 
 
 
 
11 
 
 
1 
Right 
Trial 1 61.39 
25.066 < .05 Trial 2 23.43 
Trial 3 54.00 
Left 
Trial 1 8.83 
0.626 0.73 Trial 2 8.00 
Trial 3 10.40 
2 
Right 
Trial 1 52.35 
21.330 < .05 Trial 2 20.00 
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Figure C.1 – Dataset III histograms of the following variables: Class, AIx, SPT, SPA, RPT, RPA, DWT, DWA; 
Appendix C – Dataset III 
 
Dataset III characterization  
(note: all attributes except the class label are normalized between 0 and 1) 
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Figure C.2 – Dataset III histograms of the following variables: R1, R2, R3, R4, FWMH, RMSE, RMSSD_SPT, 
RMSSD_SPA, RMSSD_RPT, RMSSD_RPA; 
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Figure C.3 – Dataset III histograms of the following variables: RMSSD_DWT, RMSSD_DWA; 
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Figure D.1 – Dataset IV histograms of the following variables: Class, AIx, SPT, SPA, RPT, RPA, DWT, DWA; 
Appendix D – Dataset IV 
 
Dataset IV characterization 
(Values expressed as mean ± SD) 
 
 
4471
0.35 ± 15.69
163.44 ± 60.64 0.996 ± 0.008
159.29 ± 43.28 0.87 ± 0.092
281.99 ± 53.06 0.74 ± 0.12
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Figure D.2 – Dataset IV histograms of the following variables: R1, R2, R3, R4, FWMH, RMSE, RMSSD_SPT, 
RMSSD_SPA, RMSSD_RPT, RMSSD_RPA; 
 
 
118.54 ± 60.38 0.75 ± 0.12
0.003 ± 0.154 -0.105 ± 0.875
448.21 ± 0.875 0.053 ± 0.043
24.35 ± 38.85 0.004 ± 0.011
41.60 ± 55.29 0.161 ± 0.287
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Figure D.3 – Dataset IV histograms of the following variables: RMSSD_DWT, RMSSD_DWA, Age, Gender, 
Smoker, Diabetes, Height, Weight, BMI, SBP; 
 
 
35.51 ± 49.03 0.087 ± 0.096
21.42 ± 2.34
1327
3144
4240
231
4471
1.68 ± 0.09 60.46 ± 9.98
21.36 ± 2.49 107.89 ± 11.21
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Figure D.4 – Dataset IV histograms of the following variables: DBP, HR; 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
69.48 ± 7.24 71.00 ± 10.03
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Abstract—This paper envisages showing the potential of 
innovative non-invasive techniques based on affordable and 
easily operated instrumentation as well as user-friendly computer 
aided algorithms in the screening of cardiovascular (CV) 
diseases. These techniques are based on the assumption that 
arterial stiffness is currently an important predicator of the CV 
diseases development and can be assessed by analyzing the 
arterial pressure waveform (APW). A previously developed PZ 
based device for non-invasive APW capture is currently under 
test in clinical environment, using a heterogeneous population 
constituted by healthy and unhealthy subjects. A dedicated 
Matlab analysis tool was designed and developed to extract 
relevant information and further APW analysis. Several 
recordings of the APW in the same day and in consecutive 
months are being performed by trained observers, to evaluate its 
reproducibility. Data mining analysis is subsequently the last task 
where the Weka 3-6-5 package software is used. The usefulness of 
developing data mining algorithms for cardiovascular 
applications can benefit the CV screenings contributing for the 
early identification of arterial stiffness related patterns. 
Index Terms—Cardiovascular diseases, arterial stiffness, 
reproducibility tests, arterial pulse waveform, data mining 
analysis. 
 INTRODUCTION 
Cardiovascular (CV) diseases are the number one cause of 
death globally, representing 30% of all global deaths. Their 
prevalence occur essentially in low and middle income 
countries due to higher exposition to risk factors and less 
prevention efforts than in high-income countries [1]. The 
importance of identifying the most important risk factor 
associated to the CV morbid events and develop efficient 
diagnostic tools to be used in early stages of development is 
evident. 
Arterial stiffness has been associated with CV diseases 
development by several authors. Its occurrence can denote 
alterations in the mechanical properties of the arteries, 
generally related with the decay of elasticity in the arterial wall 
fibers [2, 3]. Much interest has been paid to the arterial 
pressure waveform (APW) analysis over the last years, using 
methods that accurately extract important clinical information 
[4]. Many parameters have already been proposed in the 
literature, such as the Augmentation Index (AIx). This 
parameter is described as the augmentation of systolic pressure 
peak imparted to the APW by the propagating reflected wave 
[4].  
The use of piezoelectric sensors in APW measurements has 
been reported by several authors. In a previously work, a non-
invasive device for APW monitoring was developed and tested 
in laboratory and in vivo data applications [5, 6], with good 
accuracy results in the signal reproduction. 
The recent emergence of computer-aided diagnosis (CAD) 
technologies has claimed for work on innovative algorithms to 
assist health professionals in interpreting and in building new 
insights from cardiac data. CAD algorithms have been already 
proposed in the literature for coronary arterial disease detection 
[7, 8], or electrocardiogram (ECG) abnormalities [9].  The 
determination of the key indicator parameters from the APW 
signals [10] can become an important tool in CV screening 
trials, contributing for the early identification of arterial 
stiffness related patterns. 
GOALS 
This projects aims at the development of efficient 
diagnostic tools based on non-invasive devices that can be 
easily operated in diagnostic trials. In previous tasks, important 
hardware and firmware developments contributed to the 
development of a non-invasive PZ probe. The use of this probe 
can be a convenient and affordable solution to assess the 
hemodynamic condition. 
Currently, we are working on the clinical validation of the 
PZ probe, which includes repeatability and reproducibility tests 
in a controlled medical environment. Likewise, data mining 
techniques are used in the conviction that a full APW analysis 
can contribute to arterial stiffness pattern recognition, which 
could prove as an outstanding achievement in entrusting a 
premature and correct diagnosis of CV diseases.   
TEAM AND INSTITUTIONS 
The Electronics and Instrumentation Group (GEI) is located 
on the Physics Department is strongly involved in the 
development of instrumentation and processing techniques in 
the fields of Biomedical Engineering. In the last years, an 
interdisciplinary expertise in biomedical instrumentation 
required to meeting the challenges outlined above was 
developed. The strength of this project relies on the 
simultaneous integration of instrumentation previously 
developed and innovative algorithms to signal analysis.  
The Coimbra University Hospital and Coimbra’s Hospital 
Center are important partners where clinical tests are being 
performed. 
  
Fig.1 Schematic representation of the main tasks in this project: a) APW capture, b) demographic data registration, c) 
prominent points analysis, d) algorithms development for patterns identification. 
 
IMPLEMENTATION 
The main tasks performed in this project are schematized in 
Figure 1. The non-invasive probe used in clinical validation is 
shown in Figure 1(a) (upper row). A segment data composed 
by 8 pulses is also shown after baseline removal (lower row). 
Each APW is then analyzed and morphological parameters are 
obtained from it. This information is then stored in a database 
alongside with the subject’s demographic data (Figure 1(b) and 
(c)). Finally, previously selected classification algorithms are 
tested and evaluated in order to be used in the model prediction 
development (figure 1 (d)), where the new data from 
undiagnosed subjects are studied. 
A. Subjects and study protocol 
In order to prove the importance of the APW analysis we 
are studying two groups. Group I is used for repeatability and 
reproducibility measurements and Group II for data mining 
analysis. The demographic data of both groups are presented in 
Table I. 
APWs were recorded at the sampling rate of 1kHz using 
the non-invasive PZ probe previously developed [5]. The 
probe, shown on Figure 1c), is placed over the carotid artery, 
and is held by a collar to avoid noise and artifacts that arise 
from the interaction between the probe and the human 
operator’s hand. 
Age, sex, weight, height, smoking habits and diabetes 
history were registered and BMI was later calculated for all 
subjects. Blood pressure (BP) and heart rate (HR) values were 
measured in the left arm with an automated digital 
oscillometric sphygmomanometer (Omron M6 Comfort). The 
study was approved by the Committees of the Coimbra 
University Hospital and Coimbra’s Hospital Center where the 
data acquisition were taken.  
Dataset I 
This group is composed by 8 healthy subjects (5 female 3 
male). All of the subjects were non – smokers, and had no 
documented history of CV disorders or diabetes. All 
measurements were made in a similar time of the day on each 
month, at the same temperature controlled room (22 – 23ºC). 
Subjects remained quiet and seated on a comfortable chair 
during the measurements.  
In two successive months, at least four measurements 
separated by 1 – minute intervals were made for each subject, 
by one observer. As a quality control procedure, the four best 
trials (two per month) were chosen for statistical analysis. 
Then, 20 continuous pulses were randomly chosen from each 
trial summing 80 pulses for each subject. and 740 pulses in the 
whole dataset. 
TABLE I. DEMOGRAPHIC DATA  
Variable 
Dataset I 
Mean ± SD 
Dataset II 
Mean ± SD 
Sub-group I Sub-group II 
Age (years) 
Sex (male/female) 
Smoker (yes/no) 
Weight (kg) 
Height (m) 
23,88 ± 2,85 
3/5 
0/8 
59,13 ± 8,69 
1,66 ± 0,07 
24,16 ± 3,86 
12/13 
3/22 
65,28 ± 10,42 
1,70 ± 0,06 
58,16 ± 11,77 
12/13 
4/21 
75,25 ± 10,42 
1,64 ± 0,08 
BMI (kg/m
2
) 
SBP (mmHg) 
DBP (mmHg) 
HR (beats/min) 
21,23 ± 1,91 
102,63 ± 8,4 
69,13 ± 10,60 
70,63 ± 14,84 
22,48 ± 2,69 
110,20 ± 11,94 
71,00 ± 11,17 
68,44 ± 10,72 
28,18 ± 5,24 
161,05 ± 17,88 
94,90 ± 11,73 
68,73 ± 6,48 
Dataset II 
This group is composed by a heterogeneous population 
(N=50), divided in two sub-groups. Sub-group I is constituted 
by 25 healthy volunteers without documented history of CV 
disorders. Sub-group II is constituted by 25 hypertensive 
subjects. The hypertensive data were acquired during 
hospitalization but prior to taking any medication. 
B. Feature analysis 
A set of morphological features were chosen to be used in 
APW characterization [11]. The list includes time and 
amplitude position of the most important prominent points: 
systolic peak (SP), dicrotic wave (DW) and reflection point 
(RP), represented in Figure 1c).The relevance of SP amplitude 
analysis is negligible due to the previously normalization. 
The time and amplitude analysis is essential in the study of 
the most important predictive patterns that are used in data 
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mining analysis. The elimination of low predictive parameters 
as DW was possible due to the similar values in both groups.  
C. Statistical analysis 
As a “a priori” statistical analysis, all data were tested for 
normality, applying the Kolmogorov – Smirnov one-sample 
test, where the maximum difference between the sample 
cumulative distribution and the hypothesized cumulative 
distribution are compared. All continuous variables in Table II 
presented a non – normal distribution.  
For each parameter, the mean of each trial was computed 
and compared with the following month using the Bland 
Altman method [12] to assess the repeatability and 
reproducibility of the PZ sensor. This method calculates the 
mean difference between measurements (the ‘bias’) and 95% 
limits of agreement as the mean difference (1,96 SD). It is 
expected that the 95% limits include ≈ 95% of the differences.  
All data were analyzed as Mean ± SD with Predictive 
Analytics Software Statistics 18 (SPSS, Inc, Chicago, IL). The 
level of statistical significance was set at p < 0.05 for all 
analyses.  
D. Data mining analysis 
The Weka system was selected as the analysis tool due to 
its efficiency, versatility and affordability. A set of Weka 
classifiers (Random Forest, J48, and JRIP) were chosen and 
applied in our dataset (hypertensive and normal subjects) with 
objective of choose the most accurate. The number of True 
Positives (TP), True Negatives (TN), False Positives (FP), and 
False Negatives (FN) were determined for each classifier. 
ROC (receiver operating characteristic) curves were plotted 
for all classifiers (sensitivity vs. 1-specificity). A large area 
under the ROC curve (AUC=1) reflects superior classifier 
discrimination between the patterns. The accuracy (ACC) of 
the system is determined by equation (1), where C= TP + TN + 
FP + FN. 
    
     
 
 
(1) 
 
Type A Type D 
 
Fig.2 Two waveform types: type A and D, taken from the 
dataset II.  
 
Results from ACC and AUC are used to choose the best 
model predictors. This model is used in the patterns 
identification from undiagnosed subjects.  
RESULTS 
E. In vivo APW 
The in vivo APW analysis includes different APW 
waveform types, according classification purposed by Murgo 
et. al. [13]. The Figure 2 illustrates two waveform types, which 
were taken from our dataset, from a middle age and an old 
subject, respectively 
F. Statistical Analysis 
Descriptive data analysis for both datasets is shown of Table 
II.  Bland – Altman plots were constructed using dataset I 
shown in Figure 3 for time and amplitude measurements, as 
well as AIx.  
Repeatability tests 
Even if only Figure 3(d) includes > 95% of the differences, 
all figures show a reasonable value of agreement of 93.75% for 
Figure (b), (c), (e) and (f) and 87,5% for Figure (a). This 
suggests that even though further tests have to be done to reach 
sufficient agreement, a good repeatability level has already 
been reached. It is worth of notice the gap between values in 
Figure 3(b). This represents the separation between type the 
APWs type A and type C [13]. 
 
Fig.3 Bland Altman plots from reproducibility tests. 
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Features analysis 
Table II shows the time and amplitude related parameters 
obtained for each group and sub-group, the values between 
group I and sub-group I are similar, as expected, due to the 
same healthy subject constitution in both groups. SP occurs 
later in hypertensive subjects (sub-group II) contrasting with 
early occurring of RP in these subjects. DW arrival time is 
similar for both groups, as referred below.  
TABLE II. FEATURE POINT VALUES OBTAINED FOR ALL GROUPS. 
Variable 
Group I 
(Mean ± SD) 
Group II (Mean ± SD) 
Sub-group I Sub-group II 
SP time (ms) 
DN time (ms) 
RP time (ms) 
177,68 ± 62,06 
291,47 ± 39,83 
158,38 ± 36,40 
159,09 ± 57,69 
294,48 ± 33,63 
188,12 ± 39,87 
222,61 ± 53,83 
300,28 ± 50,99 
119,37 ± 39,23 
DN amplitude (ratio) 
RP amplitude (ratio) 
0,75 ± 0,11 
0,87 ± 0,08 
0,70 ± 0,12 
0,86 ± 0,10 
0,84 ± 0,09 
0,74 ± 0,17 
G. Data mining analysis 
The AUC values obtained for each one of the three 
classifiers were: 0.994 for Random Forest, 0.961 for J48 and 
0.965 for JRIP classifier. The results demonstrated the high 
accuracy values obtained for all of the classifiers, in special the 
performance of Random Forest classifier. 
The ACC results, shown in Table II, confirm the superior 
performance of Random Forest classifier. The J48 and JRIP 
have similar performance values. 
TABLE II. ACUURACY RESULTS FOR THE TESTED ALGORITHMS. 
Classifier RANDOM FOREST J48 JRIP 
ACC (%) 96.95 95.90 94.78 
AUC 0.994 0.961 0.965 
CONCLUSIONS 
The nature of arterial wave propagation of incident and 
reflected waves plays a major role in the determination of 
important parameter indicators, which serve as health status 
predictors of the CV system. The APW signal is an interesting 
signal to this purpose and can be easily and affordable obtained 
by the non invasive instrumentation developed in our group. 
The reliability and repeatability tests demonstrated its clinical 
value.  
The use of the data mining tools in the biomedicine should 
bring revolutionary impact to this field. The study of 
biomedical processes is heavily based on the identification of 
understandable patterns which are present in the data. These 
patterns may be used for diagnostic or prognostic purpose. The 
performance values obtained by the model predictors allow 
anticipating the good results in its application. 
 PLANNED DEVELOPMENTS 
Currently, we are running a set of clinical tests to improve 
the number of dataset subjects, to prove that this system is a 
valid and low-cost alternative to the standard devices. 
Parameters from other cardiac setups, as biochemical analysis, 
will be included in attributes list in future trials, to address a 
more accurate diagnosis tool for CV risk assessment.  
Also, the use of neural networks as superior data mining 
algorithms has been reported by some authors, with good 
results so far, and there are plans for implementing different 
types of neural networks as data mining classifiers in this 
project. 
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